Hamazaki K,
Morikawa T,
Nezu M, Oh K, Nishio C,
*Morimoto T. Change in feeding and swallowing function in elderly patients with isolated hospitalization for COVID-19: A retrospective cohort study.
J Gen Intern Med2025 (in press).
*Morimoto T,
Sakakibara F. Endovascular thrombectomy for large ischaemic stroke: outcomes beyond 90 days.
Lancet Neurol2024;23:847-849.
*Morimoto T,
Morikawa T, Imura H,
Nezu M, Hamazaki K,
Sakuma M, Chaumont A, Moitinho de Almeida M, Moreno VP, Ho Y, Harrington L, Matsuki T, Nakamura T. Rationale and protocol for a prospective cohort study of respiratory viral infections in patients admitted from emergency departments of community hospitals: Effect of respiratory Virus infection on EmeRgencY admission (EVERY) study.
BMJ Open2024;14:e081037.
Yamashita Y,
Morimoto T, Muraoka N, Shioyama W, Chatani R, Shibata T, Nishimoto Y, Ogihara Y, Doi K, Oi M, Shiga T, Sueta D, Kim K, Tanabe Y, Koitabashi N, Takada T, Ikeda S, Nakagawa H, Tsukahara K, Shoji M, Sakamoto J, Hisatake S, Ogino Y, Fujita M, Nakanishi N, Dohke T, Hiramori S, Nawada R, Kaneda K, Ono K, Kimura T; ONCO PE trial investigators. Rivaroxaban for 18 months versus 6 months in patients with cancer and acute low-risk pulmonary embolism: An open-label, multicenter, randomized clinical trial (ONCO PE Trial).
Circulation2025;151:589-600.
Taniguchi T,
Morimoto T, Takeji Y, Shirai S, Ando K, Tabata H, Yamamoto K, Murai R, Osakada K, Sakamoto H, Tada T, Murata K, Obayashi Y, Amano M, Kitai T, Izumi C, Toyofuku M, Kanamori N, Miyake M, Nakayama H, Izuhara M, Nagao K, Nakatsuma K, Furukawa Y, Inoko M, Kimura M, Ishii M, Usami S, Nakazeki F, Shirotani M, Inuzuka Y, Ono K, Minatoya K, Kimura T; CURRENT AS registry-2 investigators. Low-gradient severe aortic stenosis: Insights from the CURRENT AS registry-2.
JACC Cardiovasc Interv2025;18:471-487.
Obayashi Y, Natsuaki M, Watanabe H,
Morimoto T, Yamamoto K, Nishikawa R, Kimura T, Ando K, Suwa S, Isawa T, Takenaka H, Ishikawa T, Tokuyama H, Sakamoto H, Fujita T, Nanasato M, Okayama H, Nishikura T, Kirigaya H, Nishida K, Ono K, Kimura T; STOPDAPT-3 investigators. Aspirin versus clopidogrel 1 month after acute coronary syndrome with high-bleeding risk or ST-segment elevation.
JACC Cardiovasc Interv2025 (in press).
Fujiwara S, Uchida K, Ohta T, Ohara N, Kawamoto M, Yamagami H, Toyoda K, Matsumaru Y, Matsumoto Y, Todo K, Hayakawa M, Shindo S, Ota S, Morimoto M, Takeuchi M, Imamura H, Ikeda H, Tanaka K, Ishihara H, Kakita H, Sano T, Araki H, Nomura T, Beppu M,
Sakakibara F, Shirakawa M, Yoshimura S, Sakai N. Hemorrhagic complications following endovascular treatment for atherothrombotic large vessel occlusion.
J Stroke2025;27:149-153.
Takeji Y, Taniguchi T,
Morimoto T, Shirai S, Kitai T, Tabata H, Ohno N, Murai R, Osakada K, Murata K, Nakai M, Tsuneyoshi H, Tada T, Amano M, Watanabe S, Shiomi H, Watanabe H, Yoshikawa Y, Nishikawa R, Obayashi Y, Yamamoto K, Toyofuku M, Tatsushima S, Kanamori N, Miyake M, Nakayama H, Nagao K, Izuhara M, Nakatsuma K, Inoko M, Fujita T, Kimura M, Ishii M, Usami S, Nakazeki F, Togi K, Inuzuka Y, Ando K, Komiya T, Ono K, Minatoya K, Kimura T; CURRENT AS registry-2 investigators. Cardiac damage stages and clinical outcomes in patients with severe aortic stenosis.
JACC Adv2025 (in press).
Horie N, Inoue M,
Morimoto T, Sadakata E, Okamura K, Morofuji Y, Hara T, Kuwabara M, Kondo H, Ishii D. Recanalization does not always equate to reperfusion: No-reflow phenomenon after successful thrombectomy.
Stroke2025;56:183-189.
Sarraj A, Yoshimura S, Thomalla G, Huo X, Arquizan C, Yoo AJ,
Morimoto T, Bendszus M, Lapergue B, Nguyen TN, Campbell B, Costalat V, Fiehler J, Jovin T, Zaidat OO, Miao Z. Mechanical thrombectomy for large ischemic stroke: A critical appraisal of evidence from six randomized controlled trials.
Stroke2025 (in press).
Kambara M,
Takeuchi J, Kumano A, Fujita C, Matsumura M, Suzuki A, Takao D, Iseki T, Kai A, Maekawa S, Shiomi M, Sumi K. Postmenstrual age at extubation as a risk factor associated with respiratory-related reintubation among extremely preterm infants: A retrospective cohort study.
Pediatr Pulmonol2025;60:e27500.
Yamamoto K, Natsuaki M, Watanabe H,
Morimoto T, Obayashi Y, Nishikawa R, Ando K, Suwa S, Isawa T, Takenaka H, Ishikawa T, Ikari Y, Kurita T, Kaitani K, Sugimoto A, Ogata N, Ikuta A, Hashimoto K, Ishibashi Y, Masuda K, Miyabe T, Ono K, Kimura T; STOPDAPT-3 investigators. An aspirin-free strategy for percutaneous coronary intervention in patients with diabetes: A pre-specified subgroup analysis of the STOPDAPT-3 trial.
Eur Heart J Cardiovasc Pharmacother2025;11:34-44.
Ikeda S, Yamashita Y,
Morimoto T, Chatani R, Kaneda K, Nishimoto Y, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Sakamoto J, Ogihara Y, Inoue T, Usami S, Chen PM, Togi K, Koitabashi N, Hiramori S, Doi K, Mabuchi H, Tsuyuki Y, Murata K, Takabayashi K, Nakai H, Sueta D, Shioyama W, Dohke T, Nishikawa R, Ono K, Kimura T. Association between white blood cell counts at diagnosis and the clinical outcomes in venous thromboembolism - from the COMMAND VTE registry-2.
Circ J2025;89:592-601.
Takeji Y, Taniguchi T,
Morimoto T, Shirai S, Kitai T, Tabata H, Ohno N, Murai R, Osakada K, Murata K, Nakai M, Tsuneyoshi H, Tada T, Amano M, Watanabe S, Shiomi H, Watanabe H, Yoshikawa Y, Nishikawa R, Obayashi Y, Yamamoto K, Toyofuku M, Tatsushima S, Kanamori N, Miyake M, Nakayama H, Nagao K, Izuhara M, Nakatsuma K, Inoko M, Fujita T, Kimura M, Ishii M, Usami S, Nakazeki F, Togi K, Inuzuka Y, Ando K, Komiya T, Ono K, Minatoya K, Kimura T; CURRENT AS registry-2 investigators. Availability of transcatheter aortic valve implantation across hospitals and differences in strategies and clinical outcomes in patients with severe aortic stenosis.
Cardiovasc Interv Ther2025;40:152-163.
Hanazawa K, Shiomi H,
Morimoto T, Ando K, Furukawa Y, Tada T, Tazaki J, Kadota K, Tamura T, Sato Y, Matsuda M, Inoko M, Shirotani M, Onodera T, Shioda E, Yamamoto T, Tamura T, Miki S, Aoyama T, Suwa S, Minatoya K, Soga Y, Koyama T, Komiya T, Ohno N, Ogawa T, Yamazaki F, Nishizawa J, Esaki J, Kanemitsu N, Nakagawa Y, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 and -3 investigators. Suspected fatal arrhythmic events in Japanese patients with coronary artery disease: From the CREDO-Kyoto PCI/CABG Registries Cohort-2 and -3.
Circ J2025;89:364-372.
Shigeno R, Kim K, Yamashita Y,
Morimoto T, Chatani R, Kaneda K, Nishimoto Y, Ikeda N, Kobayashi Y, Ikeda S, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Sakamoto J, Ogihara Y, Inoue T, Usami S, Chen PM, Togi K, Koitabashi N, Hiramori S, Doi K, Mabuchi H, Tsuyuki Y, Murata K, Takabayashi K, Nakai H, Sueta D, Shioyama W, Dohke T, Nishikawa R, Furukawa Y, Kimura T; COMMAND VTE Registry-2 investigators. Initial anticoagulation therapy with single direct oral anticoagulant in patients with intermediate-high risk acute pulmonary embolism: From the COMMAND VTE registry-2.
Int J Cardiol2025;419:132680.
Domei T, Yamamoto K, Natsuaki M, Watanabe H,
Morimoto T, Obayashi Y, Nishikawa R, Kimura T, Ando K, Suwa S, Isawa T, Takenaka H, Ishikawa T, Tamura T, Kawahatsu K, Hayashi F, Abe M, Serikawa T, Mori H, Kawamura T, Hagikura A, Shibata N, Ono K, Kimura T; STOPDAPT-3 investigators. Aspirin versus clopidogrel monotherapy beyond 1 month after complex percutaneous coronary intervention: A pre-specified subgroup analysis of the STOPDAPT-3 trial
Eur Heart J Cardiovasc Pharmacother2025 (in press).
Gohbara M, Hibi K,
Morimoto T, Kirigaya H, Yamamoto K, Ono K, Shiomi H, Ohya M, Yamaji K, Watanabe H, Amano T, Morino Y, Takagi K, Honye J, Matsuo H, Abe M, Kadota K, Ando K, Nakao K, Sonoda S, Suwa S, Kawai K, Kozuma K, Nakagawa Y, Ikari Y, Nanasato M, Hanaoka K, Tanabe K, Hata Y, Akasaka T, Kimura T; OPTIVUS-complex PCI investigators. Complex PCI and one-year outcomes in the OPTIVUS-Complex PCI study multivessel cohort.
Cardiovasc Interv Ther2025 (in press).
Funatsu T, Imamura H, Ohara N,
Fujiwara S, Uchida K,
Morimoto T, Yamagami H, Sakai N, Yoshimura S. Outcomes of Patients with Acute Ischemic Stroke Associated with Large Vessel occlusion admitted during regular and off-hours: A sub-analysis of the RESCUE-Japan registry 2.
J Neurointerv Surg2025 (in press).
Kuno T, Koitabashi N, Yamashita Y,
Morimoto T, Ohyama Y, Takama N, Obokata M, Chatani R, Kaneda K, Nishimoto Y, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Sakamoto J, Ogihara Y, Inoue T, Usami S, Chen PM, Togi K, Hiramori S, Doi K, Mabuchi H, Tsuyuki Y, Murata K, Takabayashi K, Nakai H, Sueta D, Shioyama W, Dohke T, Nishikawa R, Ishii H, Kimura T; COMMAND VTE registry-2 investigators.. Management strategies and clinical outcomes of venous thromboembolism in patients with antiphospholipid syndrome in the direct oral anticoagulant era: Insight from the COMMAND VTE Registry-2.
Thromb Res2025:249:109311.
Kanamori N, Takeji Y, Taniguchi T,
Morimoto T, Shirai S, Ando K, Tabata H, Kitai T, Ohno N, Murai R, Osakada K, Murata K, Nakai M, Tsuneyoshi H, Tada T, Amano M, Watanabe S, Shiomi H, Watanabe H, Yoshikawa Y, Nishikawa R, Obayashi Y, Yamamoto K, Toyofuku M, Tatsushima S, Miyake M, Nakayama H, Nagao K, Izuhara M, Nakatsuma K, Inoko M, Fujita T, Kimura M, Ishii M, Usami S, Nakazeki F, Togi K, Inuzuka Y, Komiya T, Ono K, Aoyama T, Minatoya K, Kimura T; CURRENT AS registry-2 investigators. Prognostic value of the six-minute walk test in patients with severe aortic stenosis.
Circ J2025 (in press).
Takahashi M,
Morimoto T, Tsushima R, Sudo Y, Sakamoto A, Sogo M, Ozaki M, Okawa K. Impact of factor Xa inhibitors on cardiovascular events in older patients with nonvalvular atrial fibrillation.
Aging2025 (in press).
Ogihara Y, Yamashita Y,
Morimoto T, Muraoka N, Umetsu M, Nishimoto Y, Takada T, Nishikawa T, Ikeda N, Otsui K, Sueta D, Tsubata Y, Shoji M, Shikama A, Hosoi Y, Tanabe Y, Chatani R, Tsukahara K, Nakanishi N, Kim K, Ikeda S, Sato T, Kimura T, Dohi K; ONCO DVT study investigators. Clinical outcomes of cancer-associated isolated distal deep vein thrombosis: A comparison between asymptomatic and symptomatic thrombosis - Findings from the ONCO DVT study.
Res Pract Thromb Haemost2025 (in press).
Ogita C, Noguchi K,
Takeuchi J, Azuma N, Omura S, Nakagomi D, Abe Y, Kadoya M, Takizawa N, Nomura A, Kukida Y, Kondo N, Yamano Y, Yanagida Y, Endo K, Hirata S, Takeuchi T, Ichinose K, Kato M, Yanai R, Matsuo Y, Shimojima Y, Nishioka R, Okazaki R, Takata T, Ito T, Moriyama M, Takatani A, Miyawaki Y, Kawahito Y, Ito-Ihara T, Kida T, Yajima N, Kawaguchi T, Matsui K. Effectiveness for remission maintenance rate and safety of different rituximab regimens for treating anti-neutrophil cytoplasmic antibody-associated vasculitis in Japan: A J-CANVAS study.
Immunol Med 2025:1-8.
Nomura S, Toyofuku M, Tazaki J, Tatsushima S, Fujita T, Tsuji S, Iseda T, Kimura T, Shibamori Y, Matsui Y, Ueda K, Ichiyanagi T, Yoshida A, Sakamoto R, Kai R,
Morimoto T, Kimura T. Validation for the diagnostic use of the HEART score in patients with acute chest pain in Japan.
Circ Rep2025 (in press).
Yamamoto K, Shiomi H, Nishikawa R,
Morimoto T, Miyazawa A, Naganuma T, Suwa S, Fujita T, Domei T, Tatsushima S, Takasaki A, Kikuchi A, Okamura A, Suematsu N, Isawa T, Honda S, Kawase Y, Kadota K, Ando K, Hibi K, Ono K, Kimura T; OPTIVUS-complex PCI investigators. Optimal intravascular ultrasound-guided percutaneous coronary intervention in patients with multivessel disease and left ventricular dysfunction.
Circ Rep2025 (in press).
Nishikawa T, Yamashita Y, Fujita M,
Morimoto T, Muraoka N, Umetsu M, Nishimoto Y, Takada T, Ogihara Y, Ikeda N, Otsui K, Sueta D, Tsubata Y, Shoji M, Shikama A, Hosoi Y, Tanabe Y, Chatani R, Tsukahara K, Nakanishi N, Kim K, Ikeda S, Yasui T, Yamamoto H, Ono K, Kimura T; ONCO DVT study investigators. D-dimer after 3 months of anticoagulation therapy and outcomes in cancer-associated isolated distal deep vein thrombosis.
Blood Vessel Thromb Hemost2025 (in press).
Yamamoto K, Natsuaki M, Watanabe H,
Morimoto T, Obayashi Y, Nishikawa R, Kimura T, Ando K, Suwa S, Isawa T, Takenaka H, Ishikawa T, Yokomatsu T, Chinen T, Doijiri T, Kozuma K, Nishida Y, Yamaguchi K, Kitahara H, Ishino M, Ono K, Kimura T; STOPDAPT-3 investigators. An aspirin-free strategy in patients undergoing staged percutaneous coronary intervention: A subgroup analysis of the STOPDAPT-3 trial.
Circ Rep2025 (in press).
Shimizu F, Uchida K,
Takeuchi J, Kakita H, Sawamura S, Kanbara A, Kitada Y, Akiyama Y, Yoshida T, Asada K,
Fujiwara S, Imamura H, Sakai C, Shirakawa M, Yoshimura S, Sakai N, Kasahara M, the JR-NET4 Study Group. Outcome after endovascular treatment of ruptured cerebral aneurysm patients over 90 years of age.
Neurol Med Chir (Tokyo)2025 (in press).
Yamamoto K, Shiomi H, Nishikawa R,
Morimoto T, Miyazawa A, Naganuma T, Suwa S, Fujita T, Domei T, Tatsushima S, Hamaguchi Y, Nishimoto Y, Matsuda K, Takayama Y, Kuribata J, Kirigaya H, Yoneda K, Shigetoshi M, Yokomatsu T, Kadota K, Ando K, Hibi K, Ono K, Kimura T; OPTIVUS-complex PCI investigators. Optimal intravascular ultrasound-guided percutaneous coronary intervention in patients with multivessel disease and chronic kidney disease.
Am J Cardiol2025;239:20-27.
Liu Q, Mo S, Wu J, Tong X, Wang K, Chen X, Chen S, Guo S, Li X, Li M, Peng L, Sun X, Wang Y, Sun J, Pu J, Zheng K, Zhang J, Liu Y, Yang Y, Wen Z, Nie X, Feng Y, Lan C, Tang H, Wang N, Li J, Miao Z, Lu X, Ning B, Zhao B, Kang D, Chen X, Zhang Y, Zhang Y, Wang A, Zhu C, Araki Y, Uda K, Yoshimura S, Uchida K,
Morimoto T, Yoshioka H, Hasan D, Du R, Levitt MR, Cao Y, Wang S, Zhao J; E-start collaborators. Safety and efficacy of early versus delayed acetylsalicylic acid after surgery for spontaneous intracerebral haemorrhage in China (E-start): a prospective, multicentre, open-label, blinded-endpoint, randomised trial.
Lancet Neurol2024;23:1195-1204.
Natsuaki M, Watanabe H,
Morimoto T, Yamamoto K, Obayashi Y, Nishikawa R, Ando K, Domei T, Suwa S, Ogita M, Isawa T, Takenaka H, Yamamoto T, Ishikawa T, Hisauchi I, Wakabayashi K, Onishi Y, Hibi K, Kawai K, Yoshida R, Suzuki H, Nakazawa G, Kusuyama T, Morishima I, Ono K, Kimura T. An aspirin-free versus dual antiplatelet strategy for coronary stenting: STOPDAPT-3 randomized trial.
Circulation2024;149:585-600.
Chatani R, Yamashita Y,
Morimoto T, Mushiake K, Kadota K, Kaneda K, Nishimoto Y, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Kimura T; COMMAND VTE registry-2 investigators. Transition of management strategies and long-term outcomes in cancer-associated venous thromboembolism from the warfarin era to the direct oral anticoagulant era.
Eur J Intern Med2024;123:72-80.
Watanabe H,
Morimoto T, Natsuaki M, Yamamoto K, Obayashi Y, Nishikawa R, Ando K, Ono K, Kadota K, Suwa S, Morishima I, Yoshida R, Hata Y, Akao M, Yagi M, Suematsu N, Morino Y, Yokomatsu T, Takamisawa I, Noda T, Doi M, Okayama H, Nakamura Y, Hibi K, Sakamoto H, Noguchi T, Kimura T; STOPDAPT-2 investigators. Clopidogrel vs aspirin monotherapy beyond 1 year after percutaneous coronary intervention.
J Am Coll Cardiol2024;83:17-31.
Watanabe H, Natsuaki M,
Morimoto T, Yamamoto K, Obayashi Y, Nishikawa R, Kimura T, Ando K, Domei T, Suwa S, Ogita M, Isawa T, Takenaka H, Yamamoto T, Ishikawa T, Hisauchi I, Wakabayashi K, Onishi Y, Hibi K, Kawai K, Yoshida R, Suzuki H, Nakazawa G, Kusuyama T, Morishima I, Ono K, Kimura T; STOPDAPT-3 investigators. Aspirin vs. clopidogrel monotherapy after percutaneous coronary intervention: 1-year follow-up of the STOPDAPT-3 trial.
Eur Heart J2024;45:5042-5054.
Rinkel LA, Ospel JM,
Uchida K, Diprose WK, Goyal M. Intravenous thrombolysis prior to endovascular treatment for large ischemic cores: Need for qualitative assessment of the ischemic core.
Radiology2024;310:e232827.
Inoue M, Yoshimoto T, Yamagami H, Toyoda K, Sakai N, Matsumaru Y, Matsumoto Y, Kimura K, Ishikura R, Uchida K, Beppu M,
Sakakibara F,
Morimoto T, Yoshimura S; RESCUE-Japan LIMIT investigators. Expanding the treatable imaging profile in large ischemic stroke patients: sub analysis from a randomized clinical trial.
Stroke2024;55:1730-1738.
Abdalkader M, Ning S, Qureshi MM, Haussen DC, Strbian D, Nagel S, Demeestere J, Puetz V, Mohammaden MH, Olive Gadea M, Winzer S, Yamagami H, Tanaka K, Marto JP, Tomppo L, Henon H, Sheth SA, Ortega-Gutierrez S, Martinez-Majander N, Caparros F, Lemmens R, Dusart A, Bellante F, Zaidi SF, Siegler JE, Nannoni S, Kaesmacher J, Dobrocky T, Farooqui M, Salazar-Marioni S, Virtanen P, Vandewalle L, Wouters A, Jesser J, Ventura R, Castonguay AC,
Uchida K, Puri AS, Masoud HE, Klein P, Mansoor Z, Bui J, Kang M, Mujanovic A, Rizzo F, Kokkonen T, Ramos JN, Strambo D, Michel P, Möhlenbruch MA, Lin E, Kaiser DPO, Yoshimura S, Sakai N, Cordonnier C, Ringleb PA, Roy D, Zaidat OO, Fischer U, Ribo M, Raymond J, Nogueira RG, Nguyen TN. Sex differences in outcomes of late-window endovascular stroke therapy.
Stroke2024;55:278-287.
Uchida K,
Sakakibara F, Sakai N, Iihara K, Imamura H, Ishii A, Matsumaru Y, Sakai C, Satow T, Yamada K, Shirakawa M, Yoshimura S; JR-NET4 Study Group. Real-world outcomes of carotid artery stenting in symptomatic and asymptomatic patients with carotid artery stenosis.
JACC Cardiovasc Interv2024;17:1148-1159.
*Uchida K, Sowlat MM, Matsukawa H, Elawady SS, Alawieh A, Cunningham C, Al Kasab S, Maier I, Jabbour P, Kim JT, Wolfe SQ, Rai A, Starke RM, Psychogios MN, Shaban A, Arthur A, Cuellar H, Grossberg JA, Romano DG, Tanweer O, Mascitelli J, Fragata I, Polifka A, Osbun J, Crosa R, Matouk C, Park MS, Levitt MR, Brinjikji W, Moss M, Williamson R, Navia P, Kan P, De Leacy R, Chowdhry SA, Ezzeldin M, Shinichi Yoshimura, Alejandro M. Spiotta and for the Stroke Thrombectomy and Aneurysm Registry (STAR) Collaborators. Impact of successful recanalization and clinical outcomes of patients with acute ischemic stroke with 5 or more thrombectomy passes.
Stroke Vasc Interv Neurol2024;4:e00110.
Uchida K, Yamagami H, Sakai N, Shirakawa M, Beppu M, Toyoda K, Matsumaru Y, Matsumoto Y, Todo K, Hayakawa M, Shindo S, Ota S, Morimoto M, Takeuchi M, Imamura H, Ikeda H, Tanaka K, Ishihara H, Kakita H, Sano T, Araki H, Nomura T,
Sakakibara F, Yoshimura S. Endovascular therapy for acute intracranial large vessel occlusion due to atherothrombosis: Multicenter historical registry.
J Neurointerv Surg2024;16:884-891.
Yamamoto K, Natsuaki M, Watanabe H,
Morimoto T, Obayashi Y, Nishikawa R, Ando K, Suwa S, Isawa T, Takenaka H, Ishikawa T, Tamura T, Kawahatsu K, Hayashi F, Akao M, Serikawa T, Mori H, Kawamura T, Hagikura A, Shibata N, Ono K, Kimura T; STOPDAPT-3 investigators. An aspirin-free strategy for immediate treatment following complex percutaneous coronary intervention.
JACC Cardiovasc Interv2024;17:1119-1130.
Kuwahara S,
Uchida K, Sakai N, Yamagami H, Imamura H, Takeuchi M, Shirakawa M,
Sakakibara F, Haraguchi K, Kimura N, Suzuki K, Yoshimura S. Impact of atherosclerotic etiology on technical and clinical outcomes of mechanical thrombectomy with a stent retriever: subanalysis of the Japan Trevo Registry.
J Neurointerv Surg2024;17:e96-e101.
Ito S, Inoko M, Yamashita Y,
Morimoto T, Kimura T; COMMAND VTE registry-2 investigators. Thrombocytopenia and bleeding events in patients with venous thromboembolism.
Eur J Intern Med2024;122:132-134.
Sudo Y,
Morimoto T, Tsushima R, Oka A, Sogo M, Ozaki M, Takahashi M, Okawa K. Eicosapentaenoic acid and the outcomes in older patients undergoing atrial fibrillation ablation.
J Am Heart Assoc2024;13:e033969.
Obayashi Y, Natsuaki M, Watanabe H,
Morimoto T, Yamamoto K, Nishikawa R, Ando K, Suwa S, Isawa T, Takenaka H, Ishikawa T, Tokuyama H, Sakamoto H, Fujita T, Nanasato M, Okayama H, Nishikura T, Kirigaya H, Nishida K, Ono K, Kimura T; STOPDAPT-3 investigators. Aspirin-free strategy for percutaneous coronary intervention in acute coronary syndrome based on the subtypes of acute coronary syndrome and high bleeding risk: The STOPDAPT-3 trial.
Eur Heart J Cardiovasc Pharmacother2024;10:374-390.
*Uchida K, Matsukawa H, Sowlat MM, Elawady SS, Alawieh A, Jabbour P, Mascitelli J, Levitt MR, Cuellar H, Samaniego EA, Kan P, Moss M, Spiotta AM, Yoshimura S. Gender differences in procedural clinical complications and outcomes of intracranial aneurysms: Analysis of the stroke thrombectomy and aneurysm registry.
Neurosurgery2024;94:545-551.
Arai H, Nozoe M, Kamiya K, Matsumoto S,
Morimoto T. Anemia and rehabilitation outcomes in patients undergoing convalescent rehabilitation.
Arch Phys Med Rehabil2024;105:539-545.
Masutani N, Ogawa H, Soejima H, Okada S, Masuda I, Waki M, Jinnouchi H, Saito Y,
*Morimoto T. Long-term effects of low-dose aspirin on gastrointestinal symptoms and bleeding complications in patients with type 2 diabetes.
Am J Cardiovasc Drugs2024;25:95-112.
Nishimoto Y, Yamashita Y,
Morimoto T, Muraoka N, Umetsu M, Takada T, Ogihara Y, Nishikawa T, Ikeda N, Sato Y, Yamada T, Kimura T; ONCO DVT study investigators. Net clinical benefit of 12-month over 3-month edoxaban in cancer-associated isolated distal deep vein thrombosis.
JACC CardioOncol 2024;6:979-981.
Scarcia L, Clarençon F, Dmytriw AA, Shotar E, Premat K, Jabbour P, Tjoumakaris SI, Gooch RM, Psychogios MN, Ntoulias N, Sporns P, Puri AS, Singh J, Kuhn AL, Hassan AE, Algin O, Möhlenbruch MA, Hohenstatt S, Russo R, Bergui M, Goren O, Kole MJ, Bankole ND, Bibi R, Boulouis G,
Morimoto T, Sakakibara F, Pop R, Juravle C, Ho JWK, Ferrario A, Lereis VP, Cooper J, Gandhi CD, Salsano G, Castellan L, Camilli A, Consoli A, Sgreccia A, Raz E, Chung C, Burel J, Papagiannaki C, Rasheed U, Hassan KMB, Tao H, Ji Z, Rautio R, Sinisalo M, Ruggiero M, Lafe E, Ros VD, Bellini L, Gabrieli JD, Cester G, Levitt MR, Carroll K, Abecassis Z, Caragliano AA, Vinci SL, Bellanger G, Cognard C, Marnat G, Saleille L, Limbucci N, Capasso F, Piano M, Rollo C, Guedon A, Arpaia F, Romi A, Caterino FD, Biondi A, Kalsoum E, Mykola V, Guenego A, Patel AB, Pereira VM, Pedicelli A, Alexandre AM, on behalf of the CRETA investigators. Flow-diverting stents for the treatment of unruptured distal anterior cerebral artery aneurysms: analysis of the CRETA registry.
J Neurointerv Surg2024 (in press).
Nishimoto Y, Yamashita Y,
Morimoto T, Chatani R, Kaneda K, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Sato Y, Watanabe T, Yamada T, Fukunami M, Kimura T; COMMAND VTE registry-2 investigators. Direct oral anticoagulant-associated bleeding complications in patients with gastrointestinal cancer and venous thromboembolism.
Eur J Intern Med2024;127:74-83.
Nishikawa R, Yamashita Y,
Morimoto T, Kaneda K, Chatani R, Nishimoto Y, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Sakamoto J, Ogihara Y, Inoue T, Usami S, Chen PM, Togi K, Koitabashi N, Hiramori S, Doi K, Mabuchi H, Tsuyuki Y, Murata K, Takabayashi K, Nakai H, Sueta D, Shioyama W, Dohke T, Ono K, Kimura T; COMMAND VTE registry-2 investigators. Selection of home treatment and identification of low-risk patients with pulmonary embolism based on simplified PESI score in the era of direct oral anticoagulants.
J Am Heart Assoc 2024;13:e034953.
Ikeda N, Yamashita Y,
Morimoto T, Chatani R, Kaneda K, Nishimoto Y, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Sakamoto J, Ogihara Y, Inoue T, Usami S, Chen PM, Togi K, Koitabashi N, Hiramori S, Doi K, Mabuchi H, Tsuyuki Y, Murata K, Takabayashi K, Nakai H, Sueta D, Shioyama W, Dohke T, Kimura T; COMMAND VTE Registry-2 investigators. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism in the era of direct oral anticoagulants: From the COMMAND VTE registry-2.
J Am Heart Assoc 2024;13:e035997.
Natsuaki M, Watanabe H,
Morimoto T, Yamamoto K, Obayashi Y, Nishikawa R, Ando K, Suwa S, Isawa T, Takenaka H, Ishikawa T, Yamada M, Wakatsuki T, Nozaki Y, Kitahara H, Kato R, Kawai R, Kobayashi Y, Ishii M, Goto Y, Ono K, Kimura T. Aspirin-free strategy for percutaneous coronary intervention in patients with oral anticoagulation: Prespecified subgroup analysis from the STOPDAPT-3 trial.
J Am Heart Assoc2024;13:e034201.
Kaneda K, Yamashita Y,
Morimoto T, Chatani R, Nishimoto Y, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Sakamoto J, Ogihara Y, Inoue T, Usami S, Chen PM, Togi K, Koitabashi N, Hiramori S, Doi K, Mabuchi H, Tsuyuki Y, Murata K, Takabayashi K, Nakai H, Sueta D, Shioyama W, Dohke T, Nishikawa R, Ono K, Kimura T. Temporal Changes in long-term outcomes of venous thromboembolism from the warfarin era to the direct oral anticoagulant era.
J Am Heart Assoc 2024;13:e034412.
Tanaka K, Yoshimoto T, Koge J, Yamagami H, Imamura H, Sakai N, Uchida K, Beppu M, Matsumaru Y, Matsumoto Y, Kimura K, Ishikura R, Inoue M, Sakakibara F,
Morimoto T, Yoshimura S, Toyoda K; RESCUE‐Japan LIMIT investigators. Detrimental effect of acute hyperglycemia on the outcomes of large ischemic region stroke.
J Am Heart Assoc 2024;13:e034556.
Yamamoto K, Ueda H, Uchiyama D, Takeji Y, Taniguchi T,
Morimoto T, Tabata H, Ishizu K, Morofuji T, Hayashi M, Isotani A, Shirai S, Ohno N, Kakumoto S, Ando K, Minatoya K, Kimura T. Cerebrovascular disease detected on preprocedural computed tomography in patients with severe aortic stenosis undergoing aortic valve replacement.
J Am Heart Assoc2024;13:e035078.
Nishimoto Y, Yamashita Y,
Morimoto T, Chatani R, Kaneda K, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Sakamoto J, Ogihara Y, Inoue T, Usami S, Chen PM, Togi K, Koitabashi N, Hiramori S, Doi K, Mabuchi H, Tsuyuki Y, Murata K, Takabayashi K, Nakai H, Sueta D, Shioyama W, Dohke T, Nishikawa R, Sato Y, Watanabe T, Yamada T; Fukunami M, Kimura T; COMMAND VTE registry-2 investigators. External validation of the PE-SARD bleeding score for early major bleeding in patients with acute pulmonary embolism: From the COMMAND VTE Registry-2.
J Thromb Haemost2024;22:2784-2796.
Xiong W, Yamashita Y,
Morimoto T, Muraoka N, Umetsu M, Nishimoto Y, Takada T, Ogihara Y, Nishikawa T, Ikeda N, Otsui K, Sueta D, Tsubata Y, Shoji M, Shikama A, Hosoi Y, Tanabe Y, Chatani R, Tsukahara K, Nakanishi N, Kim K, Ikeda S, Ono K, Kimura T; ONCO DVT study investigators. Utility of the modified Ottawa score for identification of more preferable candidates of extended anticoagulation therapy in cancer-associated isolated distal deep vein thrombosis: insight from the ONCO DVT Study.
J Thromb Haemost2024;22:3542-3551.
Chatani R, Yamashita Y,
Morimoto T, Muraoka N, Umetsu M, Nishimoto Y, Takada T, Ogihara Y, Nishikawa T, Ikeda N, Otsui K, Sueta D, Tsubata Y, Shoji M, Shikama A, Hosoi Y, Tanabe Y, Tsukahara K, Nakanishi N, Kim K, Ikeda S, Mushiake K, Kadota K, Ono K, Kimura T. Edoxaban for 12 vs. 3 months in cancer-associated isolated distal deep vein thrombosis according to different doses: insights from the ONCO DVT study.
Eur Heart J Cardiovasc Pharmacother2024;10:422-431.
Sueta D, Yamashita Y,
Morimoto T, Chatani R, Nishimoto Y, Kaneda K, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takeda T, Otsui K, Sakamoto J, Ogihara Y, Inoue T, Usami S, Chen PM, Togi K, Koitabashi N, Hiramori S, Doi K, Mabuchi H, Tsuyuki Y, Murata K, Takabayashi K, Nakai H, Shioyama W, Dohke T, Nishikawa R, Kimura T, Tsujita K; COMMAND VTE registry-2 investigators. Edoxaban, rivaroxaban or apixaban for cancer-associated venous thromboembolism in the real world: Insights from the COMMAND VTE Registry-2.
Thromb Haemost2024;124:1013-1023.
Takabayashi K, Yamashita Y,
Morimoto T, Chatani R, Kaneda K, Nishimoto Y, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Sakamoto J, Ogihara Y, Inoue T, Usami S, Chen PM, Togi K, Koitabashi N, Hiramori S, Doi K, Mabuchi H, Tsuyuki Y, Murata K, Nakai H, Sueta D, Shioyama W, Dohke T, Nishikawa R, Ono K, Kimura T; COMMAND VTE registry-2 investigators. Clinical characteristics and short-term outcomes of patients with critical acute pulmonary embolism requiring extracorporeal membrane oxygenation: From the COMMAND VTE Registry-2.
J Intensive Care2024;12:45.
Ikeda S, Yamashita Y,
Morimoto T, Chatani R, Kaneda K, Nishimoto Y, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Sakamoto J, Ogihara Y, Inoue T, Usami S, Chen PM, Togi K, Koitabashi N, Hiramori S, Doi K, Mabuchi H, Tsuyuki Y, Murata K, Takabayashi K, Nakai H, Sueta D, Shioyama W, Dohke T, Nishikawa R, Ono K, Kimura T. Subclass phenotypes in patients with unprovoked venous thromboembolisms using a latent class analysis.
Thromb Res2024;238:27-36.
Sueta D, Yamashita Y,
Morimoto T, Muraoka N, Umetsu M, Nishimoto Y, Takada T, Ogihara Y, Nishikawa T, Ikeda N, Otsui K, Tsubata Y, Shoji M, Shikama A, Hosoi Y, Tanabe Y, Chatani R, Tsukahara K, Nakanishi N, Kim K, Ikeda S, Mo M, Kimura T, Tsujita K; ONCO-DVT study investigators. The impact of renal function on clinical outcomes of patients with cancer-associated isolated distal deep vein thrombosis: Insights from the ONCO DVT study.
Thromb Res2024;235:107-115.
Chatani R, Yamashita Y,
Morimoto T, Mushiake K, Kadota K, Kaneda K, Nishimoto Y, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Sakamoto J, Ogihara Y, Inoue T, Usami S, Chen PM, Togi K, Koitabashi N, Hiramori S, Doi K, Mabuchi H, Tsuyuki Y, Murata K, Takabayashi K, Nakai H, Sueta D, Shioyama W, Dohke T, Nishikawa R, Kimura T; COMMAND VTE registry-2 investigators. Cancer-associated venous thromboembolism in the direct oral anticoagulants era: Insight from the COMMAND VTE Registry-2.
Thromb Res2024;234:86-93.
Ogihara Y, Yamashita Y,
Morimoto T, Chatani R, Kaneda K, Nishimoto Y, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Sakamoto J, Inoue T, Usami S, Chen PM, Togi K, Koitabashi N, Hiramori S, Doi K, Mabuchi H, Tsuyuki Y, Murata K, Takabayashi K, Nakai H, Sueta D, Shioyama W, Dohke T, Sato T, Nishikawa R, Kimura T, Dohi K; COMMAND VTE Registry-2 Investigators. Fragility and long-term clinical outcomes in patients with venous thromboembolism receiving direct oral anticoagulants: From the COMMAND VTE registry-2.
Thromb Res2024;236:191-200.
Fujiwara S, Uchida K,
Sakakibara F, Sakai N, Imamura H, Ohta T, Kawamoto M, Ohara N, Tanaka K, Yamagami H, Matsumoto Y, Takeuchi M, Yoshimura S,
*Morimoto T. Characteristics and prognostic impact of unsuccessful recanalization after endovascular therapy for acute ischemic stroke.
J Neurol Sci2024;466:123247.
Kuwahara S, Uchida K, Sakai N, Yamagami H, Imamura H, Takeuchi M, Shirakawa M,
Sakakibara F, Haraguchi K, Kimura N, Suzuki K, Yoshimura S; Japan Trevo Registry Investigators. Technical and clinical outcomes of thrombectomy in patients with acute medium vessel occlusion and large vessel occlusion; sub-analyses of Japan Trevo registry.
J Neurol Sci2024;459:122956.
Uchida K, Yamagami H, Sakai N, Iihara K, Imamura H, Ishii A, Matsumaru Y, Sakai C, Satow T,
Sakakibara F, Shirakawa M, Yoshimura S; JR-NET4 Study Group. Early neurological changes following endovascular therapy for acute stroke due to intracranial atherosclerotic disease.
J Neurol Sci2024;460:122978.
Uchida K, Shirakawa M,
Sakakibara F, Sakai N, Iihara K, Imamura H, Ishii A, Matsumaru Y, Sakai C, Satow T, Yoshimura S; JR-NET4 Study Group. Sex differences in outcomes of carotid artery stenting.
J Neurol Sci2024;461:123062.
Beppu M, Uchida K, Sakai N, Yamagami H, Toyoda K, Matsumaru Y, Matsumoto Y, Todo K, Hayakawa M, Shindo S, Ota S, Morimoto M, Takeuchi M, Imamura H, Ikeda H, Tanaka K, Ishihara H, Kakita H, Sano T, Araki H, Nomura T,
Sakakibara F, Shirakawa M, Yoshimura S; RESCUE AT-LVO Investigators. Optimal endovascular therapy technique for isolated intracranial atherothrombotic stroke-related large-vessel occlusion in the acute-to-subacute stage.
AJNR Am J Neuroradiol2024;45:1692-1700.
Yamashita Y,
Morimoto T, Chatani R, Nishimoto Y, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Sakamoto J, Ogihara Y, Inoue T, Usami S, Chen PM, Togi K, Koitabashi N, Hiramori S, Doi K, Mabuchi H, Tsuyuki Y, Murata K, Takabayashi K, Nakai H, Sueta D, Shioyama W, Dohke T, Nishikawa R, Kaneda K, Ono K, Kimura T. Newly diagnosed cancer after diagnosis of venous thromboembolism: Insight from the COMMAND VTE registry-2.
Circ J2024;24:0786.
Fujiki S, Yamashita Y,
Morimoto T, Muraoka N, Umetsu M, Nishimoto Y, Takada T, Ogihara Y, Nishikawa T, Ikeda N, Otsui K, Sueta D, Tsubata Y, Shoji M, Shikama A, Hosoi Y, Tanabe Y, Chatani R, Tsukahara K, Nakanishi N, Kim K, Ikeda S, Kimura T, Inomata T; ONCO-DVT study investigators. The impact of anemia on clinical outcomes of patients with cancer-associated isolated distal deep vein thrombosis received edoxaban: Insights from the ONCO DVT study.
Circ J2024;24:0571.
Oka A, Sudo Y,
Morimoto T, Tsushima R, Sogo M, Ozaki M, Takahashi M, Okawa K. Pre-procedural stratification by the endothelial function in patients with heart failure undergoing atrial fibrillation ablation.
Hellenic J Cardiol2024 (in press).
Miyagami T, Nishizaki Y, Imada R, Yamaguchi K, Nojima M, Kataoka K, Sakairi M, Aoki N, Furusaka T, Kushiro S, Yang K,
Morikawa T, Tohara H, Naito T. Dental care to reduce aspiration pneumonia recurrence: A prospective cohort study.
Int Dent J2024;74(4):816-822.
Nagao K, Kato T, Yaku H,
Morimoto T, Aida K, Kawakami Maruichi S, Inuzuka Y, Tamaki Y, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Su K, Kawato M, Seko Y, Inada T, Inoko M, Toyofuku M, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Sato Y, Kuwahara K, Ozasa N, Ono K, Kimura T. Differential prognostic impact of clinical congestion between preserved versus reduced ejection fraction in patients hospitalized for acute decompensated heart failure: Findings from the Japanese KCHF registry.
J Card Fail2024 (in press).
Sato T, Ogihara Y, Yamashita Y,
Morimoto T, Chatani R, Kaneda K, Nishimoto Y, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Sakamoto J, Inoue T, Usami S, Chen PM, Togi K, Koitabashi N, Hiramori S, Doi K, Mabuchi H, Tsuyuki Y, Murata K, Takabayashi K, Nakai H, Sueta D, Shioyama W, Dohke T, Nishikawa R, Kimura T, Dohi K; COMMAND VTE registry-2 investigators. Incidence and risk factors of ischemic stroke in patients with cancer-associated venous thromboembolism: from the COMMAND VTE registry-2.
Res Pract Thromb Haemost2024;8:102617.
Tanaka M, Kohjitani H, Yamamoto E,
Morimoto T, Kato T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Seko Y, Shiba M, Yoshikawa Y, Yamashita Y, Kitai T, Taniguchi R, Iguchi M, Nagao K, Kawai T, Komasa A, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Okuno Y, Kimura T, Ono K; KCHF study investigators. Development of interpretable machine learning models to predict in-hospital prognosis of acute heart failure patients.
ESC Heart Fail2024;11:2798-2812.
Chatani R, Yamashita Y,
Morimoto T, Muraoka N, Shioyama W, Shibata T, Nishimoto Y, Ogihara Y, Doi K, Oi M, Shiga T, Sueta D, Kim K, Tanabe Y, Koitabashi N, Takada T, Ikeda S, Nakagawa H, Mitsuhashi T, Shoji M, Sakamoto J, Hisatake S, Ogino Y, Fujita M, Nakanishi N, Dohke T, Hiramori S, Nawada R, Kaneda K, Mushiake K, Yamamoto H, Kadota K, Ono K, Kimura T; ONCO PE trial investigators. Home treatment for active cancer patients with low-risk pulmonary embolism: A predetermined companion report from the ONCO PE trial.
Circ J2024 (in press).
Yamamoto K, Takeji Y, Taniguchi T,
Morimoto T, Shirai S, Kitai T, Tabata H, Ohno N, Murai R, Osakada K, Murata K, Nakai M, Tsuneyoshi H, Tada T, Amano M, Watanabe S, Shiomi H, Watanabe H, Yoshikawa Y, Nishikawa R, Obayashi Y, Toyofuku M, Tatsushima S, Kanamori N, Miyake M, Nakayama H, Nagao K, Izuhara M, Nakatsuma K, Inoko M, Fujita T, Kimura M, Ishii M, Usami S, Nakazeki F, Togi K, Inuzuka Y, Ando K, Komiya T, Ono K, Minatoya K, Kimura T; CURRENT AS registry-2 investigators. Safety of calcium channel blockers in patients with severe aortic stenosis and hypertension.
Circ J2024 (in press).
Obayashi Y, Takeji Y, Taniguchi T,
Morimoto T, Shirai S, Kitai T, Tabata H, Ohno N, Murai R, Osakada K, Murata K, Nakai M, Tsuneyoshi H, Tada T, Amano M, Watanabe S, Shiomi H, Watanabe H, Yoshikawa Y, Nishikawa R, Yamamoto K, Toyofuku M, Tatsushima S, Kanamori N, Miyake M, Nakayama H, Nagao K, Izuhara M, Nakatsuma K, Inoko M, Fujita T, Kimura M, Ishii M, Usami S, Nakazeki F, Togi K, Inuzuka Y, Ando K, Komiya T, Ono K, Minatoya K, Kimura T; CURRENT AS registry-2 investigators. Concomitant mitral regurgitation in severe aortic stenosis: Insights from the CURRENT AS registry-2.
Circ J2024;88:1996-2007.
Yamaguchi K, Miyagami T, Imada R, Kushiro S, Yanagida R,
Morikawa T, Nakagawa K, Yoshimi K, Naito T, Tohara H. Effect of poor oral health status at hospital admission on in-hospital outcomes of older patients with aspiration pneumonia.
Eur Geriatr Med2024;15:489-496.
Yoshimoto T, Yamagami H, Sakai N, Uchida K, Shirakawa M, Beppu M, Toyoda K, Matsumaru Y, Matsumoto Y, Todo K, Hayakawa M, Shindo S, Morimoto M, Takeuchi M, Imamura H, Ikeda H, Tanaka K, Ishihara H, Kakita H, Sano T, Araki H, Nomura T,
Sakakibara F, Yoshimura S; for RESCUE AT-LVO Investigators. Association of perioperative P2Y12 inhibitor administration with outcomes for tandem occlusion: RESCUE AT-LVO sub-study.
Front Neurol2024;15:1475882.
Murakami Y, Todo K,
Uchida K, Yamagami H, Sakai N, Gon Y, Okazaki S, Sasaki T, Yoshimura S,
Morimoto T, Mochizuki H. One-year morbidity and mortality in patients treated with standard-dose and low-dose apixaban after acute large vessel occlusion stroke.
J Thromb Thrombolysis2024;57:622-629.
Miyama M, Matsukawa H,
Sakakibara F,
Uchida K, Shirakawa M, Yoshimura S. Perioperative antiplatelet management in the flow-diverter treatment for unruptured cerebral aneurysms: A single-center, retrospective analysis.
WorldNeurosurg2024;183:e44-e50.
Xiong W, Yamashita Y,
Morimoto T, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Chen PM, Murata K, Tsuyuki Y, Nishimoto Y, Sakamoto J, Togi K, Mabuchi H, Takabayashi K, Kato T, Ono K, Kimura T; COMMAND VTE registry investigators. Initial hemodynamic status and acute mortality in cancer patients with acute pulmonary embolism: From the COMMAND VTE registry.
J Thromb Thrombolysis2024;57:1183-1192.
Takeji Y, Taniguchi T,
Morimoto T, Shirai S, Kitai T, Tabata H, Kitano K, Ohno N, Murai R, Osakada K, Murata K, Nakai M, Tsuneyoshi H, Tada T, Amano M, Watanabe S, Shiomi H, Watanabe H, Yoshikawa Y, Nishikawa R, Yamamoto K, Obayashi Y, Toyofuku M, Tatsushima S, Kanamori N, Miyake M, Nakayama H, Nagao K, Izuhara M, Nakatsuma K, Inoko M, Fujita T, Kimura M, Ishii M, Usami S, Sawada K, Nakazeki F, Okabayashi M, Shirotani M, Inuzuka Y, Ando K, Komiya T, Minatoya K, Kimura T; CURRENT AS registry-2 investigators. In-hospital outcomes after SAVR or TAVI in patients with severe aortic stenosis.
Cardiovasc Interv Ther2024;39:65-73.
Yamamoto K, Yamamoto E,
Morimoto T, Shiomi H, Domei T, Taniguchi R, Sakai H, Toyofuku M, Kaji S, Nawada R, Yokomatsu T, Suwa S, Furukawa Y, Kadota K, Ando K, Kimura T; CREDO-Kyoto PCI/CABG registry investigators. Long-term effects of proton pump inhibitors in patients undergoing percutaneous coronary intervention in high-risk subgroups.
Circ J2024;88:1778-1787.
Watanabe H, Natsuaki M,
Morimoto T, Yamamoto K, Obayashi Y, Nishikawa R, Hamatani Y, Ando K, Domei T, Suwa S, Ogita M, Isawa T, Takenaka H, Yamamoto T, Ishikawa T, Hisauchi I, Wakabayashi K, Onishi Y, Hibi K, Kawai K, Yoshida R, Suzuki H, Nakazawa G, Kusuyama T, Morishima I, Ono K, Kimura T; STOPDAPT-3 investigators. Post-procedural Anticoagulation With Unfractionated Heparin in Acute Coronary Syndrome: Insight from the STOPDAPT-3 Trial.
Am J Cardiol2024;226:83-96.
Yamamoto K, Shiomi H,
Morimoto T, Miyazawa A, Nakamura S, Suwa S, Fujita T, Kurita T, Sugawara S, Fujii K, Suematsu N, Isawa T, Matsuo H, Tanaka H, Shirota K, Hibi K, Kadota K, Ando K, Ono K, Kimura T; OPTIVUS-complex PCI investigators. Optimal intravascular ultrasound-guided percutaneous coronary intervention in patients with multivessel disease and diabetes.
Am J Cardiol2024;223:18-28.
*Arai H, Okada S, Fukuoka T, Nozoe M, Kamiya K, Matsumoto S. Baseline nutrition status and rehabilitation progress in individuals requiring inpatient rehabilitation: A retrospective cohort study.
Arch Rehabil Res Clin Transl2024;6:100362.
Nakamura T, Morikawa T, Imura H,
Nezu M, Hamazaki K,
Sakuma M,
*Morimoto T. Prevalence and prognostic impact of respiratory syncytial virus among hospitalized patients with acute respiratory symptoms during July-December, 2023 in Japan.
J Infect Chemother2024;30:1085-1087.
*Takeuchi J
, Ozaki I, Hata K, Nozawa M, Fukushima K, Fukumori N, Imanaka M, Sakanishi Y, Shima M,
Morimoto T. Mumps vaccination and immune status among Japanese university students: A multicenter cross-sectional study.
J Public Health Res 2024;13:22799036241246702.
Kojo K,
Morikawa T, Kikawa T, Sasaki K, Suyama Y, Shimizu T. Diagnostic dilemma of syncope: Esophageal hiatal hernia and high-risk bundle-branch block.
Intern Med2024;63:83-86.
Kawabata A, Motoyama Y,
Takeuchi J, Kusunoki T. Swimming was associated with rhinitis and pollinosis in a duration-dependent manner.
Pediatr Int 2024;66:e15758.
Yamauchi K, Inaba T,
Morimoto T, Aya Y, Colvin HS, Nagahara T, Ishikawa S, Wato M, Imagawa A. The risk of metastatic recurrence after non-curative endoscopic resection with negative deep margins for early colorectal cancer: Two-center retrospective cohort study.
Digestion2024;105:320-330.
Sano M, Toyota T,
Morimoto T, Noguchi Y, Shigeno R, Murai R, Okada T, Sasaki Y, Taniguchi T, Kim K, Kobori A, Ehara N, Kinoshita M, Doi A, Tomii K, Kihara Y, Furukawa Y. Risk stratification and prognosis prediction using cardiac biomarkers in Coronavirus 2019: A single-center retrospective cohort study.
BMJ Open2024;14:e082220.
Miyamoto S, Hayakawa M, Tsuruta W, Shirakawa M, Beppu M, Sakai N, Yamagami H, Matsumoto Y, Toyoda K, Todo K, Imamura H, Uchida K,
Sakakibara F, Yoshimura S, Ishikawa E, Matsumaru Y. Antiplatelets before or during endovascular therapy after intravenous thrombolysis for atherothrombotic large vessel occlusion.
J Clin Neurosci2024;133:111014.
Kanenawa K, Yamaji K,
Morimoto T, Yamamoto K, Domei T, Hyodo M, Shiomi H, Furukawa Y, Nakagawa Y, Kadota K, Watanabe H, Yoshikawa Y, Tada T, Tazaki J, Ehara N, Taniguchi R, Tamura T, Iwakura A, Tada T, Suwa S, Toyofuku M, Inada T, Kaneda K, Ogawa T, Takeda T, Sakai H, Yamamoto T, Tambara K, Esaki J, Eizawa H, Yamada M, Shinoda E, Nishizawa J, Mabuchi H, Tamura N, Shirotani M, Nakayama S, Uegaito T, Matsuda M, Takahashi M, Inoko M, Kanemitsu N, Tamura T, Ishii K, Nawada R, Onodera T, Ohno N, Koyama T, Tsuneyoshi H, Sakamoto H, Aoyama T, Miki S, Tanaka M, Sato Y, Yamazaki F, Hanyu M, Soga Y, Komiya T, Minatoya K, Ando K, Kimura T. Prognostic significance of baseline low-density lipoprotein cholesterol in patients undergoing coronary revascularization: A report from the CREDO-Kyoto registry.
J Cardiol2024;84:300-310.
Obayashi Y, Natsuaki M, Watanabe H,
Morimoto T, Yamamoto K, Nishikawa R, Miyazawa A, Suzuki N, Suwa S, Kirigaya H, Wakabayashi K, Kawai K, Onishi Y, Morishima I, Okayama H, Uehara H, Hibi K, Ono K, Kimura T; STOPDAPT-3 investigators. An aspirin-free strategy and optical coherence tomography observations after percutaneous coronary intervention: Insights from the STOPDAPT-3 trial.
J Cardiol2024;84:342-344.
Miyake M, Izumi C, Watanabe H, Ozasa N,
Morimoto T, Matsutani H, Takahashi S, Ohtani Y, Baba M, Sakamoto J, Tamaki Y, Enomoto S, Kondo H, Tamura T, Nakagawa Y, Kimura T; CAPITAL-RCT investigators. Prognostic value of E/e' ratio and its change over time in ST-segment elevation myocardial infarction with preserved left ventricular ejection fraction in the reperfusion era. J Cardiol 2024;84:253-259.
Yamamoto K, Takeji Y, Taniguchi T, Morimoto T, Tabata H, Ishizu K, Morofuji T, Hayashi M, Isotani A, Shirai S, Ohno N, Kakumoto S, Ando K, Minatoya K, Kimura T. Clinically significant incidental noncardiac findings on preprocedural computed tomography in patients with aortic stenosis undergoing aortic-valve replacement. J Cardiol 2024;84:326-332.
Mabuchi H, Nishikawa R, Yamashita Y, Morimoto T, Chatani R, Kaneda K, Nishimoto Y, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Sakamoto J, Ogihara Y, Inoue T, Usami S, Chen PM, Togi K, Koitabashi N, Hiramori S, Doi K, Tsuyuki Y, Murata K, Takabayashi K, Nakai H, Sueta D, Shioyama W, Dohke T, Ono K, Nakagawa Y, Kimura T. Statins use and recurrent venous thromboembolism in the direct oral anticoagulant era: Insight from the COMMAND VTE registry-2. J Thromb Thrombolysis 2024;57:907-917.
Maeda Y, Ikawa F, Kuwabara M, Hosogai M, Ishii D, Morimoto T, Nakayama T, Suzuki M, Horie N. Declining trend in the estimated annual rupture rate of unruptured cerebral aneurysms in Japan: a nationwide study. Neurosurg Rev 2024;47:336.
Nabika S, Nakamura T, Ito Y, Nagasawa A, *Morimoto T. Incidence of and factors associated with emergency caesarean section in pregnant women with gestational diabetes mellitus: A retrospective cohort study. J Obstet Gynaecol Res 2024;50:849-855.
Yabushita T, Shimomura Y, Maruoka H, Katoh D, Yamashita D, Satake H, Hiramoto N, Yoshioka S, Yonetani N, Nishikori M, Morimoto T, Imai Y, Takayuki Ishikawa. Complete detection of FR1 to FR3 primer-based PCR patterns of immunoglobulin heavy chain rearrangement in the BIOMED-2 protocol is associated with poor prognosis in patients with diffuse large B-cell lymphoma. EJHaem 2024;5:698-708.
Yamashita Y, Morimoto T, Muraoka N, Oyakawa T, Umetsu M, Akamatsu D, Nishimoto Y, Sato Y, Takada T, Jujo K, Minami Y, Ogihara Y, Dohi K, Fujita M, Nishikawa T, Ikeda N, Hashimoto G, Otsui K, Mori K, Sueta D, Tsubata Y, Shoji M, Shikama A, Hosoi Y, Tanabe Y, Chatani R, Tsukahara K, Nakanishi N, Kim K, Ikeda S, Mo M, Yoshikawa Y, Kimura T; ONCO-DVT study investigators. Edoxaban for 12 months versus 3 months in patients with cancer with isolated distal deep vein thrombosis (ONCO-DVT study): An open-label, multicenter, randomized clinical trial. Circulation 2023;148:1665-1676.
*Morimoto T, Hoshino H, Matsuo Y, Ibuki T, Miyata K, Koretsune Y. Safety and effectiveness of apixaban versus warfarin in Japanese patients with nonvalvular atrial fibrillation stratified by renal function: A retrospective cohort study. Am J Cardiovasc Drugs 2023;23:721-733.
Ospel JM, Kunz WG, McDonough RV, Goyal M, Uchida K, Sakai N, Yamagami H, Yoshimura S; RESCUE-Japan LIMIT Investigators. Cost-effectiveness of endovascular treatment for acute stroke with large infarct: A united states perspective. Radiology 2023;309:e223320.
Fujimoto D, Morimoto T, Tamiya M, Hata A, Matsumoto H, Nakamura A, Yokoyama T, Taniguchi Y, Uchida J, Sato Y, Yokoi T, Tanaka H, Furuya N, Masuda T, Sakata Y, Miyauchi E, Hara S, Saito G, Miura S, Kanazu M, Yamamoto N, Akamatsu H. Outcomes of chemoimmunotherapy among patients with extensive-stage small cell lung cancer according to potential clinical trial eligibility. JAMA Netw Open 2023;6:e230698.
Namitome S, Uchida K, Shindo S, Yoshimura S, Sakai N, Yamagami H, Toyoda K, Matsumaru Y, Matsumoto Y, Kimura K, Ishikura R, Inoue M, Beppu M, Sakakibara F, Shirakawa M, Ueda M, *Morimoto T; RESCUE-Japan LIMIT investigators. Number of passes of endovascular therapy for stroke with a large ischemic core: Secondary analysis of RESCUE-Japan LIMIT. Stroke 2023;54:1985-1992.
Kaneda K, Yamashita Y, Morimoto T, Chatani R, Nishimoto Y, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Kimura T; COMMAND VTE registry-2 investigators. Anticoagulation strategies and long-term recurrence in patients with venous thromboembolism in the era of direct oral anticoagulants. Eur J Intern Med 2023;118:59-72.
Tsujisaka Y, Yamashita Y, Morimoto T, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Chen PM, Murata K, Tsuyuki Y, Nishimoto Y, Sakamoto J, Togi K, Mabuchi H, Takabayashi K, Kato T, Ono K, Kimura T; COMMAND VTE registry investigators. Application of the RIETE score to identify low-risk patients with pulmonary embolism: from the COMMAND VTE Registry. Thromb Res 2023;232:35-42.
Dabhi N, Kumar JS, Ironside N, Kellogg RT, Sowlat MM, Uchida K, Maier I, Al Kasab S, Jabbour P, Kim JT, Wolfe SQ, Rai A, Starke RM, Psychogios MN, Samaniego EA, Arthur AS, Yoshimura S, Cuellar H, Howard BM, Alawieh A, Romano DG, Tanweer O, Mascitelli J, Fragata I, Polifka AJ, Osbun JW, Crosa RJ, Matouk C, Levitt MR, Brinjikji W, Moss M, Dumont TM, Williamson R, Navia P, Kan P, De Leacy R, Chowdhry SA, Ezzeldin M, Spiotta AM, Park MS. Mechanical thrombectomy for the treatment of primary and secondary anterior cerebral artery occlusions: insights from STAR. J Neurointerv Surg 2024;16:1282-1287.
Yamamoto K, Shiomi H, Morimoto T, Miyazawa A, Watanabe H, Natsuaki M, Watanabe H, Yamaji K, Ohya M, Nakamura S, Mitomo S, Suwa S, Domei T, Tatsushima S, Ono K, Sakamoto H, Shimamura K, Shigetoshi M, Taniguchi R, Nishimoto Y, Okayama H, Matsuda K, Yokomatsu T, Muto M, Kawaguchi R, Kishi K, Hadase M, Fujita T, Nishida Y, Nishino M, Otake H, Suematsu N, Ajimi T, Tanabe K, Abe M, Hibi K, Kadota K, Ando K, Kimura T; OPTIVUS-Complex PCI investigators. Target lesion revascularization after intravascular ultrasound-guided percutaneous coronary intervention. Circ Cardiovasc Interv 2023;16:e012922.
Yamamoto K, Shiomi H, Morimoto T, Kimura T. Response by Yamamoto et al to Letter Regarding Article, "Target lesion revascularization after intravascular ultrasound-guided percutaneous coronary intervention". Circ Cardiovasc Interv 2023;16:e013439.
Sakakibara F, Uchida K, Yoshimura S, Sakai N, Yamagami H, Toyoda K, Matsumaru Y, Matsumoto Y, Kimura K, Ishikura R, Inoue M, Ando K, Yoshida A, Tanaka K, Yoshimoto T, Koge J, Beppu M, Shirakawa M, *Morimoto T; RESCUE-Japan LIMIT investigators. Mode of imaging study and endovascular therapy for a large ischemic core: Insights from the RESCUE-Japan LIMIT. J Stroke 2023;25:388-398.
Maeda H, Saito N, Igarashi A, Ishida M, Terada M, Ito T, Ikeda H, Kamura H, Motohashi I, Kimura Y, Komino M, Arai H, Kuwamitsu O, Akuzawa N, Sando E, Morikawa T, Imura H, Inoue H, Hayakawa T, Teshigahara O, Ohara Y, Suzuki M, Morimoto K. Effectiveness of mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections during the SARS-CoV-2 Omicron BA.1 and BA.2 epidemic in Japan: Vaccine Effectiveness Real-time Surveillance for SARS-CoV-2 (VERSUS). Expert Rev Vaccines 2023;22:288-298.
Natsuaki M, Watanabe H, Morimoto T, Kozuma K, Kadota K, Muramatsu T, Nakagawa Y, Akasaka T, Hanaoka KI, Tanabe K, Morino Y, Ishikawa T, Katoh H, Nishikawa H, Tamura T, Ono K, Yamamoto K, Ishihara T, Abe M, Taniguchi R, Ikari Y, Okada K, Kimura T. Biodegradable- or durable-polymer drug-eluting stents in patients with coronary artery disease: Ten-year outcomes of the randomised NEXT trial. EuroIntervention 2023;19:e402-e413.
Shiba M, Kato T, Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Seko Y, Yamamoto E, Yoshikawa Y, Kitai T, Yamashita Y, Iguchi M, Nagao K, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T. Heterogeneity in characteristics and outcomes of patients who met the indications for vericiguat approved by the Japanese agency: From the KCHF registry. J Card Fail 2023;29:976-978.
Maruichi-Kawakami S, Nagao K, Aida K, Matsuto K, Imamoto K, Tamura A, Takazaki T, Nakatsu T, Tanaka M, Nakayama S, Morimoto T, Kimura T, Inada T. Peripheral venous pressure measurements to evaluate congestion in heart failure. J Card Fail 2023;29:1319-1323.
Okawa K, Sogo M, Morimoto T, Tsushima R, Sudo Y, Saito E, Ozaki M, Takahashi M. Relationship between endothelial dysfunction and the outcomes after atrial fibrillation ablation. J Am Heart Assoc 2023;12:e028482.
Okawa K, Taya S, Morimoto T, Tsushima R, Sudo Y, Sakamoto A, Saito E, Sogo M, Ozaki M, Takahashi M. Cardiovascular events and death after catheter ablation in very old patients with nonvalvular atrial fibrillation. Aging 2023;15:7343-7361.
Fujiwara S, Sakai N, Imamura H, Ohara N, Tanaka K, Yamagami H, Matsumoto Y, Takeuchi M, Uchida K, Yoshimura S, *Morimoto T. Impact of thrombocytopenia on hemorrhagic complications after endovascular therapy for acute large vessel occlusion: Sub-analysis of RESCUE-Japan registry 2. J Neurol Sci 2023;449:120659.
Saito T, Sakakibara F, Uchida K, Yoshimura S, Sakai N, Imamura H, Yamagami H, *Morimoto T. Effect of edaravone on symptomatic intracranial hemorrhage in patients with acute large vessel occlusion on apixaban for non-valvular atrial fibrillation. J Neurol Sci 2023;453:120806.
*Arai H, Okada S, Fukuoka T, Nozoe M, Kamiya K, Matsumoto S, Morimoto T. Association of baseline skeletal muscle mass index with adverse events and rehabilitation outcomes in patients admitted for rehabilitation. Arch Rehabil Res Clin Transl 2023;6:100314.
Shindo S, Uchida K, Yoshimura S, Sakai N, Yamagami H, Toyoda K, Matsumaru Y, Matsumoto Y, Kimura K, Ishikura R, Inoue M, Sakakibara F, Nakajima M, Ueda M, *Morimoto T. Intravenous alteplase before endovascular therapy for acute large vessel occlusion with large ischemic core: Subanalysis of a randomized clinical trial. J Neurointerv Surg 2024;16:1094-1100.
Taniguchi T, Morimoto T, Yamaji K, Shirai S, Ando K, Shiomi H, Takeji Y, Ohno N, Kanamori N, Yamazaki F, Koyama T, Kim K, Ehara N, Furukawa Y, Komiya T, Iwakura A, Shirotani M, Esaki J, Sakaguchi G, Fujii K, Nakayama S, Mabuchi H, Tsuneyoshi H, Eizawa H, Shiraga K, Hanyu M, Nakano A, Ishii K, Tamura N, Higashitani N, Kouchi I, Yamada T, Nishizawa J, Jinnai T, Morikami Y, Minatoya K, Kimura T. Life expectancy of patients with severe aortic stenosis in relation to age and surgical risk score. Ann Thorac Surg 2023;116:1195-1203.
Sudo Y, Morimoto T, Tsushima R, Sogo M, Ozaki M, Takahashi M, Okawa K. P-wave terminal force in lead V1 and outcomes in patients with persistent atrial fibrillation undergoing catheter ablation. Am Heart J 2023;260:141-150.
Nishikawa R, Kato T, Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Yamamoto E, Ozasa N, Tada T, Sakamoto H, Seko Y, Shiba M, Yoshikawa Y, Yamashita Y, Kitai T, Taniguchi R, Iguchi M, Nagao K, Kawai T, Komasa A, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T; KCHF study investigators. The characteristics and outcomes in patients with acute heart failure who used tolvaptan: from KCHF registry. ESC Heart Fail 2023;10:3141-3151.
*Arai H, Nozoe M, Kamiya K, Matsumoto S, Morimoto T. Association between skeletal muscle mass index and falls in patients with functional impairment. Am J Phys Med Rehabil 2023;102:913-918.
Seko Y, Kato T, Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Shiba M, Yamamoto E, Yoshikawa Y, Yamashita Y, Kitai T, Taniguchi R, Iguchi M, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T; KCHF study investigators. Association between changes in loop diuretic dose and outcomes in acute heart failure. ESC Heart Fail 2023;10:1757-1770.
Obayashi Y, Kato T, Yaku H, Morimoto T, Seko Y, Inuzuka Y, Tamaki Y, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Su K, Kawato M, Inoko M, Toyofuku M, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Sato Y, Kuwahara K, Ozasa N, Kimura T; KCHF study investigators. Tricuspid regurgitation in patients with acute heart failure: Insights from the KCHF registry. ESC Heart Fail 2023;10:1948-1960.
Aida K, Nagao K, Kato T, Yaku H, Morimoto T, Inuzuka Y, Tamaki Y, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Su K, Kawato M, Seko Y, Inada T, Inoko M, Toyofuku M, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Sato Y, Kuwahara K, Ozasa N, Kimura T. Prognostic value of the severity of clinical congestion in patients hospitalized for decompensated heart failure: Findings from the Japanese KCHF registry. J Card Fail 2023;29:1150-1162.
Matsunashi A, Nagata K, Morimoto T, Tomii K. Mechanical ventilation for acute exacerbation of fibrosing interstitial lung diseases. Respir Investig 2023;61:306-313.
Yamashita Y, Morimoto T, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Chen PM, Murata K, Tsuyuki Y, Nishimoto Y, Sakamoto J, Togi K, Mabuchi H, Takabayashi K, Kato T, Ono K, Kimura T; COMMAND VTE registry investigators. Impact of heart rate at diagnosis on clinical outcomes in patients with acute pulmonary embolism. Am J Cardiol 2023;187:38-47.
Hamatani Y, Kato T, Morimoto T, Iguchi M, Yaku H, Inuzuka Y, Kitai T, Nagao K, Tamaki Y, Yamamoto E, Ozasa N, Yamashita Y, Abe M, Sato Y, Kuwahara K, Akao M, Kimura T; KCHF registry investigators. Association of intravenous heparin administration with in-hospital clinical outcomes among hospitalized patients with acute heart failure. Int J Cardiol 2023;370:229-235.
Uchida K, Ueda S, Sakakibara F, Kinjo N, Nezu M, Arai H, *Morimoto T. Statins reduce bleeding risk in patients taking oral anticoagulants for nonvalvular atrial fibrillation: A retrospective registry study. Am J Cardiovasc Drugs 2023;23:89-99.
Yoshimura A, Ishikawa H, Uchida K, Takesue Y, Mori J, Kinoshita T, Morikawa S, Okamoto F, Sawada T, Ohji M, Kanda T, Takeuchi M, Miki A, Kusuhara S, Ueda T, Ogata N, Sugimoto M, Kondo M, Yoshida S, Ogata T, Kimura K, Mitamura Y, Jujo T, Takagi H, Terasaki H, Sakamoto T, Sugisawa T, Komuku-Yamamoto Y, Gomi F. Risk Factors for Legal Blindness in 237 Japanese Patients with Exogenous Endophthalmitis: A Multicenter Cohort Study from J-CREST. Ocul Immunol Inflamm 2023;26:1-9.
Sugisawa T, Ishikawa H, Uchida K, Takesue Y, Mori J, Kinoshita T, Morikawa S, Okamoto F, Sawada T, Ohji M, Kanda T, Takeuchi M, Miki A, Kusuhara S, Ueda T, Ogata N, Sugimoto M, Kondo M, Yoshida S, Ogata T, Kimura K, Mitamura Y, Jujo T, Takagi H, Terasaki H, Sakamoto T, Komuku Y, Gomi F. Risk factors for legal blindness in 77 Japanese patients with endogenous endophthalmitis: A multicenter cohort study from J-CREST. Ocul Immunol Inflamm 2023;31:1505-1512.
Siegler ASJE, Qureshi MM, Nogueira RG, Tanaka K, Nagel S, Michel P, Vigilante N, Ribo M, Yamagami H, Yoshimura S, Abdalkader M, Haussen DC, Mohammaden MH, Nannoni S, Möhlenbruch M, Henon H, Sheth SA, Gutierrez SO, Olive-Gadea M, Caparros F, Şeker F, Zaidi S, Castonguay A, Uchida K, Sakai N, Puri AS, Farooqui M, Toyoda K, Salazar-Marioni S, Takeuchi M, Farzin B, Masoud HE, Kuhn AL, Rana A, Morimoto M, Shibata M, Nonaka T, Klein P, Sathya A, Kiley NL, Cordonnier C, Strambo D, Demeestere J, Ringleb PA, Roy D, Zaidat OO, Jovin TG, Kaesmacher J, Fischer U, Raymond J, Nguyen TN. Endovascular vs Medical Management for Late Anterior Large Vessel Occlusion With Prestroke Disability: Analysis of CLEAR and RESCUE-Japan. Neurology 2023;100:e751-e763.
Kataoka K, Takahashi K, Takeuchi J, Ito K, Beppu N, Ceelen W, Kanemitsu Y, Ajioka Y, Endo I, Hasegawa K, Takahashi K, Ikeda M, on behalf of Joint Committee of Liver Metastases Survey from Colorectal Cancer. Correlation between recurrence free survival and overall survival after upfront surgery for resected colorectal liver metastases. Br J Surg 2023;110:864-869.
Sato T, Uchino M, Takeuchi J, Fujihira F, Shimizu K, Yokoyama K, Yagi S, Kaku K, Takashima Y, Ikenouchi M, Kojima K, Kawai M, Nagase K, Kamikozuru K, Yokoyama Y, Takagawa T, Ikeuchi H, Watanabe K, Shinzaki S. Short-term clinical evaluation of teduglutide for patients with Crohn's disease on home parenteral support for postoperative short bowel syndrome with intestinal failure.
Clin Nutr2023;18:42:722-731.
Ikeda S, Yamashita Y,
Morimoto T, Ono K, Kimura T; COMMAND VTE registry investigators. Impact of chronic lung disease on long-term clinical outcomes in patients with venous thromboembolism: From the COMMAND VTE registry.
Eur J Intern Med2023;109:135-137.
Yamamoto K, Watanabe H,
Morimoto T, Obayashi Y, Natsuaki M, Yamaji K, Domei T, Ogita M, Ohya M, Tatsushima S, Suzuki H, Tada T, Ishii M, Nikaido A, Watanabe N, Fujii S, Mori H, Nishikura T, Suematsu N, Hayashi F, Komiyama K, Shigematsu T, Isawa T, Suwa S, Ando K, Kimura T; STOPDAPT-2 and STOPDAPT-2 ACS investigators. Clopidogrel monotherapy after 1-month dual antiplatelet therapy in patients with diabetes undergoing percutaneous coronary intervention.
JACC Cardiovasc Interv2023;16:19-31.
Tsushima R, Okawa K,
Morimoto T, Sudo Y, Sogo M, Ozaki M, Takahashi M, Tobiume T. Effect of direct slow pathway capture mapping-guided ablation on typical atrioventricular nodal re-entrant tachycardia.
JACC Clin Electrophysiol2023;9:209-218.
Washida K, Kato T, Ozasa N,
Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Seko Y, Yamamoto E, Yoshikawa Y, Shiba M, Kitai T, Yamashita Y, Taniguchi R, Iguchi M, Nagao K, Kawase Y, Nishimoto Y, Kuragaichi T, Hotta K, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T. A comparison between hospital follow-up and collaborative follow-up in patients with acute heart failure.
ESC Heart Fail2023;10:353-365.
Yaku H, Kato T,
Morimoto T, Kaneda K, Nishikawa R, Kitai T, Inuzuka Y, Tamaki Y, Yamazaki T, Kitamura J, Ezaki H, Nagao K, Yamamoto H, Isotani A, Arita T, Izumi C, Sato Y, Nakagawa Y, Matoba S, Sakata Y, Kuwahara K, Kimura T; GOREISAN-HF trial investigators. Rationale and study design of the GOREISAN for heart failure (GOREISAN-HF) trial: A randomized clinical trial.
Am Heart J2023;260:18-25.
Seko Y, Kato T,
Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Shiba M, Yamamoto E, Yoshikawa Y, Kitai T, Yamashita Y, Iguchi M, Nagao K, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T. Weight loss during follow-up in patients with acute heart failure: from the KCHF registry.
PLoS One2023;18:e0287637.
Takahashi K, Yamashita Y,
Morimoto T, Tada T, Sakamoto H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Chen PM, Murata K, Tsuyuki Y, Nishimoto Y, Sakamoto J, Togi K, Mabuchi H, Takabayashi K, Kato T, Ono K, Kimura T; COMMAND VTE registry investigators. Age and long-term outcomes of patients with venous thromboembolism: From the COMMAND VTE registry.
Int J Cardiol2023;383:89-95.
Hirabayashi R, Nagata K, Sato Y, Nakagawa A, Tachikawa R, Kuroda H, Seo R,
Morimoto T, Tomii K. Reliability of the respiratory rate and oxygenation index for successful high-flow nasal cannula support in coronavirus disease pneumonia: a retrospective cohort study.
BMC Pulm Med2023;23:294.
Takeji Y,
Morimoto T, Shiomi H, Kato E, Imada K, Yoshikawa Y, Matsumura-Nakano Y, Yamamoto K, Yamaji K, Toyota T, Tada T, Tazaki J, Yamamoto E, Nakatsuma K, Suwa S, Ehara N, Taniguchi R, Tamura T, Watanabe H, Toyofuku M, Yamamoto T, Shinoda E, Mabuchi H, Inoko M, Onodera T, Sakamoto H, Inada T, Ando K, Furukawa Y, Sato Y, Kadota K, Nakagawa Y, Kimura T. Sex differences in clinical outcomes after percutaneous coronary intervention.
Circ J2023;87:277-286.
Onishi N, Kaitani K, Nakagawa Y, Kobori A, Inoue K, Kurotobi T, Morishima I, Matsui Y, Yamaji H, Nakazawa Y, Kusano K, Shimizu Y, Hanazawa K, Tamura T, Izumi C,
Morimoto T, Ono K, Kimura T, Shizuta S; KPAF investigator. Radiofrequency catheter ablation for atrial fibrillation patients on hemodialysis (from the Kansai Plus Atrial Fibrillation registry): Clinical impact of early recurrence.
Circ J2024;88:1057-1064.
Yamamoto K,
Morimoto T, Natsuaki M, Shiomi H, Ozasa N, Sakamoto H, Takeji Y, Domei T, Tada T, Taniguchi R, Uegaito T, Yamada M, Takeda T, Eizawa H, Suwa S, Shirotani M, Tamura T, Inoko M, Sakai H, Ishii K, Toyofuku M, Miki S, Onodera T, Furukawa Y, Inada T, Ando K, Kadota K, Nakagawa Y, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-3 investigators. Polypharmacy and bleeding outcomes after percutaneous coronary intervention.
Circ J2024;88:888-899.
Yamamoto K, Shiomi H,
Morimoto T, Miyazawa A, Watanabe H, Nakamura S, Suwa S, Domei T, Ono K, Sakamoto H, Shigetoshi M, Taniguchi R, Okayama H, Yokomatsu T, Muto M, Kawaguchi R, Kishi K, Hadase M, Fujita T, Nishida Y, Nishino M, Otake H, Natsuaki M, Watanabe H, Suematsu N, Tanabe K, Abe M, Hibi K, Kadota K, Ando K, Kimura T; OPTIVUS-Complex PCI investigators. Dual antiplatelet therapy duration after multivessel optimal intravascular ultrasound-guided percutaneous coronary intervention.
Circ J2023;87:1661-1671.
Toyota T,
Morimoto T, Iimuro S, Fujita R, Iwata H, Miyauchi K, Inoue T, Nakagawa Y, Nishihata Y, Daida H, Ozaki Y, Suwa S, Sakuma I, Furukawa Y, Shiomi H, Watanabe H, Yamaji K, Saito N, Natsuaki M, Ohashi Y, Matsuzaki M, Nagai R, Kimura T. Low-density lipoprotein cholesterol levels on statins and cardiovascular event risk in stable coronary artery disease- An observation from the REAL-CAD study.
Circ J2023;87:360-367.
Matsukawa H,
Uchida K, Shirakawa M, Kinjo N, Kuramoto Y,
Sakakibara F, Shindo S, Yamada K, Yoshimura S. Prognostic factors in patients with unruptured vertebral and basilar fusiform aneurysms treated with endovascular procedures: A single center retrospective analysis.
Clin Neuroradiol2023;33:1035-1044.
Marko M, Singh N, Ospel JM,
Uchida K, Almekhlafi MA, Demchuk AM, Nogueira RG, McTaggart RA, Poppe AY, Rempel JL, Tymianski M, Hill MD, Goyal M, Menon BK; ESCAPE-NA1 Investigators. Symptomatic non-stenotic carotid disease in embolic stroke of undetermined source: Analysis of the ESCAPE-NA1 trial.
Clin Neuroradiol2024;34:333-339.
Koyanagi M, Hatano T,
Uchida K, Ogura T, Yamagami H, Shibata M, Enomoto Y, Fukawa N, Matsumoto Y, Sakai N, Takeuchi M, Nonaka T, Shimizu F, Ezura M, Ota T, Ohta H, Morimoto M,
Morimoto T, Yoshimura S; ALVO investigators. Safety of apixaban monotherapy for non-valvular atrial fibrillation-related acute stroke with intra-/extracranial artery stenosis.
Cerebrovasc Dis2023;52:255-265.
Obayashi Y, Shiomi H,
Morimoto T, Miyake M, Inoko M, Nishikawa R, Kaneda K, Yamamoto K, Takeji Y, Tada T, Nagao K, Uegaito T, Ehara N, Sakai H, Suwa S, Tamura T, Sakamoto H, Inada T, Matsuda M, Sato Y, Furukawa Y, Ando K, Kadota K, Nakagawa Y, Kimura T; CREDO-Kyoto AMI registry wave-2 investigators. The impact of mitral regurgitation on long-term outcomes in acute myocardial infarction undergoing percutaneous coronary intervention.
Am J Cardiol2023;203:384-393.
Yamamoto K,
Morimoto T, Natsuaki M, Shiomi H, Ogita M, Tada T, Toyota T, Nakatsuma K, Ehara N, Yamaji K, Tazaki J, Toyofuku M, Yokomatsu T, Kadota K, Ando K, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-3 investigators. Statin discontinuation after coronary revascularization.
Am J Cardiol2023;207:479-489.
Gohbara M, Hibi K,
Morimoto T, Kirigaya H, Yamamoto K, Ono K, Shiomi H, Ohya M, Yamaji K, Watanabe H, Amano T, Morino Y, Takagi K, Honye J, Matsuo H, Abe M, Kadota K, Ando K, Nakao K, Sonoda S, Suwa S, Kawai K, Kozuma K, Nakagawa Y, Ikari Y, Nanasato M, Hanaoka K, Tanabe K, Hata Y, Akasaka T, Kimura T; OPTIVUS-complex PCI investigators. SYNTAX score and 1-year outcomes in the OPTIVUS-complex PCI study multivessel cohort.
Am J Cardiol2023;205:431-441.
Kaneda K, Shiomi H, Abe M,
Morimoto T, Yamamoto K, Obayashi Y, Nishikawa R, Tamura A, Kadota K, Domei T, Nakatsuma K, Yokomatsu T, Imai M, Taniguchi T, Nawada R, Toyofuku M, Tamura T, Inada T, Matsuda M, Sato Y, Furukawa Y, Ando K, Nakagawa Y, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-3 investigators. Post-contrast acute kidney injury after emergent and elective percutaneous coronary intervention (from the CREDO-Kyoto PCI/CABG registry cohort 3).
Am J Cardiol2023;202:58-66.
Amano M, Izumi C, Watanabe H, Ozasa N,
Morimoto T, Bingyuan B, Suwa S, Miyake M, Tamura T, Nakagawa Y, Kadota K, Inuzuka Y, Minamimoto Y, Furukawa Y, Kaji S, Suzuki T, Akao M, Inada T, Kimura T; CAPITAL-RCT investigators. Effects of long-term carvedilol therapy in patients with ST-segment elevation myocardial infarction and mildly reduced left ventricular ejection fraction.
Am J Cardiol2023;199:50-58.
Morishima I, Kanzaki Y, Morita Y, Inoue K, Kobori A, Kaitani K, Kurotobi T, Yamaji H, Matsui Y, Nakazawa Y, Kusano K, Tomomatsu T, Ikai Y, Furui K, Yamauchi R, Miyazawa H, Tanaka N,
Morimoto T, Kimura T, Shizuta S; KPAF investigators. Catheter ablation for paroxysmal atrial fibrillation with sick sinus syndrome: Insights from the Kansai Plus Atrial Fibrillation registry.
Heart Lung Circ2023;32:205-214.
Saito T, Itabashi R,
Uchida K, Kawabata Y, Igasaki S, Sato K, Chiba T,
Morimoto T, Yazawa Y. Identifying large vessel occlusion using the hyperdense artery sign in patients treated with mechanical thrombectomy.
J Stroke Cerebrovasc Dis2023;32:106846.
Saito T, Itabashi R,
Uchida K, Kawabata Y, Igasaki S, Sato K, Chiba T,
Morimoto T, Yazawa Y. In reply to the letter to the editor regarding: Identifying large vessel occlusion using the hyperdense artery sign in patients treated with mechanical thrombectomy.
J Stroke Cerebrovasc Dis2023;32:107328.
Matsukawa H,
Uchida K, Rajbhandari S, Shirakawa M, Yoshimura S. Difference in the cumulative incidence of aneurysmal occlusion by flow re-direction endoluminal device and pipeline embolization device in the treatment of unruptured internal carotid artery aneurysms: A propensity score-matched cohort study.
Neurosurg Rev2023;46:125.
Uchida K, Sakai N, Yamagami H, Uemura K, Imamura H, Takeuchi M, Shirakawa M,
Sakakibara F, Haraguchi K, Kimura N, Suzuki K, Ayabe J, Yamamoto D, Shindo S, Kimoto A, Morita K, Akiyama Y, Takezawa H, Toyota S, Tanaka K, Kasakura S, Tsukagoshi E, Ueda T, Yoshimura S; Japan Trevo Registry Investigators. Japan Trevo Registry: Real-world registry of stent retriever alone or in combined therapy with aspiration catheter for acute ischemic stroke in Japan.
Neurol Med Chir (Tokyo)2023;63:503-511.
Matsuda S, Kato T,
Morimoto T, Taniguchi T, Minamino-Muta E, Matsuda M, Shiomi H, Ando K, Shirai S, Kanamori N, Murata K, Kitai T, Kawase Y, Izumi C, Miyake M, MitsuokaH, Kato M, Hirano Y, Nagao K, Inada T, Mabuchi H, Takeuchi Y, Yamane K, Toyofuku M, Ishii M, Inoko M, Ikeda T, Komasa A, Ishii K, Hotta K, Higashitani N, Jinnai T, Kato Y, Inuzuka Y, Morikami Y, Saito N, Minatoya K, Kimura T. Atrial fibrillation in patients with severe aortic stenosis.
J Cardiol2023;81:144-153.
Kinjo N, Ueda S,
Uchida K,
Sakakibara F,
Nezu M,
Arai H,
*Morimoto T. Impact of anemia on major bleeding in patients taking oral anticoagulants for nonvalvular atrial fibrillation.
J Arrhythm2023;39:556-565.
Shiomi H, Kozuma K,
Morimoto T, Kadota K, Tanabe K, Morino Y, Tamura T, Abe M, Suwa S, Ito Y, Kobayashi M, Dai K, Nakao K, Tarutani Y, Taniguchi R, Nishikawa H, Yamamoto Y, Yamasaki T, Okamura A, Nakagawa Y, Ando K, Kobayashi K, Kawai K, Hibi K, Kimura T; RESET Investigators. Ten-year clinical outcomes from a randomized trial comparing new-generation everolimus-eluting stent versus first-generation sirolimus-eluting stent: Results from the RESET extended study.
Catheter Cardiovasc Interv2023;102:594-607.
Ozasa N, Kato T,
Morimoto T, Yaku H, Yamamoto E, Inuzuka Y, Tamaki Y, Kitai T, Washida K, Seko Y, Yoshikawa Y, Sato Y, Motoki H, Kuwahara K, Kimura T. Polypharmacy and clinical outcomes in hospitalized patients with acute decompensated heart failure.
J Cardiovasc Nurs 2023;38:33-43.
Yamamoto K, Shiomi H,
Morimoto T, Watanabe H, Miyazawa A, Yamaji K, Ohya M, Nakamura S, Mitomo S, Suwa S, Domei T, Tatsushima S, Ono K, Sakamoto H, Shimamura K, Shigetoshi M, Taniguchi R, Nishimoto Y, Okayama H, Matsuda K, Nakatsuma K, Takayama Y, Kuribara J, Kirigaya H, Yoneda K, Imai Y, Kaneko U, Ueda H, Komiyama K, Okamoto N, Sasaki S, Tanabe K, Abe M, Hibi K, Kadota K, Ando K, Kimura T; OPTIVUS-Complex PCI investigators. Comparison of the OPTIVUS-Complex PCI multivessel cohort with the historical CREDO-Kyoto registry cohort-3.
Circ J2023;87:1689-1702.
Nishiwaki S, Watanabe S, Yoneda F, Tanaka M, Aizawa T, Yamagami S, Komasa A, Kawaji T, Yoshizawa T, Kohjitani H,
Morimoto T, Kimura T, Shizuta S. Impact of catheter ablation on functional tricuspid regurgitation in patients with atrial fibrillation.
J Interv Card Electrophysiol2023;66:1441-1453.
Yamamoto K, Shiomi H,
Morimoto T, Miyazawa A, Watanabe H, Nakamura S, Suwa S, Domei T, Ono K, Sakamoto H, Shigetoshi M, Taniguchi R, Okayama H, Toyota T, Yokomatsu T, Muto M, Kawaguchi R, Kishi K, Hadase M, Fujita T, Nishida Y, Nishino M, Otake H, Natsuaki M, Watanabe H, Suematsu N, Tanabe K, Abe M, Hibi K, Kadota K, Ando K, Kimura T; OPTIVUS-Complex PCI investigators. Single-session versus staged multivessel optimal intravascular ultrasound-guided percutaneous coronary intervention in patients with CCS or NSTE-ACS.
JACC Asia2023;3:649-661.
Nezu M, Ueda S,
Uchida K,
Sakakibara F, Kinjo N,
Arai H,
*Morimoto T. Association between body mass index and long-term clinical outcomes in patients with nonvalvular atrial fibrillation taking oral anticoagulants.
Heart Vessels2023;38:551-561.
Watanabe H,
Morimoto T, Yamamoto K, Obayashi Y, Natsuaki M, Yamaji K, Ogita M, Suwa S, Isawa T, Domei T, Ando K, Tatsushima S, Watanabe H, Ohya M, Kadota K, Tokuyama H, Tada T, Sakamoto H, Mori H, Suzuki H, Nishikura T, Wakabayashi K, Kimura T; STOPDAPT-2 ACS investigators. Prevalence and effects of high-intensity statins for Japanese patients presenting with acute coronary syndrome: A post hoc secondary analysis of the STOPDAPT-2 ACS.
Circ J2023;87:657-668.
Shima Y, Sato Y,
Morimoto T, Hara S, Hirabayashi R, Nagata K, Nakagawa A, Tachikawa R, Hamakawa H, Takahashi Y, Tomii K. Predictive performance of PD-L1 tumor proportion score for nivolumab response evaluated using archived specimens in patients with non-small cell lung cancer experiencing a postoperative recurrence.
Invest New Drugs2023;41:35-43.
Yamamoto K, Shiomi H,
Morimoto T, Watanabe H, Miyazawa A, Yamaji K, Ohya M, Nakamura S, Mitomo S, Suwa S, Domei T, Tatsushima S, Ono K, Sakamoto H, Shimamura K, Shigetoshi M, Taniguchi R, Nishimoto Y, Okayama H, Matsuda K, Yokomatsu T, Muto M, Kawaguchi R, Kishi K, Hadase M, Fujita T, Nishida Y, Nishino M, Otake H, Tanabe K, Abe M, Hibi K, Kadota K, Ando K, Kimura T; OPTIVUS-Complex PCI investigators. Optimal intravascular ultrasound-guided percutaneous coronary intervention in patients with multivessel disease.
JACC Asia2023;3:211-225.
Yamamoto K, Watanabe H,
Morimoto T, Obayashi Y, Natsuaki M, Domei T, Yamaji K, Suwa S, Isawa T, Watanabe H, Yoshida R, Sakamoto H, Akao M, Hata Y, Morishima I, Tokuyama H, Yagi M, Suzuki H, Wakabayashi K, Suematsu N, Inada T, Tamura T, Okayama H, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Morino Y, Kadota K, Furukawa Y, Nakagawa Y, Kimura T; STOPDAPT-2 and STOPDAPT-2 ACS investigators. Clopidogrel monotherapy after 1-month dual-antiplatelet therapy in patients with high bleeding risk or complex PCI.
JACC Asia2023;3:31-46.
Tanaka N, Inoue K, Kobori A, Kaitani K,
Morimoto T, Kurotobi T, Morishima I, Yamaji H, Matsui Y, Nakazawa Y, Kusano K, Tanaka K, Hirao Y, Okada M, Koyama Y, Okamura A, Iwakura K, Fujii K, Kimura T, Shizuta S; KPAF investigator. Atrial fibrillation ablation outcomes and heart failure (from the Kansai plus atrial fibrillation registry).
Am J Cardiol2023;189:108-118.
Soejima H, Ogawa H,
Morimoto T, Okada S, Matsumoto C, Nakayama M, Masuda I, Jinnouchi H, Waki M, Saito Y; JPAD trial investigators. Dipeptidyl peptidase-4 inhibitors reduce the incidence of first cardiovascular events in Japanese diabetic patients.
Heart Vessels2023;38:1371-1379.
Toyoshima T, Harada Y,
Morikawa T, Shimizu T. Dapsone-induced Heinz-body haemolytic anaemia.
BMJ Case Rep2023;16:e256775.
Ishihara H, Nishimoto T, Shimokawa M, Oka F, Sakai N, Yamagami H, Toyoda K, Matsumaru Y, Matsumoto Y, Kimura K, Ishikura R, Inoue M,
Uchida K,
Sakakibara F,
Morimoto T, Yoshimura S; RESCUE-Japan LIMIT investigators. Association of time course of thrombectomy and outcomes for large acute ischemic region: RESCUE-Japan LIMIT sub-analysis.
Stroke Vasc Interv Neurol2023;3:e000880.
Takahashi M,
Morimoto T, Tsushima R, Sudo Y, Sakamoto A, Sogo M, Ozaki M, Okawa K. Serial changes in the trends of direct oral anticoagulant use and incidence of thromboembolisms and major bleeding events in very old patients with nonvalvular atrial fibrillation.
Eur Heart J Open2023;3:oead107.
Yoshimura S, Sakai N, Yamagami H,
Uchida K, Beppu M, Toyoda K, Matsumaru Y, MatsumotoY, Kimura K, Takeuchi M, Yazawa Y, Kimura N, Shigeta K, Imamura H, Suzuki I, Enomoto Y, Tokunaga S, Morita K,
Sakakibara F, Kinjo N, Saito T, Ishikura R, Inoue M,
*Morimoto T. Endovascular therapy for acute stroke with a large ischemic region.
N Engl J Med2022;386:1303-1313.
Yoshimura S,
Uchida K,
*Morimoto T. Endovascular therapy for large acute strokes. Reply
N Engl J Med2022;386:2440-2441.
Yoshimura S,
Uchida K, Sakai N, Yamagami H, Inoue M, Toyoda K, Matsumaru Y, Matsumoto Y, Kimura K, Ishikura R,
Morimoto T. Randomized clinical trial of endovascular therapy for acute large vessel occlusion with large ischemic core (RESCUE-Japan LIMIT): Rationale and study protocol.
Neurol Med Chir 2022;62:156-164.
Watanabe H,
Morimoto T, Natsuaki M, Yamamoto K, Obayashi Y, Ogita M, Suwa S, Isawa T, Domei T, Yamaji K, Tatsushima S, Watanabe H, Ohya M, Tokuyama H, Tada T, Sakamoto H, Mori H, Suzuki H, Nishikura T, Wakabayashi K, Hibi K, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Morino Y, Kadota K, Furukawa Y, Nakagawa Y, Kimura T; STOPDAPT-2 ACS investigators. Comparison of clopidogrel monotherapy after 1 to 2 months of dual antiplatelet therapy with 12 months of dual antiplatelet therapy in patients with acute coronary syndrome: The STOPDAPT-2 ACS randomized clinical trial.
JAMA Cardiol2022;7:407-417.
Uchida K, Shindo S, Yoshimura S, Toyoda K, Sakai N, Yamagami H, Matsumaru Y, Matsumoto Y, Kimura K, Ishikura R, Yoshida A, Inoue M, Beppu M,
Sakakibara F, Shirakawa M,
*Morimoto T; RESCUE-Japan LIMIT investigators. Association between Alberta Stroke Program Early Computed Tomography Score and efficacy and safety outcomes with endovascular therapy in patients with stroke from large-vessel occlusion: A secondary analysis of the recovery by endovascular salvage for cerebral ultra-acute embolism-Japan large ischemic core trial (RESCUE-Japan LIMIT).
JAMA Neurol 2022;79:1260-1266.
Fujiwara S, Sakai N, Imamura H, Ohara N, Tanaka K, Yamagami H, Matsumoto Y, Takeuchi M,
Uchida K, Yoshimura S,
*Morimoto T. Association between anemic status on admission and clinical outcomes of acute large vessel occlusion.
J Neurol Sci2022;440:120343.
Arai H, Ueda S,
Uchida K,
Sakakibara F, Kinjo N,
Nezu M,
*Morimoto T. Association between acid-suppressive drugs and clinical outcomes in patients with nonvalvular atrial fibrillation.
Drugs R D2022;22:213-222.
Matsumoto C, Ogawa H, Saito Y, Okada S, Soejima H,
Sakuma M, Masuda I, Nakayama M, Doi N, Jinnouchi H, Waki M,
*Morimoto T. Incidence of atrial fibrillation in elderly patients with type 2 diabetes mellitus.
BMJ Open Diabetes Res Care2022;10:e002745.
Sakakibara F, Ueda S,
Uchida K, Kinjo N,
Arai H,
Nezu M,
*Morimoto T. Association between dihydropyridine calcium channel blockers and ischemic strokes in patients with nonvalvular atrial fibrillation.
Hypertens Res2022;45:1028-1036.
Rajbhandari S, Matsukawa H,
Uchida K, Shirakawa M, Yoshimura S. Clinical results of flow diverter treatments for cerebral aneurysms under local anesthesia.
Brain Sci2022;12:1076.
Matsubara H, Enomoto Y, Egashira Y,
Uchida K, Yamagami H, Sakai N, Yoshimura S. The safety and efficacy of periprocedural intravenous anticoagulants for acute ischemic stroke patients who underwent endovascular treatment: Sub-analysis of the RESCUE-Japan Registry 2.
J Neurol Sci2022;442:120390.
Fujiwara S, Sakai N, Imamura H, Ohara N, Tanaka K, Yamagami H, Matsumoto Y, Takeuchi M,
Uchida K, Yoshimura S,
*Morimoto T. Impact of prior antiplatelet therapy on outcomes of endovascular therapy for acute ischemic stroke with large vessel occlusion: Sub-analysis of the RESCUE-Japan registry 2.
J Neurol Sci2022;438:120278.
Yamashita Y,
Morimoto T, Kadota K, Takese T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Inoko M, Tada T, Chen PM, Murata K, Tsuyuki Y, Nishimoto Y, Sakamoto J, Togi K, Mabuchi H, Takabayashi K, Kato T, Ono K, Kimura T. Clinical characteristics, management strategies and outcomes of patients with recurrent venous thromboembolism in the real world.
Sci Rep2022;12:22437.
Yamashita Y,
Morimoto T, Kadota K, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Inoko M, Tada T, Chen PM, Murata K, Tsuyuki Y, Nishimoto Y, Sakamoto J, Togi K, Mabuchi H, Takabayashi K, Kato T, Ono K, Kimura T; COMMAND VTE registry investigators. Causes of long-term mortality in patients with venous thromboembolism in the real world: From the COMMAND VTE registry.
Thromb Res2022;219:30-39.
Obayashi Y, Watanabe H,
Morimoto T, Yamamoto K, Natsuaki M, Domei T, Yamaji K, Suwa S, Isawa T, Watanabe H, Yoshida R, Sakamoto H, Akao M, Hata Y, Morishima I, Tokuyama H, Yagi M, Suzuki H, Wakabayashi K, Suematsu N, Inada T, Tamura T, Okayama H, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Morino Y, Kadota K, Furukawa Y, Nakagawa Y, Kimura T; STOPDAPT-2 and STOPDAPT-2 ACS investigators. Clopidogrel monotherapy after 1-month dual antiplatelet therapy in percutaneous coronary intervention: From the STOPDAPT-2 total cohort.
Circ Cardiovasc Interv2022;15:e012004.
Obayashi Y, Shiomi H,
Morimoto T, Tamaki Y, Inoko M, Nishikawa R, Kaneda K, Yamamoto K, Takeji Y, Komasa A, Yamaji K, Shizuta S, Tada T, Nagao K, Suwa S, Tamura T, Sakamoto H, Inada T, Matsuda M, Sato Y, Furukawa Y, Ando K, Kadota K, Nakagawa Y, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-3 investigators. Stroke risk stratification with the CHADS2 score in patients without atrial fibrillation who underwent percutaneous coronary intervention.
Am J Cardiol2022;181:9-17.
Arai H, Ueda S,
Uchida K,
Sakakibara F, Kinjo N,
Nezu M,
*Morimoto T. Effect of current smoking on ischemic events in patients with atrial fibrillation taking vitamin K antagonist.
Int J Cardiol Cardiovasc Risk Prev2022;14:200135.
Fujita Y,
Morimoto T, Tokushige A, Ikeda M, Shimabukuro M, Node K, Ueda S. Women with type 2 diabetes and coronary artery disease have a higher risk of heart failure than men, with a significant gender interaction between heart failure risk and risk factor management: A retrospective registry study.
BMJ Open Diabetes Res Care2022;10:e002707.
Natsuaki M,
Morimoto T, Shiomi H, Yamamoto K, Yamaji K, Watanabe H, Uegaito T, Matsuda M, Tamura T, Taniguchi R, Inoko M, Mabuchi H, Takeda T, Domei T, Shirotani M, Ehara N, Eizawa H, Ishii K, Tanaka M, Inada T, Onodera T, Nawada R, Shinoda E, Yamada M, Yamamoto T, Sakai H, Toyofuku M, Tamura T, Takahashi M, Tada T, Sakamoto H, Tada T, Kaneda K, Miki S, Aoyama T, Suwa S, Sato Y, Ando K, Furukawa Y, Nakagawa Y, Kadota K, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-3 investigators. Bleeding outcomes after percutaneous coronary intervention in the past two decades in Japan-From the CREDO-Kyoto registry cohort-2 and cohort-3.
Circ J2022;86:748-759.
Takeji Y, Taniguchi T,
Morimoto T, Shirai S, Kitai T, Hiroyuki Tabata H, Kitano K, Ono N, Murai R, Osakada K, Murata K, Nakai M, Tsuneyoshi H, Tada T, Amano M, Shiomi H, Watanabe H, Yoshikawa Y, Yamamoto K, Toyofuku M, Tatsushima S, Kanamori N, Miyake M, Nakayama H, Nagao K, Izuhara M, Nakatsuma K, Inoko M, Fujita T, Kimura M, Ishii M, Usami S, Sawada K, Nakazeki F, Okabayashi M, Shirotani M, Inuzuka Y, Komiya T, Minatoya K, Kimura T; CURRENT AS registry-2 investigators. Rationale, design, and baseline characteristics of the CURRENT AS registry-2.
Circ J2022;86:1769-1776.
Soejima H, Ogawa H,
Morimoto T, Okada S,
Matsumoto C, Nakayama M, Masuda I, Jinnouchi H, Waki M, Saito Y; JPAD trial investigators. Kidney function deterioration is dependent on blood pressure levels: 11.2-year follow-up in diabetic patients.
Heart Vessels2022;37:1873-1881.
Watanabe M, Aonuma K, Murohara T, Okumura Y,
Morimoto T, Okada S, Nakamura S, Uemura S, Kuwahara K, Takayama T, Doi N, Nakajima T, Horii M, Ishigami K, Nomoto K, Abe D, Oiwa K, Tanaka K, Koyama T, Sato A, Ueda T, Soeda T, Saito Y. Prevention of contrast-induced nephropathy after cardiovascular catheterization and intervention with high-dose strong statin therapy in Japan - the PREVENT CINC-J study.
Circ J2022;86:1455-1463.
Fujimoto D, Akamatsu H,
Morimoto T, Wakuda K, Sato Y, Kawa Y, Yokoyama T, Tamiya M, Hiraoka R, Shingu N, Ikeda H, Tamiya A, Kanazu M, Miyauchi E, Miura S, Yanai M, Yomota M, Morinaga R, Yokoi T, Hata A, Suzuki H, Matsumoto H, Sakata S, Furuya N, Harutani Y, Nakaji I, Otsuki A, Uematsu S, Hara S, Yokoo K, Sugimoto T, Yamamoto N. Histologic transformation of epidermal growth factor receptor-mutated lung cancer.
Eur J Cancer2022;166:41-50.
Takahashi M, Okawa K,
Morimoto T, Tsushima R, Sudo Y, Sakamoto A, Sogo M, Ozaki M, Doi M, Morita H, Okumura K, Ito H. Impact of direct oral anticoagulant use on mortality in very old patients with non-valvular atrial fibrillation.
Age Ageing2022;51:afac146.
Seko Y, Yamamoto E, Kato T,
Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Shiba M, Yoshikawa Y, Yamashita Y, Kitai T, Taniguchi R, Iguchi M, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T; KCHF study investigators. Insomnia in patients with acute heart failure: From the KCHF registry.
ESC Heart Fail2022;9:2988-2996.
Yoshimura J, Yamakawa K, Ohta Y, Nakamura K, Hashimoto H, Kawada M, Takahashi H, Yamagiwa T, Kodate A, Miyamoto K, Fujimi S,
Morimoto T. Effect of gram stain-guided initial antibiotic therapy on clinical response in patients with ventilator-associated pneumonia: The GRACE-VAP randomized clinical trial.
JAMA Netw Open2022;5:e226136.
Nishimoto Y, Kato T,
Morimoto T, Taniguchi R, Yaku H, Inuzuka Y, Tamaki Y, Yamamoto E, Yoshikawa Y, Kitai T, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Su K, Kawato M, Seko Y, Inoko M, Toyofuku M, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Kuwahara K, Ozasa N, Sato Y, Kimura T. Public assistance in patients with acute heart failure: A report from the KCHF registry.
ESC Heart Fail2022;9:1920-1930.
Nagao K, Maruichi-Kawakami S, Aida K, Matsuto K, Imamoto K, Tamura A, Takazaki T, Nakatsu T, Tanaka M, Nakayama S,
Morimoto T, Kimura T, Inada T. Association of peripheral venous pressure with adverse post-discharge outcomes in patients with acute heart failure: A prospective cohort study.
Eur Heart J Acute Cardiovasc Care2022;11:407-417.
Yamashita Y,
Morimoto T, Klok FA, Barco S, Nishimoto Y, Kato T, Ono K, Kimura T; COMMAND VTE registry investigators. Anticoagulation strategies and clinical outcomes after bleeding events during anticoagulation therapy for venous thromboembolism in the practice-based Japanese registry.
J Thromb Thrombolysis2022;54:524-534.
Shiba M, Kato T,
Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Seko Y, Yamamoto E, Yoshikawa Y, Kitai T, Yamashita Y, Iguchi M, Nagao K, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T. Left atrial reverse remodeling improves risk stratification in patients with heart failure with recovered ejection fraction.
Sci Rep2022;12:4473.
Kawaji T, Shizuta S, Yamaji K, Tanaka M, Kitano K, Aizawa T, Yamagami S, Komasa A, Yoshizawa T, Kato M, Yokomatsu T, Miki S, Ono K,
Morimoto T, Kimura T. Matched comparison of catheter ablation versus conservative management for atrial fibrillation.
Heart Vessels2022;37:1242-1254.
Takeda C, Yamashita Y, Takeuchi M, Yonekura H, Dong L, Hamada M, Hirotsu A, Ono K, Kawakami K, Fukuda K,
Morimoto T, Kimura T, Mizota T. Incidence, clinical characteristics, and long-term prognosis of postoperative symptomatic venous thromboembolism: A retrospective cohort study.
BMJ Open2022;12:e055090.
Shiba M, Kato T,
Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Seko Y, Yamamoto E, Yoshikawa Y, Kitai T, Yamashita Y, Iguchi M, Nagao K, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Nakagawa Y, Kuwahara K, Kimura T. Changes in BNP levels from discharge to 6-month visit predict subsequent outcomes in patients with acute heart failure.
PLoS One 2022;17:e0263165.
Yamamoto E, Kato T, Yaku H,
Morimoto T, Inuzuka Y, Tamaki Y, Ozasa N, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Kawato M, Seko Y, Shiba M, Toyofuku M, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Sato Y, Kuwahara K, Kimura T; KCHF study investigators. Appetite loss at discharge from acute decompensated heart failure: Observation from KCHF registry.
PLoS One 2022;17:e0267327.
Seko Y, Kato T,
Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Shiba M, Yamamoto E, Yoshikawa Y, Yamashita Y, Kitai T, Taniguchi R, Iguchi M, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T; KCHF study investigators. Starting neurohormonal antagonists in patients with acute heart failure with mid-range and preserved ejection fraction.
Circ J2022;86:1547-1558.
Shimamura N, Naraoka M,
Uchida K, Tokuda K, Sakai N, Imamura H, Yamagami H, Tanaka K, Ezura M, Nonaka T, Matsumoto Y, Shibata M, Ohta H, Morimoto M, Fukawa N, Hatano T, Enomoto Y, Takeuchi M, Ota T, Shimizu F, Kimura N, Kamiya Y,
Morimoto T, Yoshimura S. Reperfusion therapy brings apixaban administration forward in patients with nonvalvular arterial fibrillation with anterior circulation large vessel occlusion or stenosis.
World Neurosurg2022;162:e503-e510.
Teragawa H,
Morimoto T, Fujii Y, Ueda T,
Sakuma M, Shimabukuro M, Arasaki O, Node K, Nomiyama T, Ueda S. Effect of anagliptin versus sitagliptin on renal function: Subanalyzes from the REASON trial.
Diabetes Metab Syndr Obes2022;15:685-694.
Miyagawa N, Kawazoe Y, Sato T, Kushimoto S, Miyamoto K, Ohta Y,
Morimoto T, Yamamura H; DESIRE trial investigators. Comparison between midazolam and propofol in acute phase for ventilated patients with sepsis: A post-hoc analysis of the DESIRE trial.
Acute Med Surg2022;9:e746.
*Takeuchi J, Kusunoki T,
Morimoto T. Association of skin carotenoid score and food intake among school children: A multicenter cross-sectional study.
J Nutr Sci Vitaminol2022;68:127-130.
Kamogawa N, Tanaka K, Yamagami H, Yoshimoto T,
Uchida K,
Morimoto T, Imamura H, Sakai N, Ohara N, Matsumoto Y, Takeuchi M, Shigeta K, Toyoda K, Yoshimura S. Outcomes of symptomatic anterior large vessel occlusion by initial imaging assessment using diffusion-weighted imaging versus noncontrast computed tomography.
Stroke Vasc Interv Neurol2022;2:e000170.
Araki H,
Uchida K, Yoshimura S, Kurisu K, Shime N, Sakamoto S, Aoki S, Ichinose N, Kajihara Y, Tominaga A, Naka H, Mizoue T, Sumida M, Hirotsune N, Nomura E, Matsushige T, Kanazawa J, Kato Y, Kawamoto Y, Kuroki K,
*Morimoto T. Effect of region-wide use of prehospital stroke triage scale on management of patients with acute stroke.
J Neurointerv Surg2022;14:677-682.
Koretsune Y, Hoshino H, Matsuo Y, Ibuki T,
*Morimoto T. Comparative safety and effectiveness of apixaban vs. warfarin in oral anticoagulant-naïve Japanese patients with non-valvular atrial fibrillation - A retrospective chart review study.
Circ J2022;86:213-221.
Kawaji T,
Morimoto T, Aizawa T, Hojo S, Kushiyama A, Yaku H, Nakatsuma K, Kaneda K, Kato M, Yokomatsu T, Miki S, Kimura T. Different kinetics of activated clotting time among uninterrupted oral anticoagulants during catheter ablation procedure.
J Clin Pharmacol2022;62:792-800.
Nagao K, Kato T, Yaku H,
Morimoto T, Inuzuka Y, Tamaki Y, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Su K, Kawato M, Seko Y, Inada T, Inoko M, Toyofuku M, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Sato Y, Kuwahara K, Ozasa N, Kimura T. Current use of inotropes according to initial blood pressure and peripheral perfusion in the treatment of congestive heart failure: Findings from a multicenter observational study.
BMJ Open2022;12:e053254.
Numa S,
Uchida K, Sakai N, Yamagami H, Shirakawa M, Kageyama H,
Morimoto T, Yoshimura S; RESCUE-Japan registry 2 investigators. Influence of single pass recanalization in acute ischemic stroke with large vessel occlusion in patients of Asian ethnicity.
J Neurol Sci 2022;432:120076.
Yamashita Y,
Morimoto T, Kimura T. Venous thromboembolism: Recent advancement and future perspective.
J Cardiol2022;79:79-89.
Yamashita Y,
Morimoto T, Kimura T. Optimal duration of anticoagulation therapy for venous thromboembolism in autoimmune diseases.
Eur J Intern Med2022;95:102-103.
Yamamoto K, Natsuaki M,
Morimoto T, Shiomi H, Takeji Y, Yamaji K, Matsumura-Nakano Y, Yoshikawa Y, Yamamoto E, Fuki M, Kato E, Yamashita Y, Yaku H, Nakatsuma K, Watanabe H, Matsuda M, Tamura T, Inoko M, Mabuchi H, Shirotani M, Eizawa H, Ishii K, Inada T, Onodera T, Shinoda E, Yamamoto T, Toyofuku M, Takahashi M, Sakamoto H, Miki S, Aoyama T, Suwa S, Sato Y, Furukawa Y, Ando K, Kadota K, Nakagawa Y, Kimura T; CREDO-Kyoto PCI/CABG registry investigators. Coronary artery disease without standard cardiovascular risk factors.
Am J Cardiol2022;164:34-43.
Yamamoto K, Natsuaki M,
Morimoto T, Shiomi H, Yoshikawa Y, Tazaki J, Tada T, Watanabe H, Kato E, Toyofuku M, Inada T, Kaneda K, Takeda T, Sakai H, Yamamoto T, Eizawa H, Yamada M, Shinoda E, Mabuchi H, Shirotani M, Matsuda M, Takahashi M, Ishii K, Onodera T, Sakamoto H, Aoyama T, Miki S, Ando K, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-3 investigators. Ischemic and bleeding events after first major bleeding event in patients undergoing coronary stent implantation.
Am J Cardiol2022;162:13-23.
Seko Y, Kishimori T, Kato T,
Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Shiba M, Yamamoto E, Yoshikawa Y, Yamashita Y, Kitai T, Taniguchi R, Iguchi M, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T; KCHF study invesigators. Coronary angiography in patients with acute heart failure: From the KCHF registry.
ESC Heart Fail2022;9:531-544.
Yamaji K, Shiomi H,
Morimoto T, Matsumura-Nakano Y, Ehara N, Sakamoto H, Takeji Y, Yoshikawa Y, Yamamoto K, Kato E, Imada K, Tada T, Taniguchi R, Nishikawa R, Tada T, Uegaito T, Ogawa T, Yamada M, Takeda T, Eizawa H, Tamura N, Tambara K, Suwa S, Shirotani M, Tamura T, Inoko M, Nishizawa J, Natsuaki M, Sakai H, Yamamoto T, Kanemitsu N, Ohno N, Ishii K, Marui A, Tsuneyoshi H, Terai Y, Nakayama S, Yamazaki K, Takahashi M, Tamura T, Esaki J, Miki S, Onodera T, Mabuchi H, Furukawa Y, Tanaka M, Komiya T, Soga Y, Hanyu M, Domei T, Ando K, Kadota K, Minatoya K, Nakagawa Y, Kimura T; CREDO-Kyoto PCI/CABG registry investigators. Modifiers of the risk of diabetes for long-term outcomes after coronary revascularization: CREDO-Kyoto PCI/CABG registry.
JACC Asia2022;2:294-308.
Harada J, Nagata K,
Morimoto T, Iwata K, Matsunashi A, Sato Y, Tachikawa R, Ishikawa A, Tomii K. Effect of high-flow nasal cannula oxygen therapy on exercise tolerance in patients with idiopathic pulmonary fibrosis: A randomized crossover trial.
Respirology2022;27:144-151.
Yamashita Y, Amano H,
Morimoto T, Kadota K, Hata R, Matsushita K, Osakada K, Sano A, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Inoko M, Tada T, Chen PM, Murata K, Tsuyuki Y, Nishimoto Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Kato T, Ono K, Kimura T; COMMAND VTE registry investigators. Risk factors of thrombotic recurrence and major bleeding in patients with intermediate-risk for recurrence of venous thromboembolism.
J Thromb Thrombolysis2022;53:182-190.
Miwa Y, Matsushita-Mutoh A,
Morimoto T, Ikehara Y, Yasu T, Koba S, Ako J, Higashi Y, Kajikawa M, Uehara H, Ishikawa K, Sakuma I, Tomiyama H, Node K, Kumagai Y, Ueda S. Effects of low-dose colchicine on serum high-sensitivity C-reactive protein level in coronary artery disease patients with type 2 diabetes mellitus and enhanced inflammatory response: Protocol for a randomized, double-blind, placebo-controlled, phase 2, dose-finding study.
Biomed Hub2022;7:156-164.
Murai R, Kawase Y, Taniguchi T,
Morimoto T, Kadota K, Ohya M, Shimada T, Maruo T, Fuku Y, Komiya T, Ando K, Hanyu M, Kanamori N, Aoyama T, Murata K, Onodera T, Yamazaki F, Kitai T, Furukawa Y, Koyama T, Miyake M, Izumi C, Nakagawa Y, Yamanaka K, Mitsuoka H, Shirotani M, Kato M, Miki S, Nakajima H, Hirano Y, Miyazaki S, Saga T, Sugioka S, Matsuda S, Matsuda M, Ogawa T, Nagao K, Inada T, Nakayama S, Mabuchi H, Takeuchi Y, Sakamoto H, Sakaguchi G, Yamane K, Eizawa H, Toyofuku M, Tamura T, Iwakura A, Ishii M, Akao M, Shiraga K, Minamino-Muta E, Kato T, Inoko M, Ueyama K, Ikeda T, Himura Y, Komasa A, Ishii K, Hotta K, Sato Y, Fujiwara K, Kato Y, Kouchi I, Inuzuka Y, Ikeguchi S, Miwa S, Maeda C, Shinoda E, Nishizawa J, Jinnai T, Higashitani N, Kitano M, Morikami Y, Kitaguchi S, Minatoya K, Kimura T; CURRENT AS registry investigators. Concomitant mitral regurgitation in severe aortic stenosis: A report from the CURRENT AS registry.
Circ J2022;86:427-437.
Hara H, Watanabe H, Esaki J, Hori Y, Hirao S, Kanemitsu N,
Morimoto T, Shiomi H, Yamaji K, Furukawa Y, Nakagawa Y, Kadota K, Ando K, Watanabe H, Natsuaki M, Hanyu M, Komiya T, Minatoya K, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Five-year outcomes after coronary artery bypass grafting and percutaneous coronary intervention in octogenarians with complex coronary artery disease.
Gen Thorac Cardiovasc Surg2022;70:419-429.
Furuhashi M, Sakuma I,
Morimoto T, Higashiura Y, Sakai A, Matsumoto M,
Sakuma M, Shimabukuro M, Nomiyama T, Arasaki O, Node K, Ueda S. Differential effects of DPP-4 inhibitors, anagliptin and sitagliptin, on PCSK9 levels in patients with type 2 diabetes mellitus who are receiving statin therapy.
J Atheroscler Thromb 2022;29:24-37.
Yoshimura S,
Uchida K, Sakai N, Imamura H, Yamagami H, Tanaka K, Ezura M, Nonaka T, Matsumoto Y, Shibata M, Ohta H, Morimoto M, Fukawa N, Hatano T, Enomoto Y, Takeuchi M, Ota T, Shimizu F, Kimura N, Kamiya Y, Shimamura N,
*Morimoto T. Safety of early administration of apixaban on clinical outcomes in patients with acute large vessel occlusion.
Transl Stroke Res 2021;12:266-274.
Uchida K, Yoshimura S,
Sakakibara F, Kinjo N, Araki H, Saito S,
*Morimoto T; JUST score investigators. Simplified prehospital prediction rule to estimate the likelihood of 4 types of stroke: The 7-item Japan urgent stroke triage (JUST-7) score.
Prehosp Emerg Care2021;25:465-474.
Okada S,
Morimoto T, Ogawa H, Soejima H,
Matsumoto C,
Sakuma M, Nakayama M, Doi N, Jinnouchi H, Waki M, Masuda I, Saito Y. Association between statins and cancer incidence in diabetes: A cohort study of Japanese patients with type 2 diabetes.
J Gen Intern Med2021;36:632-639.
Yaku H, Seko Y, Kato T,
Morimoto T, Kimura T; KCHF study investigators. Prognostic implications of residual pleural effusions at discharge in patients with acute decompensated heart failure.
Eur J Intern Med.2021;85:133-135.
Tokuda K, Yamada Y,
Uchida K,
Sakakibara F, Sakai N, Imamura H, Yamagami H, Tanaka K, Ezura M, Nonaka T, Matsumoto Y, Shibata M, Ohta H, Kageyama H, Morimoto M, Fukawa N, Hatano T, Enomoto Y, Takeuchi M, Ota T, Shimizu F, Kimura N, Kamiya Y, Shimamura N,
Morimoto T, Yoshimura S. Effect of prior antiplatelet therapy on large vessel occlusion in patients with non-valvular atrial fibrillation newly initiated on apixaban.
J Neurol Sci 2021;428:117603.
Okawa K, Hara S,
Morimoto T, Tsushima R, Sudo Y, Sogo M, Ozaki M, Takahashi M, Doi M, Morita H, Ito H. Effect of pre-procedural pharmacologic cardioversion on pulmonary vein isolation in patients with persistent atrial fibrillation.
Heart Rhythm2021;18:1473-1479.
Yamashita Y,
Morimoto T, Kadota K, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Inoko M, Tada T, Izumi T, Chen PM, Murata K, Tsuyuki Y, Nishimoto Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Kato T, Ono K, Kimura T; COMMAND VTE registry investigators. Severity of pulmonary embolism at initial diagnosis and long-term clinical outcomes: From the COMMAND VTE registry.
Int J Cardiol2021;343:107-113.
Shiomi H,
Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Yoshikawa Y, Yamaji K, Tada T, Tazaki J, Ehara N, Taniguchi R, Tamura T, Iwakura A, Tada T, Watanabe H, Suwa S, Toyofuku M, Inada T, Kaneda K, Ogawa T, Takeda T, Sakai H, Yamamoto T, Tambara K, Esaki J, Eizawa H, Yamada M, Shinoda E, Nishizawa J, Mabuchi H, Tamura N, Shirotani M, Nakayama S, Uegaito T, Matsuda M, Takahashi M, Inoko M, Kanemitsu N, Tamura T, Ishii K, Nawada R, Onodera T, Ohno N, Koyama T, Tsuneyoshi H, Sakamoto H, Aoyama T, Miki S, Tanaka M, Sato Y, Yamazaki F, Hanyu M, Soga Y, Komiya T, Ando K, Minatoya K, Kimura T. Coronary revascularization in the past two decades in Japan (From the CREDO-Kyoto PCI/CABG registries cohort-1, -2, and -3).
Am J Cardiol2021;153:20-29.
Seko Y, Kato T,
Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Shiba M, Yamamoto E, Yoshikawa Y, Yamashita Y, Kitai T, Taniguchi R, Iguchi M, Nagao K, Jinnai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T; KCHF study invesigators. Newly diagnosed infection after admission for acute heart failure: From the KCHF registry.
J Am Heart Assoc 2021;10:e023256.
Obayashi Y, Shiomi H,
Morimoto T, Tamaki Y, Inoko M, Yamamoto K, Takeji Y, Tada T, Nagao K, Yamaji K, Kaneda K, Suwa S, Tamura T, Sakamoto H, Inada T, Matsuda M, Sato Y, Furukawa Y, Ando K, Kadota K, Nakagawa Y, Kimura T; CREDO-Kyoto AMI registry wave-2 investigators. Newly diagnosed atrial fibrillation in acute myocardial infarction.
J Am Heart Assoc2021;10:e021417.
Yamamoto K, Natsuaki M,
Morimoto T, Shiomi H, Ozasa N, Sakamoto H, Takeji Y, Imada K, Tada T, Taniguchi R, Uegaito T, Yamada M, Takeda T, Eizawa H, Suwa S, Shirotani M, Tamura T, Inoko M, Sakai H, Yamamoto T, Ishii K, Takahashi M, Tamura T, Miki S, Onodera T, Furukawa Y, Tanaka M, Ando K, Kadota K, Nakagawa Y, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-3 investigators. Effect of polypharmacy on long-term mortality after percutaneous coronary intervention.
Am J Cardiol2021;159:19-29.
Hata R, Yamashita Y,
Morimoto T, Kadota K, Amano H, Murai R, Osakada K, Sano A, Takase T, Hiramori S, Kim K, Oi M, Akao M, Doi K, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Saga S, Nishimoto Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Tsujisaka Y, Seko Y, Matsushita K, Yoneda F, Kato T, Ono K, Kimura T; COMMAND VTE registry investigators. Periprocedural management and clinical outcomes of invasive procedures after venous thromboembolism: From the COMMAND VTE registry.
J Thromb Thrombolysis2021;53:540-549.
Kawabe A, Yasu T,
Morimoto T, Tokushige A, Momomura S, Sakakura K, Node K, Inoue T, Ueda S; CHD collaborative investigators. WBC count predicts heart failure in diabetes and coronary artery disease patients: A retrospective cohort study.
ESC Heart Fail2021;8:3748-3759.
Takeji Y, Shiomi H,
Morimoto T, Yamamoto K, Matsumura-Nakano Y, Nagao K, Taniguchi R, Yamaji K, Tada T, Kato E, Yoshikawa Y, Obayashi Y, Suwa S, Inoko M, Ehara N, Tamura T, Onodera T, Watanabe H, Toyofuku M, Nakatsuma K, Sakamoto H, Ando K, Furukawa Y, Sato Y, Nakagawa Y, Kadota K, Kimura T; CREDO-Kyoto AMI registry wave-2 investigators. Differences in mortality and causes of death between STEMI and NSTEMI in the early and late phases after acute myocardial infarction.
PLoS One2021;16:e0259268.
Yamamoto K, Watanabe H,
Morimoto T, Domei T, Ohya M, Ogita M, Takagi K, Suzuki H, Nikaido A, Ishii M, Fujii S, Natsuaki M, Yasuda S, Kaneko T, Tamura T, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Hanaoka KI, Morino Y, Kozuma K, Kadota K, Furukawa Y, Nakagawa Y, Kimura T; STOPDAPT-2 investigators. Very short dual antiplatelet therapy after drug-eluting stent implantation in patients who underwent complex percutaneous coronary intervention: Insight from the STOPDAPT-2 trial.
Circ Cardiovasc Interv2021;14:e010384.
Iguchi M, Kato T, Yaku H,
Morimoto T, Inuzuka Y, Tamaki Y, Ozasa N, Yamamoto E, Yoshikawa Y, Kitai T, Hamatani Y, Yamashita Y, Masunaga N, Ogawa H, Ishii M, An Y, Taniguchi R, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Kawato M, Seko Y, Toyofuku M, Furukawa Y, Ando K, Kadota K, Abe M, Akao M, Sato Y, Kuwahara K, Kimura T. Ischemic stroke in acute decompensated heart failure: From the KCHF registry.
J Am Heart Assoc 2021;10:e022525.
Todo K, Yoshimura S,
Uchida K, Yamagami H, Sakai N, Kishima H, Mochizuki H, Ezura M, Okada Y, Kitagawa K, Kimura K, Sasaki M, Tanahashi N, Toyoda K, Furui E, Matsumaru Y, Minematsu K, Kitano T, Okazaki S, Sasaki T, Sakaguchi M, Takagaki M, Nishida T, Nakamura H,
Morimoto T. Time-outcome relationship in acute large-vessel occlusion exists across all ages: Subanalysis of RESCUE-Japan registry 2.
Sci Rep2021;11:12782.
Tatebayashi K,
Uchida K, Kageyama H, Imamura H, Ohara N, Sakai N, Tanaka K, Yamagami H, Matsumoto Y, Takeuchi M,
Morimoto T, Yoshimura S; RESCUE-Japan registry 2 investigators. Differences in acute ischemic stroke management and prognosis between multiple large-vessel occlusion and single large-vessel occlusion: Subanalysis of the RESCUE-Japan registry 2.
Cerebrovasc Dis2021;50:397-404.
Enomoto Y,
Uchida K, Yamagami H, Imamura H, Ohara N, Sakai N, Tanaka K, Matsumoto Y, Egashira Y,
Morimoto T, Yoshimura S. Impact of procedure time on clinical outcomes of patients who underwent endovascular therapy for acute ischemic stroke.
Cerebrovasc Dis2021;50:443-449.
Shirakawa M, Matsukawa H, Imamura H, Sakai N, Tanaka K, Yamagami H, Matsumoto Y, Takeuchi M,
Uchida K,
Morimoto T, Yoshimura S; RESCUE-Japan registry 2 investigators. Endovascular therapy for acute ischemic stroke in patients with large-vessel occlusion due to atherosclerotic stenosis.
J Stroke Cerebrovasc Dis2021;30:105960.
Doi A, Iwata K, Kuroda H, Hasuike T, Nasu S, Nishioka H, Tomii K,
Morimoto T, Kihara Y. A cross-sectional follow up study to estimate seroprevalence of coronavirus disease 2019 (COVID-19) in Kobe, Japan.
Medicine2021;100:e28066.
Aoyama Y, Inaba T, Takahashi S, Yasuhara H, Hiraoka S,
Morimoto T, Colvin HS, Wato M, Ando M, Nakamura S, Mizobuchi K, Okada H. Anti-proteinase 3 antineutrophil cytoplasmic antibody reflects disease activity and predicts the response to steroid therapy in ulcerative colitis.
BMC Gastroenterol2021;21:325.
Nishimoto Y, Yamashita Y,
Morimoto T, Sato Y, Kimura T; COMMAND VTE registry investigators. Risk factors of recurrence in patients with cancer-associated venous thromboembolism.
Eur J Intern Med2021;91:98-101.
Onishi N, Kaitani K, Nakagawa Y, Inoue K, Kobori A, Nakazawa Y, Ozawa T, Kurotobi T, Morishima I, Miura F, Watanabe T, Masuda M, Naito M, Fujimoto H, Nishida T, Furukawa Y, Shirayama T, Tanaka M, Okajima K, Yao T, Egami Y, Satomi K, Noda T, Miyamoto K, Haruna T, Higashi Y, Ito M, Horie M, Kusano K, Shimizu W, Kamakura S, Shimizu Y, Hanazawa K, Tamura T, Izumi C,
Morimoto T, Kimura T, Shizuta S; EAST-AF investigator. The association between late-phase early recurrence within the blanking period after atrial fibrillation catheter ablation and long-term recurrence: Insights from a large-scale multicenter study.
Int J Cardiol2021;341:39-45.
Motoyama Y,
Morimoto T,
Takeuchi J, Kusunoki T. Fall birth is associated with prolonged elimination in Japanese children with hen’s egg allergy: A population-based study.
Allergol Int2021;70:498-500.
Obata H, Izumi T, Yamashita M, Mitsuma W, Suzuki K, Noto S,
Morimoto T, Isobe M. Characteristics of elderly patients with heart failure and impact on activities of daily living: A registry report from super-aged society.
J Card Fail2021;27:1203-1213.
Natsuaki M,
Morimoto T, Shiomi H, Kadota K, Tada T, Takeji Y, Matsumura-Nakano Y, Yoshikawa Y, Watanabe H, Yamamoto K, Imada K, Domei T, Yamaji K, Kaneda K, Taniguchi R, Ehara N, Nawada R, Toyofuku M, Shinoda E, Suwa S, Tamura T, Inada T, Matsuda M, Aoyama T, Sato Y, Furukawa Y, Ando K, Nakagawa Y, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-3 investigators. Effects of acute coronary syndrome and stable coronary artery disease on bleeding and ischemic risk after percutaneous coronary intervention.
Circ J2021;85:1928-1941.
Arai H, Matsumoto S,
*Morimoto T. Implication of exercise training in patients with aortic stenosis.
Circ Rep2021;3:689.
Tatebayashi K, Yoshimura S, Sakai N,
Uchida K, Yamagami H,
Morimoto T; RESCUE-Japan registry 2 investigators. Relationship between acute neurological function and long-term prognosis in patients with large arterial occlusions.
J Stroke Cerebrovasc Dis2021;30:105625.
Kawakami D, Fujitani S,
Morimoto T, Dote H, Takita M, Takaba A, Hino M, Nakamura M, Irie H, Adachi T, Shibata M, Kataoka J, Korenaga A, Yamashita T, Okazaki T, Okumura M, Tsunemitsu T. Prevalence of post-intensive care syndrome among Japanese intensive care unit patients: A prospective, multicenter, observational J-PICS study.
Crit Care2021;25:69.
Tamaki Y, Yaku H,
Morimoto T, Inuzuka Y, Ozasa N, Yamamoto E, Yoshikawa Y, Miyake M, Kondo H, Tamura T, Kitai T, Iguchi M, Nagao K, Nishikawa R, Kawase Y, Morinaga T, Kawato M, Toyofuku M, Sato Y, Kuwahara K, Nakagawa Y, Kato T, Kimura T; KCHF study investigators. Lower in-hospital mortality with beta-blocker use at admission in patients with acute decompensated heart failure.
J Am Heart Assoc 2021;10:e020012.
Seko Y, Kato T,
Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Shiba M, Yamamoto E, Yoshikawa Y, Kitai T, Yamashita Y, Iguchi M, Nagao K, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T; KCHF study investigators. Improved and new-onset anemia during follow-up in patients with acute decompensated heart failure: Characteristics and outcomes.
Medicine2021;100:e26892.
Kanenawa K, Yamaji K, Tashiro H,
Morimoto T, Hiromasa T, Hayashi M, Hiramori S, Tomoi Y, Kuramitsu S, Domei T, Hyodo M, Ando K, Kimura T. Frailty and bleeding after percutaneous coronary intervention.
Am J Cardiol2021;148:22-29.
Kawase Y, Kato T,
Morimoto T, Hata R, Murai R, Tada T, Katoh H, Kadota K, Yamamoto E, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Yoshikawa Y, Iguchi M, Nagao K, Sato Y, Kuwahara K, Kimura T. Admission systolic blood pressure as a prognostic predictor of acute decompensated heart failure: A report from the KCHF registry.
PLoS One 2021;16:e0253999.
Yamashita Y, Bikdeli B, Monreal M,
Morimoto T, Kato T, Ono K, de Ancos C, López-Núñez JJ, Braester A, Mellado M, Kimura T; COMMAND VTE registry investigators; RIETE investigators. Difference between Japanese and white patients with acute pulmonary embolism.
Thromb Res2021;204:52-56.
Ito J, Kawakami D,
Morimoto T, Ueta H, Shimozono T, Mima H. The effect of changing arterial transducer position on stroke volume measurements using FloTrac system version 4.0: A pilot experimental study.
Crit Care Explor2021;3:e0465.
Yamamoto K, Shiomi H,
Morimoto T, Kadota K, Tada T, Takeji Y, Matsumura-Nakano Y, Yoshikawa Y, Imada K, Domei T, Kaneda K, Taniguchi R, Ehara N, Nawada R, Natsuaki M, Yamaji K, Toyofuku M, Kanemitsu N, Shinoda E, Suwa S, Iwakura A, Tamura T, Soga Y, Inada T, Matsuda M, Koyama T, Aoyama T, Sato Y, Furukawa Y, Ando K, Yamazaki F, Komiya T, Minatoya K, Nakagawa Y, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-3 investigators. Percutaneous coronary intervention versus coronary artery bypass grafting among patients with unprotected left main coronary artery disease in the new-generation drug-eluting stents era (From CREDO-Kyoto PCI/CABG registry cohort-3).
Am J Cardiol2021;145:47-57.
Matsumura-Nakano Y, Shiomi H,
Morimoto T, Yamaji K, Ehara N, Sakamoto H, Takeji Y, Yoshikawa Y, Yamamoto K, Imada K, Tada T, Taniguchi R, Nishikawa R, Tada T, Uegaito T, Ogawa T, Yamada M, Takeda T, Eizawa H, Tamura N, Tambara K, Suwa S, Shirotani M, Tamura T, Inoko M, Nishizawa J, Natsuaki M, Sakai H, Yamamoto T, Kanemitsu N, Ohno N, Ishii K, Marui A, Tsuneyoshi H, Terai Y, Nakayama S, Yamazaki K, Takahashi M, Tamura T, Esaki J, Miki S, Onodera T, Mabuchi H, Furukawa Y, Tanaka M, Komiya T, Soga Y, Hanyu M, Ando K, Kadota K, Minatoya K, Nakagawa Y, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-3 investigators. Comparison of outcomes of percutaneous coronary intervention versus coronary artery bypass grafting among patients with three-vessel coronary artery disease in the new-generation drug-eluting stents era (From CREDO-Kyoto PCI/CABG registry cohort-3).
Am J Cardiol2021;145:25-36.
Yamamoto K, Natsuaki M,
Morimoto T, Shiomi H, Takeji Y, Kadota K, Imada K, Toyofuku M, Kanemitsu N, Shinoda E, Suwa S, Iwakura A, Tamura T, Soga Y, Inada T, Matsuda M, Koyama T, Aoyama T, Kato E, Sato Y, Furukawa Y, Ando K, Yamazaki F, Komiya T, Minatoya K, Nakagawa Y, Kimura T. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with versus without chronic kidney disease.
Am J Cardiol2021;145:37-46.
Takeji Y, Shiomi H,
Morimoto T, Yoshikawa Y, Taniguchi R, Matsumura-Nakano Y, Yamamoto K, Yamaji K, Tazaki J, Kato E, Watanabe H, Yamamoto E, Yamashita Y, Fukui M, Suwa S, Inoko M, Takeda T, Shirotani M, Ehara N, Ishii K, Inada T, Tamura T, Onodera T, Shinoda E, Yamamoto T, Watanabe H, Yaku H, Nakatsuma K, Sakamoto H, Ando K, Soga Y, Furukawa Y, Sato Y, Nakagawa Y, Kadota K, Komiya T, Minatoya K, Kimura T; CREDO-Kyoto AMI registry wave-1 and the CREDO-Kyoto AMI registry wave-2 investigators. Changes in demographics, clinical practices, and long-term outcomes of patients with ST-segment-elevation myocardial infarction who underwent coronary revascularization in the past two decades: Cohort study.
BMJ Open2021;11:e043683.
Takeji Y, Shiomi H,
Morimoto T, Yoshikawa Y, Taniguchi R, Matsumura-Nakano Y, Yamamoto K, Yamaji K, Tazaki J, Suwa S, Inoko M, Takeda T, Shirotani M, Ehara N, Ishii K, Inada T, Onodera T, Shinoda E, Yamamoto T, Tamura T, Nakatsuma K, Sakamoto H, Ando K, Soga Y, Furukawa Y, Sato Y, Nakagawa Y, Kadota K, Komiya T, Minatoya K, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 and the CREDO-Kyoto PCI/CABG registry cohort-3 investigators. Demographics, practice patterns and long-term outcomes of patients with non-ST-segment elevation acute coronary syndrome in the past two decades: The CREDO-Kyoto cohort-2 and cohort-3.
BMJ Open2021;11:e044329.
Shiba M, Kato T,
Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Seko Y, Yamamoto E, Yoshikawa Y, Kitai T, Yamashita Y, Iguchi M, Nagao K, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T; KCHF study investigators. Prognostic value of reduction in left atrial size during a follow-up of heart failure: An observational study.
BMJ Open2021;11:e044409.
Seko Y, Kato T,
Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Shiba M, Yamamoto E, Yoshikawa Y, Kitai T, Yamashita Y, Iguchi M, Nagao K, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T; KCHF study investigators. A decrease in tricuspid regurgitation pressure gradient associates with favorable outcome in patients with heart failure.
ESC Heart Fail2021;8:2826-2836.
Hosoya K, Fujimoto D,
Morimoto T, Kumagai T, Tamiya A, Taniguchi Y, Yokoyama T, Ishida T, Matsumoto H, Hirano K, Kominami R, Tomii K, Suzuki H, Hirashima T, Tanaka S, Uchida J, Morita M, Kanazu M, Mori M, Nagata K, Fukuda I, Tamiya M. Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-small-cell lung cancer patients: A retrospective multicenter study.
BMC Cancer2021;21:346.
Yamamoto K, Matsumura-Nakano Y, Shiomi H, Natsuaki M,
Morimoto T, Kadota K, Tada T, Takeji Y, Yoshikawa Y, Imada K, Domei T, Kaneda K, Taniguchi R, Ehara N, Nawada R, Yamaji K, Kato E, Toyofuku M, Kanemitsu N, Shinoda E, Suwa S, Iwakura A, Tamura T, Soga Y, Inada T, Matsuda M, Koyama T, Aoyama T, Sato Y, Furukawa Y, Ando K, Yamazaki F, Komiya T, Minatoya K, Nakagawa Y, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-3 investigators. Effect of heart failure on long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting in patients with severe coronary artery disease.
J Am Heart Assoc2021;10:e021257.
Washida K, Kato T, Ozasa N,
Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Seko Y, Yamamoto E, Yoshikawa Y, Kitai T, Yamashita Y, Iguchi M, Nagao K, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T. Risk factors and clinical outcomes of nonhome discharge in patients with acute decompensated heart failure: An observational study.
J Am Heart Assoc2021;10:e020292.
Tanaka K, Yamagami H, Yoshimoto T,
Uchida K,
Morimoto T, Toyoda K, Sakai N, Yoshimura S. Endovascular therapy for acute ischemic stroke in patients with prestroke disability.
J Am Heart Assoc2021;10:e020783.
Koge J, Tanaka K, Yamagami H, Yoshimoto T,
Uchida K,
Morimoto T, Toyoda K, Sakai N, Yoshimura S. Mechanical thrombectomy for stroke patients anticoagulated with direct oral anticoagulants versus warfarin.
J Neurol Sci2021;427:117545.
Yazawa Y, Ohira T, Itabashi R
Uchida K, Sakai N, Yamagami H,
Morimoto T, Yoshimura S; RESCUE-Japan registry 2 investigators. Association of admission hyperglycemia with clinical outcomes in Japanese patients with acute large vessel occlusion stroke: A post hoc analysis of the recovery by endovascular salvage for cerebral ultra-acute embolism Japan registry 2.
Cerebrovasc Dis2021;50:12-19.
Yamamoto K, Natsuaki M,
Morimoto T, Shiomi H, Matsumura-Nakano Y, Nakatsuma K, Watanabe H, Yamamoto E, Kato E, Fuki M, Yamaji K, Nishikawa R, Nagao K, Takeji Y, Watanabe H, Tazaki J, Watanabe S, Saito N, Yamazaki K, Soga Y, Komiya T, Ando K, Minatoya K, Furukawa Y, Nakagawa Y, Kadota K, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-3 investigators. Periprocedural stroke after coronary revascularization (from the CREDO-Kyoto PCI/CABG registry cohort-3).
Am J Cardiol2021;142:35-43.
Kaneda K, Yamashita Y,
Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Morita Y, Tada T, Chen PM, Murata K, Tsuyuki Y, Nakagawa Y, Nishimoto Y, Saga S, Sakamoto J, Kinoshita M, Togi K, Ishii K, Mabuchi H, Takabayashi K, Hojo S, Kawaji T, Kushiyama A, Yaku H, Nakatsuma K, Kato M, Yokomatsu T, Miki S, Kimura T; COMMAND VTE registry investigators. Influence of low body weight on long-term clinical outcomes in patients with venous thromboembolism: From the COMMAND VTE registry.
Thromb Res2021;198:26-33.
Yamashita Y,
Morimoto T, Kadota K, Ono K, Kimura T; COMMAND VTE registry investigators. Autoimmune disorders and venous thromboembolism: An update from the COMMAND VTE registry.
Eur J Intern Med2021;84:106-108.
Sato Y,
Morimoto T, Hara S, Nagata K, Hosoya K, Nakagawa A, Tachikawa R, Tomii K. Dissociated response and clinical benefit in patients treated with nivolumab monotherapy.
Invest New Drugs2021;39:1170-1178.
Dmytriw AA, Ku JC, Yang VXD, Hui N,
Uchida K,
Morimoto T, Spears J, Marotta TR, Diestro JDB. Do outcomes between women and men differ after endovascular thrombectomy? A meta-analysis.
AJNR Am J Neuroradiol2021;42:910-915.
Yamamoto K, Shiomi H,
Morimoto T, Takeji Y, Yoshikawa Y, Natsuaki M, Watanabe H, Tada T, Tazaki J, Yamaji K, Tamura T, Ando K, Kadota K, Furukawa Y, Nakagawa Y, Kimura T. Ischemic and bleeding risk after complex percutaneous coronary intervention in patients with or without high bleeding risk.
Catheter Cardiovasc Interv2021;97:E758-770.
Shiba M, Kato T,
Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Seko Y, Yamamoto E, Yoshikawa Y, Kitai T, Yamashita Y, Iguchi M, Nagao K, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T. Serum cholinesterase as a prognostic biomarker for acute heart failure.
Eur Heart J Acute Cardiovasc Care2021;10:335-342.
Yamashita Y,
Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Morita Y, Tada T, Izumi T, Chen PM, Murata K, Tsuyuki Y, Saga S, Nishimoto Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Yoshikawa Y, Shiomi H, Kato T, Makiyama T, Ono K, Kimura T; COMMAND VTE registry investigators. Clinical characteristics and outcomes of patients with venous thromboembolism according to diagnosis on weekends versus on weekdays.
J Thromb Thrombolysis2021;51:779-788.
Morillo R, Jimenez D, Bikdeli B, Rodriguez C, Tenes A, Yamashita Y,
Morimoto T, Kimura T, Vidal G, Ruiz-Gimenz N, Espitia O, Monreal M; RIETE investigators. Refinement of a modified simplified pulmonary embolism severity index for elderly patients with acute pulmonary embolism.
Int J Cardiol2021;335:111-117.
Natsuaki M,
Morimoto T, Shiomi H, Ehara N, Taniguchi R, Tamura T, Tada T, Suwa S, Kaneda K, Watanabe H, Tazaki J, Watanabe S, Yamamoto E, Saito N, Fuki M, Takeda T, Eizawa H, Shinoda E, Mabuchi H, Shirotani M, Uegaito T, Matsuda M, Takahashi M, Inoko M, Tamura T, Ishii K, Onodera T, Sakamoto H, Aoyama T, Sato Y, Ando K, Furukawa Y, Nakagawa Y, Kadota K, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-3 investigators. Application of the modified high bleeding risk criteria for Japanese patients in an all-comers registry of percutaneous coronary intervention- From the CREDO-Kyoto registry cohort-3.
Circ J2021;85:769-781.
Song X, Saito N,
Morimoto T, Taniguchi T, Shiomi H, Ando K, Nagao K, Kanamori N, Murata K, Kitai T, Kawase Y, Izumi C, Miyake M, Mitsuoka H, Kato M, Hirano Y, Matsuda S, Inada T, Murakami T, Takeuchi Y, Yamane K, Toyofuku M, Ishii M, Minamino-Muta E, Kato T, Yoshikawa Y, Inoko M, Ikeda T, Ishii K, Hotta K, Higashitani N, Kato Y, Inuzuka Y, Maeda C, Jinnai T, Morikami Y, Minatoya K, Kimura T; CURRENT AS registry investigators. Long-term impact of diabetes mellitus on initially conservatively managed patients with severe aortic stenosis.
Circ J2021;85:1083-1092.
Ohira J, Ohara N, Hinoda T,
Morimoto T, Kohara N. Patient characteristics with negative diffusion-weighted imaging findings in acute lateral medullary infarction.
Neurol Sci2021;42:689-696.
Takeji Y, Taniguchi T,
Morimoto T, Saito N, Ando K, Shirai S, Kawase Y, Kitai T, Shiomi H, Minamino-Muta E, Matsuda S, Yamazaki K, Miyake M, Murata K, Kanamori N, Izumi C, Mitsuoka H, Kato M, Hirano Y, Inada T, Nagao K, Mabuchi H, Takeuchi Y, Yamane K, Toyofuku M, Ishii M, Inoko M, Ikeda T, Ishii K, Hotta K, Jinnai T, Higashitani N, Kato Y, Inuzuka Y, Morikami Y, Minatoya K, Kimura T; CURRENT AS registry investigators. Clinical outcome after surgical aortic valve replacement in low-risk Japanese patients with severe aortic stenosis.
Cardiovasc Interv Ther2021;36:121-130.
Watanabe H, Domei T,
Morimoto T, Natsuaki M, Shiomi H, Toyota T, Ohya M, Suwa S, Takagi K, Nanasato M, Hata Y, Yagi M, Suematsu N, Yokomatsu T, Takamisawa I, Doi M, Noda T, Okayama H, Seino Y, Tada T, Sakamoto H, Hibi K, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Hanaoka KI, Morino Y, Kozuma K, Kadota K, Furukawa Y, Nakagawa Y, Kimura T; STOPDAPT-2 investigators. Details on the effect of very short dual antiplatelet therapy after drug-eluting stent implantation in patients with high bleeding risk: Insight from the STOPDAPT-2 trial.
Cardiovasc Interv Ther2021;36:91-103.
Fujita K, Tanaka K, Yamagami H, Yoshimoto T,
Uchida K,
Morimoto T, Imamura H, Sakai N, Ohara N, Matsumoto Y, Takeuchi M, Shigeta K, Toyoda K, Yoshimura S. Outcomes of large vessel occlusion stroke in patients aged ≥90 years.
Stroke2021;52:1561-1569.
Arai H, Nozoe M, Matsumoto S,
*Morimoto T. Exercise training for patients with severe aortic stenosis in a convalescent rehabilitation ward: A retrospective cohort study.
Circ Rep2021;3:361-367.
Ishiguchi H, Shimizu A, Ishikura M, Yoshida M, Imoto K, Sonoyama K, Kawabata T, Sugamori T, Ogawa M, Uchida T, Nakamura T,
Morimoto T, Yasuda Y, Tanabe K, Yoshiga Y, Okamura T, Kobayashi S, Yano M, Oda T. Association between atrial high-rate episodes and ischemic/major bleeding events in patients with a cardiac implantable electronic device - A 10-year, single-center historical cohort study.
Circ J2021;85:1329-1337.
Sato T, Kawazoe Y, Miyagawa N, Yokokawa Y, Kushimoto S, Miyamoto K, Ohta Y,
Morimoto T, Yamamura H. Effect of age on dexmedetomidine treatment for ventilated patients with sepsis: A post-hoc analysis of the DESIRE trial.
Acute Med Surg2021;8:e644.
Doi A, Iwata K, Kuroda H, Hasuike T, Nasu S, Kanda A, Nagao T, Nishioka H, Tomii K,
Morimoto T, Kihara Y. Estimation of seroprevalence of novel coronavirus disease (COVID-19) using preserved serum at an outpatient setting in Kobe, Japan: A cross-sectional study.
Clin Epidemiol Glob Health2021;11:100747.
Watanabe H,
Morimoto T, Ogita M, Suwa S, Natsuaki M, Suematsu N, Koeda Y, Morino Y, Nikaido A, Hata Y, Doi M, Hibi K, Kimura K, Yoda S, Kaneko T, Nishida K, Kawai K, Yamaguchi K, Wakatsuki T, Tonoike N, Yamamoto M, Shimizu S, Shimohama T, Ako J, Kimura T; STOPDAPT-2 investigators. Influence of CYP2C19 genotypes for the effect of 1-month dual antiplatelet therapy followed by clopidogrel monotherapy relative to 12-month dual antiplatelet therapy on clinical outcomes after percutaneous coronary intervention; A genetic substudy from the STOPDAPT-2.
Cardiovasc Interv Ther2021;36:403-415.
Yoshikawa Y, Shiomi H,
Morimoto T, Takeji Y, Matsumura-Nakano Y, Yamamoto K, Yamamoto E, Kato E, Watanabe H, Saito N, Domei T, Tada T, Nawada R, Onodera T, Suwa S, Tamura T, Ishii K, Ando K, Furukawa Y, Kadota K, Nakagawa Y; Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 and cohort-3 investigators. Stent-related adverse events as related to dual antiplatelet therapy in first- versus second-generation drug-eluting stents.
JACC Asia2021;1:345-356.
Nakamichi T, Hashimoto M, Nakamura A, Kuroda A, Tanaka T,
Takeuchi J, Matsumoto S,
Morimoto T, Kondo N, Domen K, Hasegawa S. Quality of life and lung function after pleurectomy/decortication for malignant pleural mesothelioma.
Interact Cardiovasc Thorac Surg2021;33:572-579.
Hata R, Kato T, Yaku H,
Morimoto T, Kawase Y, Yamamoto E, Inuzuka Y, Tamaki Y, Ozasa N, Yoshikawa Y, Kitai T, Yamashita Y, Iguchi M, Nagao K, Morinaga T, Furukawa Y, Kadota K, Sato Y, Kimura T. Implantable cardioverter defibrillator therapy in patients with acute decompensated heart failure with reduced ejection fraction: An observation from the KCHF registry.
J Cardiol2021;77:292-299.
Nishiwaki S, Morita Y, Yamashita Y,
Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Saga S, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Inoko M, Kimura T; COMMAND VTE registry investigators. Impact of no, distal, and proximal deep vein thrombosis on clinical outcomes in patients with acute pulmonary embolism: From the COMMAND VTE registry.
J Cardiol2021;77:395-403.
Matsumoto C, Ogawa H, Saito Y, Okada S, Soejima H,
Sakuma M, Masuda I, Nakayama M, Doi N, Jinnouchi H, Waki M,
*Morimoto T; JPAD trial investigators. Sex difference in effects of low-dose aspirin on prevention of dementia in patients with type 2 diabetes: A long-term follow-up study of a randomized clinical trial.
Diabetes Care2020;43:314-320.
Ohta Y, Miyamoto K, Kawazoe Y, Yamamura H,
*Morimoto T. Effect of dexmedetomidine on inflammation in patients with sepsis requiring mechanical ventilation: A sub-analysis of a multicenter randomized clinical trial.
Crit Care2020;24:493.
Uchida K, Yoshimura S, Imamura H, Ohara N, Sakai N, Tanaka K, Yamagami H, Matsumoto Y, Takeuchi M,
*Morimoto T; RESCUE-Japan registry 2 investigators. Effect of statin administration after onset of acute ischemic stroke with large vessel occlusion: Insights from RESCUE-Japan registry 2.
J Am Heart Assoc2020;9:e017472.
Kinjo N, Yoshimura S,
Uchida K, Sakai N, Yamagami H,
*Morimoto T; RESCUE-Japan registry 2 investigators. Incidence and prognostic impact of intracranial hemorrhage after endovascular treatment for acute large vessel occlusion.
Cerebrovasc Dis2020;49:540-549.
Sakakibara F, Yoshimura S, Numa S,
Uchida K, Kinjo N,
*Morimoto T. Diffusion-weighted imaging-fluid-attenuated inversion recovery mismatch is associated with 90-day functional outcomes in patients undergoing mechanical thrombectomy.
Cerebrovasc Dis2020;49:292-300.
Arai H,
Takeuchi J, Nozoe M, Fukuoka T, Matsumoto S,
*Morimoto T. Association between active gait training for severely disabled patients with nasogastric tube feeding or gastrostoma and recovery of oral feeding: A retrospective cohort study.
Clin Interv Aging2020;15:1963-1970.
Nishimoto Y, Kato T,
Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Su K, Kawano M, Seko Y, Inoko M, Toyofuku M, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Kuwahara K, Ozasa N, Sato Y, Kimura T. C-reactive protein at discharge and 1-year mortality in hospitalized patients with acute decompensated heart failure: An observational study.
BMJ Open2020;10:e041068.
Nakashima T, Miyamoto K, Shima N, Kato S, Kawazoe Y, Ohta Y,
Morimoto T, Yamamura H; DESIRE trial investigators. Dexmedetomidine improves mortality and renal function in patients with severe sepsis: A exploratory analysis of a randomized controlled trial.
J Intensive Care2020;8:1.
Miyamoto K, Nakashima T, Shima N, Kato S, Kawazoe Y,
Morimoto T, Ohta Y, Yamamura H. Utility of a prediction model for delirium in ICU patients (PRE-DELIRIC) in mechanically ventilated patients with sepsis.
Acute Med Surg2020;7:e589.
Saito T, Itabashi R, Yazawa Y,
Uchida K, Yamagami H, Sakai N,
Morimoto T, Yoshimura S; RESCUE-Japan registry 2 investigators. Clinical outcome of patients with large vessel occlusion and low National Institutes of Health Stroke Scale scores: Subanalysis of the RESCUE-Japan registry 2.
Stroke2020;51:1458-1463.
Taniguchi T,
Morimoto T, Takeji Y, Kato T, Kimura T; CURRENT AS registry investigators. Contemporary issues in severe aortic stenosis: Review of current and future strategies from the contemporary outcomes after surgery and medical treatment in patients with severe aortic stenosis registry.
Heart2020;106:802-809.
Yamashita Y,
Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Nishimoto Y, Saga S, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Yoshikawa Y, Shiomi H, Kato T, Makiyama T, Ono K, Kimura T; COMMAND VTE registry investigators. Usefulness of simplified pulmonary embolism severity index score for identification of patients with low-risk pulmonary embolism and active cancer: From the COMMAND VTE registry.
Chest2020;157:636-644.
Seko Y, Kato T,
Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Shiba M, Yamamoto E, Yoshikawa Y, Yamashita Y, Kitai T, Taniguchi R, Iguchi M, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T. Association between body mass index and prognosis of patients hospitalized with heart failure.
Sci Rep2020;10:16663.
Teragawa H,
Morimoto T, Fujii Y, Ueda T,
Sakuma M, Shimabukuro M, Arasaki O, Node K, Nomiyama T, Ueda S. Effect of anagliptin versus sitagliptin on inflammatory markers: Sub-analysis from the REASON trial.
Diabetes Metab Syndr Obes2020;13:4993-5001.
Furuhashi M, Sakuma I,
Morimoto T, Higashiura Y, Sakai A, Matsumoto M,
Sakuma M, Shimabukuro M, Nomiyama T, Arasaki O, Node K, Ueda S. Independent and distinct associations of FABP4 and FABP5 with metabolic parameters in type 2 diabetes mellitus.
Front Endocrinol 2020;11:575557.
Yamamoto E, Kato T, Yaku H,
Morimoto T, Inuzuka Y, Tamaki Y, Ozasa N, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Himura Y, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Kawato M, Seko Y, Toyofuku M, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Sato Y, Kuwahara K, Kimura T; KCHF study investigators. Sex differences in patients with acute decompensated heart failure in Japan: Observation from the KCHF registry.
ESC Heart Fail2020;7:2485-2493.
Furuhashi M, Sakuma I,
Morimoto T, Higashiura Y, Sakai A, Matsumoto M,
Sakuma M, Shimabukuro M, Nomiyama T, Arasaki O, Node K, Ueda S. Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving statin therapy.
Cardiovasc Diabetol2020;19:89.
Takese T, Iwanaga Y, Yamashita Y,
Morimoto T, Yoshikawa Y, Amano H, Hiramori S, Kim K, Oi M, Kobayashi Y, Nishimoto Y, Watanabe H, Yamaji K, Yasuoka R, Ueno M, Kobuke K, Kimura T, Miyazaki S; COMMAND VTE registry investigators. Long-term effects of non-retrieved inferior vena cava filters on recurrences of venous thromboembolism in cancer and non-cancer patients: From the COMMAND VTE registry.
Eur J Intern Med.2020;82:90-96.
Hirai H, Higa M,
Morimoto T,
Sakuma M, Arasaki O, Nomiyama T, Node K, Ueda S, Shimabukuro M. Dissimilar effects of anagliptin and sitagliptin on lipoprotein subclass in standard or strong statin-treated patients with type-2 diabetes mellitus: A subanalysis of the REASON (randomized evaluation of anagliptin versus sitagliptin on low-density lipoprotein cholesterol in diabetes) trial.
J Clin Med2020;9:93.
Oh A, Kisanuki K, Nishigaki N, Shimasaki Y, Sakaguchi K,
Morimoto T. Comparison of persistence and adherence between DPP-4 inhibitor administration frequencies in patients with type 2 diabetes mellitus in Japan: A claims-based cohort study.
Curr Med Res Opin2020;36:387-395.
Futakuchi A,
Morimoto T, Ikeda Y, Tanihara H, Inoue T; ROCK-S study group. Intraocular pressure-lowering effects of ripasudil in uveitic glaucoma, exfoliation glaucoma, and steroid-induced glaucoma patients: ROCK-S, a multicentre historical cohort study.
Sci Rep2020;10:10308.
Nishimoto Y, Yamashita Y,
Morimoto T, Saga S, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Yoshikawa Y, Shiomi H, Kato T, Makiyama T, Ono K, Sato Y, Kimura T; COMMAND VTE registry investigators. Predictive ability of modified Ottawa score for recurrence in patients with cancer-associated venous thromboembolism: From the COMMAND VTE registry.
Thromb Res2020;191:66-75.
Hirabayashi R, Takahashi Y, Nagata K,
Morimoto T, Wakata K, Nakagawa A, Tachikawa R, Otsuka K, Tomii K. The validity and reliability of four-meter gait speed test for stable interstitial lung disease patients: The prospective study.
J Thorac Dis2020;12:1296-1304.
Ikesue H, Kusuda K, Satsuma Y, Nishiwaki F, Miura R, Masuda Y, Hirabatake M, Muroi N, Fujimoto D,
Morimoto T, Tomii K, Hashida T. Evaluation of the usefulness of protocol-based pharmacist-facilitated laboratory monitoring to ensure the safety of immune checkpoint inhibitors in patients with lung cancer.
J Clin Pharm Ther2020;45:1288-1294.
Tsuyuki Y, Yamashita Y,
Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Kobayashi Y, Ono K, Aoyama T, Kimura T; COMMAND VTE registry investigators. Renal dysfunction and long-term clinical outcomes in patients with venous thromboembolism: From the COMMAND VTE registry.
Thromb Res2020;187:39-47.
Yamamoto K, Shiomi H,
Morimoto T, Natsuaki M, Takeji Y, Watanabe H, Yoshikawa Y, Matsumura-Nakano Y, Shizuta S, Tanabe K, Ando K, Kadota K, Morino Y, Kozuma K, Nakagawa Y, Kimura T. Effect of renal dysfunction on the risks for ischemic and bleeding events in patients with atrial fibrillation receiving percutaneous coronary intervention.
Am J Cardiol2020;125:399-408.
Yoshikawa Y, Yamashita Y,
Morimoto T, Mabuchi H, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Saga S, Nishimoto Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Murakami T, Kimura T; COMMAND VTE registry investigators. Effect of statins on recurrent venous thromboembolism (From the COMMAND VTE registry).
Am J Cardiol2020;125:189-197.
Hosoya K, Fujimoto D,
Morimoto T, Kumagai T, Tamiya A, Taniguchi Y, Yokoyama T, Ishida T, Hirano K, Matsumoto H, Kominami R, Tomii K, Suzuki H, Hirashima T, Uchida J, Morita M, Kanazu M, Sawa N, Makio T, Hara S, Tamiya M. Association between early immune-related adverse events and clinical outcomes in patients with non-small cell lung cancer treated with immune checkpoint inhibitors.
Clin Lung Cancer2020;21:e315-e328.
Yaku H, Kato T,
Morimoto T, Inuzuka Y, Tamaki Y, Ozasa N, Yamamoto E, Yoshikawa Y, Kitai T, Kato M, Ikeda T, Furukawa Y, Nakagawa Y, Sato Y, Kuwahara K, Kimura T; KCHF study investigators. Risk factors and clinical outcomes of functional decline during hospitalization in very old patients with acute decompensated heart failure: An observational study.
BMJ Open2020;10:e032674.
Kitano T, Todo K, Yoshimura S,
Uchida K, Yamagami H, Sakai N, Sakaguchi M, Nakamura H, Kishima H, Mochizuki H, Ezura M, Okada Y, Kitagawa K, Kimura K, Sasaki M, Tanahashi N, Toyoda K, Furui E, Matsumaru Y, Minematsu K,
Morimoto T. Futile complete recanalization: Patients characteristics and its time course.
Sci Rep2020;10:4973.
Yoshimoto T, Tanaka K, Yamagami H,
Uchida K, Inoue M, Koge J, Ihara M, Toyoda K, Imamura H, Ohara N,
Morimoto T, Sakai N, Yoshimura S. Treatment outcomes by initial neurological deficits in acute stroke patients with basilar artery occlusion: The RESCUE Japan registry 2.
J Stroke Cerebrovasc Dis2020;29:105256.
Kato T, Yaku H,
Morimoto T, Inuzuka Y, Tamaki Y, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Su K, Kawato M, Seko Y, Inoko M, Toyofuku M, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Sato Y, Kuwahara K, Ozasa N, Kimura T. Association with controlling nutritional status (CONUT) score and in-hospital mortality and infection in acute heart failure.
Sci Rep2020;10:3320.
Natsuaki M,
Morimoto T, Watanabe H, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Igarashi K, Morino Y, Kozuma K, Kadota K, Kimura T; STOPDAPT-1 and STOPDAPT-2 trial investigators. Clopidogrel monotherapy vs. aspirin monotherapy following short-term dual antiplatelet therapy in patients receiving everolimus-eluting coronary stent implantation.
Circ J2020;84:1483-1492.
Nishimoto Y, Yamashita Y, Kim K,
Morimoto T, Saga S, Amano H, Takase T, Hiramori S, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Yoshikawa Y, Shiomi H, Kato T, Makiyama T, Ono K, Sato Y, Kimura T; COMMAND VTE registry investigators. Risk factors for major bleeding during anticoagulation therapy in cancer-associated venous thromboembolisms - From the COMMAND VTE registry.
Circ J2020;84:2006-2014.
Natsuaki M,
Morimoto T, Yamamoto E, Watanabe H, Furukawa Y, Abe M, Nakao K, Ishikawa T, Kawai K, Yunoki K, Shimizu S, Akao M, Miki S, Yamamoto M, Okada H, Hoshino K, Kadota K, Morino Y, Igarashi K, Tanabe K, Kozuma K, Kimura T; STOPDAPT trial investigators. One-year clinical outcomes of patients with versus without acute coronary syndrome with 3-month duration of dual antiplatelet therapy after everolimus-eluting stent implantation.
PLoS One 2020;15:e0227612.
Kato T, Yaku H,
Morimoto T, Inuzuka Y, Tamaki Y, Ozasa N, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Kawato M, Seko Y, Shiba M, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T. Association of an increase in serum albumin levels with positive 1-year outcomes in acute decompensated heart failure: A cohort study.
PLoS One 2020;15:e0243818.
Yoshikawa Y, Tamaki Y,
Morimoto T, Yaku H, Yamamoto E, Inuzuka Y, Ozasa N, Kitai T, Nagao K, Sato Y, Kondo H, Tamura T, Nakagawa Y, Kuwahara K, Kato T, Kimura T. Impact of left ventricular ejection fraction on the effect of renin-angiotensin system blockers after an episode of acute heart failure: From the KCHF registry.
PLoS One 2020;15:e0239100.
Kitai T, Miyakoshi C,
Morimoto T, Yaku H, Murai R, Kaji S, Furukawa Y, Inuzuka Y, Nagao K, Tamaki Y, Yamamoto E, Ozasa N, Tang WHW, Kato T, Kimura T. Mode of death among Japanese adults with heart failure with preserved, midrange, and reduced ejection fraction.
JAMA Netw Open2020;3:e204296.
Oi M, Yamashita Y, Toyofuku M,
Morimoto T, Motohashi Y, Tamura T, Kaitani K, Amano H, Takase T, Hiramori S, Kim K, Akao M, Kobayashi Y, Tada T, Chen PM, Murata K, Tsuyuki Y, Saga S, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Sato Y, Kimura T; COMMAND VTE registry investigators. D-dimer levels at diagnosis and long-term clinical outcomes in venous thromboembolism: From the COMMAND VTE registry.
J Thromb Thrombolysis2020;49:551-561.
Tanaka N, Inoue K, Kobori A, Kaitani K,
Morimoto T, Kurotobi T, Morishima I, Yamaji H, Matsui Y, Nakazawa Y, Kusano K, Okada M, Tanaka K, Hirao Y, Oka T, Koyama Y, Okamura A, Iwakura K, Fujii K, Kimura T, Shizuta S; KPAF investigator. Sex differences in atrial fibrillation ablation outcomes: Insights from a large-scale multicenter registry.
Europace2020;22:1345-1357.
Yamashita Y,
Morimoto T, Yoshikawa Y, Yaku H, Sumita Y, Nakai M, Ono K, Kimura T. Temporal trends in the practice pattern for venous thromboembolism in Japan: Insight from JROAD-DPC.
J Am Heart Assoc 2020;9:e014582.
Nishimoto Y, Yamashita Y,
Morimoto T, Saga S, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Yoshikawa Y, Shiomi H, Kato T, Makiyama T, Ono K, Sato Y, Kimura T; COMMAND VTE registry group. Validation of the VTE-BLEED score's long-term performance for major bleeding in patients with venous thromboembolisms: From the COMMAND VTE registry.
J Thromb Haemost2020;18:624-632.
Yamamoto A, Iwanaga K, Matsukura T, Niwa F,
Morimoto T, Takita J, Kawai M. Response of preterm infants with transient hypothyroxinemia of prematurity to the thyrotropin-releasing hormone stimulation test is characterized by a delayed decrease in thyroid stimulating hormone after the peak.
Clin Endocrinol2020;93:605-612.
Watanabe H, Shiomi H,
Morimoto T, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Tazaki J, Watanabe H, Natsuaki M, Minatoya K, Hanyu M, Komiya T, Kimura T; CREDO-Kyoto PCI/CABG registry/cohort-2 investigators. Percutaneous coronary intervention versus coronary arterial bypass grafting in patients with multi-vessel coronary revascularization (From the CREDO-Kyoto PCI/CABG registry/cohort-2).
Catheter Cardiovasc Interv2020;96:42-51.
Yamamoto K, Natsuaki M, Yoshikawa Y,
Morimoto T, Shiomi H, Watanabe H, Kato T, Saito N, Kadota K, Ando K, Furukawa Y, Tamura T, Sakamoto H, Toyofuku M, Inada T, Inoko M, Suwa S, Onodera T, Ishii K, Norio Kanamori N, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Effects of body weight on bleeding and ischemic events in patients undergoing percutaneous coronary intervention - From the CREDO-Kyoto registry cohort-2.
Circ J2020;84:1734-1745.
Yamamoto K, Natsuaki M,
Morimoto T, Shiomi H, Watanabe H, Yamaji K, Watanabe H, Kato T, Saito N, Ando K, Kadota K, Furukawa Y, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Transradial vs. transfemoral percutaneous coronary intervention in patients with or without high bleeding risk criteria.
Circ J2020;84:723-732.
Taniguchi T,
Morimoto T, Shiomi H, Ando K, Shirai S, Kanamori N, Murata K, Kitai T, Kawase Y, Kadota K, Miyake M, Izumi C, Minamino-Muta E, Kato T, Ishii K, Nagao K, Saito N, Minatoya K, Kimura T; CURRENT AS registry investigators. Elective non-cardiac surgery in patients with severe aortic stenosis - Observations from the CURRENT AS registry.
Circ J2020;84:1173-1182.
Kushiyama A, Taniguchi T,
Morimoto T, Shiomi H, Ando K, Kanamori N, Murata K, Kitai T, Kawase Y, Izumi C, Miyake M, Mitsuoka H, Kato M, Hirano Y, Matsuda S, Inada T, Nagao K, Mabuchi H, Takeuchi Y, Yamane K, Toyofuku M, Ishii M, Minamino-Muta E, Kato T, Inoko M, Ikeda T, Komasa A, Ishii K, Hotta K, Higashitani N, Kato Y, Inuzuka Y, Jinnai T, Morikami Y, Saito N, Minatoya K, Kimura T; CURRENT AS registry investigators. Age-related differences in the effects of initial aortic valve replacement vs. conservative strategy on long-term outcomes in asymptomatic patients with severe aortic stenosis.
Circ J2020;84:252-261.
Takeji Y, Taniguchi T,
Morimoto T, Saito N, Ando K, Shirai S, Sakaguchi G, Arai Y, Fuku Y, Kawase Y, Komiya T, Ehara N, Kitai T, Koyama T, Watanabe S, Watanabe H, Shiomi H, Minamino-Muta E, Matsuda S, Yaku H, Yoshikawa Y, Yamazaki K, Kawatou M, Sakamoto K, Tamura T, Miyake M, Sakaguchi H, Murata K, Nakai M, Kanamori N, Izumi C, Mitsuoka H, Kato M, Hirano Y, Inada T, Nagao K, Mabuchi H, Takeuchi Y, Yamane K, Tamura T, Toyofuku M, Ishii M, Inoko M, Ikeda T, Ishii K, Hotta K, Jinnai T, Higashitani N, Kato Y, Inuzuka Y, Morikami Y, Minatoya K, Kimura T; CURRENT AS registry investigators and K-TAVI registry investigators. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for severe aortic stenosis in real-world clinical practice.
Circ J2020;84:806-814.
Yamashita Y,
Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen P, Murata K, Tsuyuki Y, Saga S, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Kimura T; COMMAND VTE registry investigators. Validation of simplified PESI score for identification of low-risk patients with pulmonary embolism: From the COMMAND VTE Registry.
Eur Heart J Acute Cardiovasc Care2020;9:262-270.
Minamino-Muta E, Kato T,
Morimoto T, Taniguchi T, Ando K, Kanamori N, Murata K, Kitai T, Kawase Y, Miyake M, Izumi C, MitsuokaH, Kato M, Hirano Y, Matsuda S, Nagao K, Murakami T, Takeuchi Y, Yamane K, Toyofuku M, Ishii M, Inoko M, Ikeda T, Ishii K, Hotta K, Jinnai T, Kato Y, Inuzuka Y, Maeda C, Morikami Y, Saito N, Minatoya K, Kimura T; CURRENT AS registry investigators. A risk prediction model in asymptomatic patients with severe aortic stenosis: CURRENT-AS risk score.
Eur Heart J Qual Care Clin Outcomes2020;6:166-174.
Jara-Palomares L, Jimenez D, Bikdeli B, Muriel A, Rali P, Yamashita Y,
Morimoto T, Kimura T, Le Mao R, Riera-Mestre A, Maestre A, Moustafa F, Monreal M. Derivation and validation of a clinical prediction rule for thrombolysis-associated major bleeding in patients with acute pulmonary embolism: The BACS score.
Eur Respir J2020;56:2002336.
Takeji Y, Shiomi H,
Morimoto T, Furukawa Y, Ehara N, Nakagawa Y, Kato T, Tazaki J, Kato E, Yaku H, Yoshikawa Y, Tada T, Hanyu M, Kadota K, Komiya T, Ando K, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Diabetes mellitus and long-term risk for heart failure after coronary revascularization.
Circ J2020;84:471-478.
Soejima H, Ogawa H,
Morimoto T, Okada S,
Matsumoto C, Nakayama M, Masuda I, Jinnouchi H, Waki M, Saito Y; JPAD Trial Investigators. Proteinuria is independently associated with the incidence of primary cardiovascular events in diabetic patients.
J Cardiol2020;75:387-393.
Yamamoto T, Mizobata Y, Kawazoe Y, Miyamoto K, Ohta Y,
Morimoto T, Yamamura H. Incidence, risk factors, and outcomes for sepsis-associated delirium in patients with mechanical ventilation: A sub-analysis of a multicenter randomized controlled trial.
J Crit Care2020;56:140-144.
Suga M, Kawakami D, Ueta H, Shimozono T, Ito J, Seo R, Nakamori Y, Korenaga A,
Morimoto T, Mima H. Longer term hemodialysis-dependent chronic renal failure increases the risk of post-cardiac surgery vasoplegic syndrome.
J Anesth2020;34:243-249.
Fujita T, Takeda T, Tsujino Y, Yamaji M, Sakaguchi T, Maeda K, Mabuchi H, Murakami T,
Morimoto T, Kimura T. Effect of glycemic control during follow-up on late target lesion revascularization after implantation of new-generation drug-eluting stents in patients with diabetes -A single-center observational study.
Circ Rep2020;2:479-489.
Uchida K, Yoshimura S, Sakai N, Yamagami H,
*Morimoto T; RESCUE-Japan registry 2 investigators. Sex differences in management and outcomes of acute ischemic stroke with large vessel occlusion.
Stroke2019;50:1915-1918.
*Morimoto T, Sakuma I,
Sakuma M, Tokushige A, Natsuaki M, Asahi T, Shimabukuro M, Nomiyama T, Arasaki O, Node K, Ueda S. Randomized evaluation of anagliptin vs sitagliptin on low-density lipoprotein cholesterol in diabetes (REASON) trial: A 52-week, open-label, randomized clinical trial.
Sci Rep2019;9:8537.
Chihara A, Tanaka A,
Morimoto T,
Sakuma M, Shimabukuro M, Nomiyama T, Arasaki O, Ueda S, Node K. Differences in lipid metabolism between anagliptin and sitagliptin in patients with type 2 diabetes on statin therapy: A secondary analysis of the REASON trial.
Cardiovasc Diabetol2019;18:158.
Kakita H, Yoshimura S,
Uchida K, Sakai N, Yamagami H,
Morimoto T; RESCUE-Japan registry 2 investigators. Impact of endovascular therapy in patients with large ischemic core: Subanalysis of recovery by endovascular salvage for cerebral ultra-acute embolism Japan registry 2.
Stroke2019;50:901-908.
Miura M, Yoshimura S, Sakai N, Yamagami H,
Uchida K, Nagao Y,
Morimoto T. Endovascular therapy for middle cerebral artery M2 segment occlusion: Subanalyses of RESCUE-Japan Registry 2.
J Neurointerv Surg2019;11:964-969.
Watanabe H, Domei T,
Morimoto T, Natsuaki M, Shiomi H, Toyota T, Ohya M, Suwa S, Takagi K, Nanasato M, Hata Y, Yagi M, Suematsu N, Yokomatsu T, Takamisawa I, Doi M, Noda T, Okayama H, Seino Y, Tada T, Sakamoto H, Hibi K, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Hanaoka KI, Morino Y, Kozuma K, Kadota K, Furukawa Y, Nakagawa Y, Kimura T; STOPDAPT-2 investigators. Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: The STOPDAPT-2 randomized clinical trial.
JAMA2019;321:2414-2427.
Watanabe H, Domei T,
Morimoto T, Natsuaki M, Shiomi H, Toyota T, Ohya M, Suwa S, Takagi K, Nanasato M, Hata Y, Yagi M, Suematsu N, Yokomatsu T, Takamisawa I, Doi M, Noda T, Okayama H, Seino Y, Tada T, Sakamoto H, Hibi K, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Hanaoka KI, Morino Y, Kozuma K, Kadota K, Furukawa Y, Nakagawa Y, Kimura T; STOPDAPT-2 investigators. Very short dual antiplatelet therapy after drug-eluting stent implantation in patients with high bleeding risk: Insight from the STOPDAPT-2 trial.
Circulation2019;140:1957-1959.
Matsumura-Nakano Y, Shizuta S, Komasa A,
Morimoto T, Masuda H, Shiomi H, Goto K, Nakai K, Ogawa H, Kobori A, Kono Y, Kaitani K, Suwa S, Aoyama T, Takahashi M, Sasaki Y, Onishi Y, Mano T, Matsuda M, Motooka M, Tomita H, Inoko M, Wakeyama T, Hagiwara N, Tanabe K, Akao M, Miyauchi K, Yajima J, Hanaoka K, Morino Y, Kenji Ando K, Furukawa Y, Nakagawa Y, Nakao K, Kozuma K, Kadota K, Kimura K, Kawai K, Ueno T, Okumura K, Kimura T; OAC-ALONE investigators. Open-label randomized trial comparing oral anticoagulation with and without single antiplatelet therapy in patients with atrial fibrillation and stable coronary artery disease beyond 1 year after coronary stent implantation.
Circulation2019;139:604-616.
Natsuaki M,
Morimoto T, Watanabe H, Nakagawa Y, Furukawa Y, Kadota K, Akasaka T, Hanaoka KI, Kozuma K, Tanabe K, Morino Y, Muramatsu T, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2, RESET and NEXT trial investigators. Ischemic and bleeding risk after percutaneous coronary intervention in patients with prior ischemic and hemorrhagic stroke.
J Am Heart Assoc 2019;8:e013356.
Nagao K, Watanabe H,
Morimoto T, Inada T, Hayashi F, Nakagawa Y, Furukawa Y, Kadota K, Akasaka T, Natsuaki M, Kozuma K, Tanabe K, Morino Y, Shiomi H, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2, RESET and NEXT trial investigators. Prognostic impact of baseline hemoglobin levels on long-term thrombotic and bleeding events after percutaneous coronary interventions.
J Am Heart Assoc 2019;8:e013703.
Toyota T,
Morimoto T, Yamashita Y, Shiomi H, Kato T, Makiyama T, Nakagawa Y, Saito N, Shizuta S, Ono K, Kimura T. More- versus less-intensive lipid-lowering therapy.
Circ Cardiovasc Qual Outcomes2019;12:e005460.
Natsuaki M,
Morimoto T, Shiomi H, Yamaji K, Watanabe H, Shizuta S, Kato T, Ando K, Nakagawa Y, Furukawa Y, Tada T, Nagao K, Kadota K, Toyofuku M, Kimura T; CREDO-Kyoto PCI/CABG registry/cohort-2 investigators. Application of the academic research consortium high bleeding risk criteria in an all-comers registry of percutaneous coronary intervention.
Circ Cardiovasc Interv2019;12:e008307.
Yaku H, Kato T,
Morimoto T, Inuzuka Y, Tamaki Y, Ozasa N, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Toyofuku M, Seko Y, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Sato Y, Kuwahara K, Kimura T; KCHF study investigators. Association of mineralocorticoid receptor antagonist use with all-cause mortality and hospital readmission in older adults with acute decompensated heart failure.
JAMA Netw Open2019;2:e195892.
Shiomi H, Kozuma K,
Morimoto T, Kadota K, Tanabe K, Morino Y, Akasaka T, Abe M, Takeji Y, Suwa S, Ito Y, Kobayashi M, Dai K, Nakao K, Tarutani Y, Taniguchi R, Nishikawa H, Yamamoto Y, Nakagawa Y, Ando K, Kobayashi K, Kawai K, Hibi K, Kimura T; RESET Investigators. 7-year outcomes of a randomized trial comparing the first-generation sirolimus-eluting stent versus the new-generation everolimus-eluting stent: The RESET trial.
JACC Cardiovasc Interv2019;12:637-647.
Takeji Y, Taniguchi T,
Morimoto T, Saito N, Ando K, Shirai S, Sakaguchi G, Arai Y, Fuku Y, Kawase Y, Komiya T, Ehara N, Kitai T, Koyama T, Watanabe S, Watanabe H, Shiomi H, Minamino-Muta E, Matsuda S, Yaku H, Yoshikawa Y, Yamazaki K, Kawatou M, Sakamoto K, Tamura T, Miyake M, Sakaguchi H, Murata K, Nakai M, Kanamori N, Izumi C, Mitsuoka H, Kato M, Hirano Y, Inada T, Nagao K, Mabuchi H, Takeuchi Y, Yamane K, Tamura T, Toyofuku M, Ishii M, Inoko M, Ikeda T, Ishii K, Hotta K, Jinnai T, Higashitani N, Kato Y, Inuzuka Y, Morikami Y, Minatoya K, Kimura T; CURRENT AS registry investigators and K-TAVI registry investigators. Transcatheter aortic valve implantation versus conservative management for severe aortic stenosis in real clinical practice.
PLoS One2019;14:e0222979.
Fujimoto D, Yomota M, Sekine A, Morita M,
Morimoto T, Hosomi Y, Ogura T, Tomioka H, Tomii K. Nivolumab for advanced non-small cell lung cancer patients with mild idiopathic interstitial pneumonia: A multicenter, open-label single-arm phase II trial.
Lung Cancer2019;134:274-278.
Minamino-Muta E, Kato T,
Morimoto T, Taniguchi T, Izumi C, Nakatsuma K, Inoko M, Shirai S, Kanamori N, Murata K, Kitai T, Kawase Y, Miyake M, MitsuokaH, Hirano Y, Sasa T, Nagao K, Inada T, Nishikawa R, Takeuchi Y, Matsuda S, Yamane K, Su K, Komasa A, Ishii K, Kato Y, Takabayashi K, Watanabe S, Saito N, Minatoya K, Kimura T; CURRENT AS registry investigators. Decline in left ventricular ejection fraction during follow-up in patients with severe aortic stenosis.
JACC Cardiovasc Interv2019;12:2499-2511.
Nakatsuma K, Taniguchi T,
Morimoto T, Shiomi H, Ando K, Kanamori N, Murata K, Kitai T, Kawase Y, Izumi C, Miyake M, Mitsuoka H, Kato M, Hirano Y, Matsuda S, Inada T, Nagao K, Mabuchi H, Takeuchi Y, Yamane K, Toyofuku M, Ishii M, Minamino-Muta E, Kato T, Inoko M, Ikeda T, Komasa A, Ishii K, Hotta K, Higashitani N, Kato Y, Inuzuka Y, Maeda C, Jinnai T, Morikami Y, Saito N, Minatoya K, Kimura T; CURRENT AS registry investigators. B-type natriuretic peptide in patients with asymptomatic severe aortic stenosis.
Heart2019;105:384-390.
Kanamori N, Taniguchi T,
Morimoto T, Watanabe H, Shiomi H, Ando K, Murata K, Kitai T, Kawase Y, Izumi C, Miyake M, Mitsuoka H, Kato M, Hirano Y, Matsuda S, Nagao K, Inada T, Mabuchi H, Takeuchi Y, Yamane K, Toyofuku M, Ishii M, Minamino-Muta E, KatoT, Inoko M, Ikeda T, Komasa A, Ishii K, Hotta K, Higashitani N, Kato Y, Inuzuka Y, Maeda C, Jinnai T, Morikami Y, Saito N, Minatoya K, Aoyama T, Kimura T; CURRENT AS registry investigators. Prognostic impact of aortic valve area in conservatively managed patients with asymptomatic severe aortic stenosis with preserved ejection fraction.
J Am Heart Assoc 2019;8:e010198.
Fujimoto D, Yoshioka H, Kataoka Y,
Morimoto T, Hata T, Kim YH, Tomii K, Ishida T, Hirabayashi M, Hara S, Ishitoko M, Fukuda Y, Hwang MH, Sakai N, Fukui M, Nakaji H, Morita M, Mio T, Yasuda T, Sugita T, Hirai T. Pseudoprogression in previously treated patients with non-small cell lung cancer who received nivolumab monotherapy.
J Thorac Oncol2019;14:468-474.
Matsumura-Nakano Y, Kawaji T, Shiomi H, Kawai-Miyake K, Kataoka M, Koizumi K, Matsuda A, Kitano K, Yoshida M, Watanabe H, Tazaki J, Kato T, Saito N, Shizuta S, Ono K, Togashi K,
Morimoto T, Kimura T. Optimal cutoff value of fractional flow reserve derived from coronary computed tomography angiography for predicting hemodynamically significant coronary artery disease.
Circ Cardiovasc Imaging2019;12:e00895.
Matsukawa H, Kiura Y, Sakai N, Yamagami H,
Uchida K,
Morimoto T, Kageyama H, Yoshimura S; RESCUE-Japan Registry 2 investigators. Effect of endovascular therapy on subsequent decompressive hemicraniectomy in cardioembolic ischemic stroke with proximal intracranial occlusion in the anterior circulation: Sub-analysis of the RESCUE-Japan registry 2.
Cerebrovasc Dis2019;48:9-16.
Todo K, Sakai N, Imamura H, Yamagami H, Adachi H, Kono T, Kobayashi J, Yamamoto S,
Morimoto T, Tani S, Kawamoto M, Sakaguchi M, Ueno Y, Kunieda T, Narumi O, Sakai C, Ishii A, Hoshi T, Koyanagi M, Mineharu Y, Ishikawa T, Kuramoto Y, Sato S, Ohara N, Arimura K, Nakamura H, Nishida T, Gon Y, Fujinaka T, Yoshiya K, Kishima H, Mochizuki H, Kohara N; KCGH-CSC Registry Investigators. Successful reperfusion with endovascular therapy has beneficial effects on long-term outcome beyond 90 days.
Cerebrovasc Dis2019;47:127-134.
Matsumura-Nakano Y, Shiomi H,
Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Ando K, Yamaji K, Shizuta S, Sakata R Hanyu M, Shimamoto M, Nishiwaki N, Komiya T, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Surgical ineligibility and long-term outcomes in patients with severe coronary artery disease.
Circ J2019;83:2061-2069.
Kogo M, Otsuka K,
Morimoto T, Nagata K, Nakagawa A, Tomii K. Pulmonary artery enlargement predicts poor outcome during acute exacerbations of fibrotic interstitial lung disease.
Respirology2019;24:777-782.
Yamashita Y, Yoshikawa Y,
Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Tada T, Chen PM, Murata K, Tsuyuki Y, Saga S, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Kimura T; COMMAND VTE registry investigators. The association of recurrence and bleeding events with mortality after venous thromboembolism: From the COMMAND VTE registry.
Int J Cardiol2019;292:198-204.
Yamashita Y, Murata K,
Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Tsuyuki Y, Saga S, Nishimoto Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Yoshikawa Y, Shiomi H, Kato T, Makiyama T, Ono K, Nawada R, Onodera T, Kimura T; COMMAND VTE registry investigators. Clinical outcomes of patients with pulmonary embolism versus deep vein thrombosis: From the COMMAND VTE registry.
Thromb Res2019;184:50-57.
Ishii M, Taniguchi T,
Morimoto T, Ogawa H, Masunaga N, Abe M, Yoshikawa Y, Shiomi H, Ando K, Kanamori N, Murata K, Kitai T, Kawase Y, Izumi C, Miyake M, Mitsuoka H, Kato M, Hirano Y, Matsuda S, Nagao K, Inada T, Mabuchi H, Takeuchi Y, Yamane K, Toyofuku M, Minamino-Muta E, Kato T, Inoko M, Ikeda T, Komasa A, Ishii K, Hotta K, Higashitani N, Kato Y, Inuzuka Y, Jinnai T, Morikami Y, Akao M, Minatoya K, Kimura T; CURRENT AS registry investigators. Reasons for choosing conservative management in symptomatic patients with severe aortic stenosis - Observations from the CURRENT AS registry.
Circ J2019;83:1944-1953.
Nagao K, Taniguchi T,
Morimoto T, Shiomi H, Ando K, Kanamori N, Murata K, Kitai T, Kawase Y, Izumi C, Miyake M, Mitsuoka H, Kato M, Hirano Y, Matsuda S, Inada T, Murakami T, Takeuchi Y, Yamane K, Toyofuku M, Ishii M, Minamino-Muta E, Kato T, Inoko M, Ikeda T, Komasa A, Ishii K, Hotta K, Higashitani N, Kato Y, Inuzuka Y, Maeda C, Jinnai T, Morikami Y, Saito N, Minatoya K, Kimura T; CURRENT AS registry investigators. Anemia in patients with severe aortic stenosis.
Sci Rep2019;9:1924.
Kim K, Yamashita Y,
Morimoto T, Kitai T, Yamane T, Ehara N, Kinoshita M, Kaji S, Amano H, Takase T, Hiramori S, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Saga S, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Furukawa Y, Kimura T; COMMAND VTE registry investigators. Risk factors for major bleeding during prolonged anticoagulation therapy in patients with venous thromboembolism: From the COMMAND VTE registry.
Thromb Haemost2019;119:1498-1507.
Yoshikawa Y, Yamashita Y,
Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Saga S, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Kimura T; COMMAND VTE registry investigators. Sex differences in clinical characteristics and outcomes of patients with venous thromboembolism- From the COMMAND VTE registry.
Circ J2019;83:1581-1589.
Sakamoto J, Yamashita Y,
Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Saga S, Nishimoto Y, Sasa T, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Yoshikawa Y, Shiomi H, Kato T, Makiyama T, Ono K, Tamura T, Nakagawa Y, Kimura T; COMMAND VTE registry investigators. Cancer-associated venous thromboembolism in the real world- From the COMMAND VTE registry.
Circ J2019;83:2271-2281.
Nishimoto Y, Yamashita Y,
Morimoto T, Saga S, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Sato Y, Kimura T; COMMAND VTE registry investigators. Clinical characteristics and outcomes of venous thromboembolisms according to an out-of-hospital vs. in-hospital onset- From the COMMAND VTE registry.
Circ J2019;83:1377-1384.
Nishimoto Y, Yamashita Y,
Morimoto T, Saga S, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Yoshikawa Y, Shiomi H, Kato T, Makiyama T, Ono K, Sato Y, Kimura T; COMMAND VTE registry investigators. Thrombolysis with tissue plasminogen activator in patients with acute pulmonary embolisms in the real world: From the COMMAND VTE registry.
J Thromb Thrombolysis2019;48:587-595.
Su K, Kato T, Toyofuku M,
Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Yamamoto E, Yoshikawa Y, Motohashi Y, Watanabe H, Kitai T, Taniguchi R, Iguchi M, Kato M, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Jinnai T, Kawato M, Sato Y, Kuwahara K, Tamura T, Kimura T; KCHF registry investigators. Association of previous hospitalization for heart failure with increased mortality in patients hospitalized for acute decompensated heart failure.
Circ Rep2019;1:517-524.
Yamashita Y,
Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Saga S, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Kimura T; COMMAND VTE registry investigators. Influence of baseline anemia on long-term clinical outcomes in patients with venous thromboembolism: From the COMMAND VTE registry.
J Thromb Thrombolysis2019;47:444-453.
Yamashita Y,
Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Saga S, Nishimoto Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Yoshikawa Y, Shiomi H, Kato T, Makiyama T, Ono K, Kimura T; COMMAND VTE registry investigators. Deep vein thrombosis in upper extremities: Clinical characteristics, management strategies and long-term outcomes from the COMMAND VTE registry.
Thromb Res2019;177:1-9.
Ohira J, Yoshimura H,
Morimoto T, Ariyoshi K, Kohara N. Factors associated with the duration of the postictal state after a generalized convulsion.
Seizure2019;65:101-105.
Fuku Y, Kadota K, Toyofuku M,
Morimoto T, Ohya M, Higami H, Yamaji K, Muranishi H, Yamaji Y, Nishida K, Furukawa D, Tada T, Ko E, Ando K, Sakamoto H, Tamura T, Kawai K, Kimura T; AOI LMCA stenting registry investigators. Long-term outcomes of drug-eluting stent implantation after rotational atherectomy for left main coronary artery bifurcation lesions.
Am J Cardiol2019;123:1796-1805.
Abe M,
Morimoto T, Morino Y, Tanaka H, Akao M, Hayashi Y, Muramatsu T, Ochiai M, Noguchi Y, Kato K, Shibata Y, Hiasa Y, Doi O, Yamashita T, Hinohara T, Kadota K, Kimura T; J-CTO registry investigators. Association between J-CTO score and long-term target lesion revascularization rate after successful chronic total coronary occlusion angioplasty (from the J-CTO Registry).
Catheter Cardiovasc Interv2019;93:1025-1032.
Kawachi H, Fujimoto D,
Morimoto T, Hosoya K, Sato Y, Kogo M, Nagata K, Nakagawa A, Tachikawa R, Tomii K. Early depth of tumor shrinkage and treatment outcomes in non-small cell lung cancer treated using nivolumab.
Invest New Drugs2019;37:1257-1265.
Fujita T, Takeda T, Hano Y, Takashima N, Yamaji M, Sakaguchi T, Maeda K, Mabuchi H, Murakami T,
Morimoto T, Kimura T. Post-intervention minimal stent area as a predictor of target lesion revascularization after everolimus-eluting stent implantation for in-stent restenosis: A single-center observational study.
Coron Artery Dis2019;30:432-439.
Watari J, Mitani S, Ito C, Tozawa K, Tomita T, Oshima T, Fukui H, Kadowaki S, Natsume S, Senda Y, Tajika M, Hara K, Yatabe Y, Shimizu Y, Muro K,
Morimoto T, Hirota S, Das KM, Miwa H. Molecular alterations and PD-L1 expression in non-ampullary duodenal adenocarcinoma: Associations among clinicopathological, immunophenotypic and molecular features.
Sci Rep2019;9:10526.
Morimoto H, Kanastu-Shinohara M, Ogonuki N, Kamimura S, Ogura A, Yabe-Nishimura C, Mori Y,
Morimoto T, Watanabe S, Otsu K, Yamamoto T, Shinohara T. ROS amplification drives mouse spermatogonial stem cell self-renewal.
Life Sci Alliance2019;2:e201300374.
Ito J, Nagata K,
Morimoto T, Kogo M, Fujimoto D, Nakagawa A, Otsuka K, Tomii K. Respiratory management of acute exacerbation of interstitial pneumonia using high-flow nasal cannula oxygen therapy: A single center cohort study.
J Thorac Dis2019;11:103-112.
Kogo M, Nagata K,
Morimoto T, Ito J, Fujimoto D, Nakagawa A, Otsuka K, Tomii. Altered consciousness, non-invasive ventilation, and hypoxemic respiratory failure: The trident question unresolved-Reply.
Intern Med2019;58:1109-1192.
Hashimoto M,
Takeuchi J, Takuwa T, Kuroda A, Nakamura A, Nakamichi T, Matsumoto S, Kondo N, Nakano T,
Morimoto T, Hasegawa S. Pleural thickness after neoadjuvant chemotherapy is a prognostic factor in malignant pleural mesothelioma.
J Thorac Cardiovasc Surg2019;157:404-413.
Amano M, Izumi C, Taniguchi T,
Morimoto T, Miyake M, Nishimura S, Kitai T, Kato T, Kadota K, Ando K, Furukawa Y, Inada T, Inoko M, Ishii K, Sakaguchi G, Yamazaki F, Koyama T, Komiya T, Yamanaka K, Nishiwaki N, Kanemitsu N, Saga T, Ogawa T, Nakayama S, Tsuneyoshi H, Iwakura A, Shiraga K, Hanyu M, Ohno N, Fukumoto A, Yamada T, Nishizawa J, Esaki J, Minatoya K, Nakagawa Y, Kimura T; CURRENT AS registry investigators. Impact of concomitant tricuspid regurgitation on long-term outcomes in severe aortic stenosis.
Eur Heart J Cardiovasc Imaging2019;20:353-360.
Nishimoto Y, Yamashita Y,
Morimoto T, Saga S, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Sato Y, Kimura T; COMMAND VTE registry investigators. Risk factors for post-thrombotic syndrome in patients with deep vein thrombosis: From the COMMAND VTE Registry.
Heart Vessels2019;34:669-677.
Soejima H, Ogawa H,
Morimoto T, Okada S,
Sakuma M, Nakayama M, Masuda I, Doi N, Uemura S, Jinnouchi H, Sugiyama S, Waki M, Saito Y; JPAD Trial Investigators. One quarter of total myocardial infarctions are silent manifestation in patients with type 2 diabetes mellitus.
J Cardiol2019;73:33-37.
Nishida K, Toyofuku M,
Morimoto T, Ohya M, Fuku Y, Higami H, Yamaji K, Muranishi H, Yamaji Y, Furukawa D, Tada T, Ko E, Kadota K, Ando K, Sakamoto H, Tamura T, Kawai K, Kimura T; AOI LMCA stenting registry investigators. Prognostic impact of final kissing balloon technique after crossover stenting for the left main coronary artery: From the AOI-LMCA registry.
Cardiovasc Interv Ther 2019;34:197-206.
Rothwell PM, Cook NR, Gaziano JM, Price JF, Belch JFF, Roncaglioni MC,
Morimoto T, Mehta Z. Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: Analysis of individual patient data from randomised trials.
Lancet2018;392:387-399.
Uchida K, Yoshimura S, Hiyama N, Oki Y, Matsumoto T, Tokuda R, Yamaura I, Saito S, Takeuchi M, Shigeta K, Araki H,
*Morimoto T. Clinical prediction rules to classify types of stroke at prehospital stage.
Stroke2018;49:1820-1827.
Yoshimura S, Sakai N,
Uchida K, Yamagami H, Ezura M, Okada Y, Kitagawa K, Kimura K, Sasaki M, Tanahashi N, Toyoda K, Furui E, Matsumaru Y, Minematsu K,
*Morimoto T. Endovascular therapy in ischemic stroke with acute large vessel occlusion: Recovery by endovascular salvage for cerebral ultra-acute embolism Japan registry 2.
J Am Heart Assoc 2018;7:e008796.
Okada S,
Morimoto T, Ogawa H,
Sakuma M,
Matsumoto C, Soejima H, Nakayama M, Doi N, Jinnouchi H, Waki M, Masuda I, Saito Y; JPAD trial investigators. Effect of aspirin on cancer chemoprevention in Japanese patients with type 2 diabetes: 10-year observational follow-up of a randomized controlled trial.
Diabetes Care 2018;41:1757-1764.
Watanabe H,
Morimoto T, Shiomi H, Natsuaki M, Kawai K, Kozuma K, Igarashi K, Kadota K, Tanabe K, Morino Y, Hibi K, Akasaka T, Abe M, Suwa S, Muramatsu T, Kobayashi M, Dai K, Nakao K, Tarutani Y, Fujii K, Kimura T; RESET and NEXT Investigators. Impact of angiographic residual stenosis on clinical outcomes after new-generation drug-eluting stents implantation: Insights from a pooled analysis of the RESET and NEXT trials.
J Am Heart Assoc 2018;7:e008718.
Nakamura T,
*Morimoto T, Katsube K, Yamamori Y, Mashino J, Kikuchi K. Clinical characteristics of pyogenic spondylitis and psoas abscess at a tertiary care hospital: A retrospective cohort study.
J Orthop Surg Res2018;13:302.
Natsuaki M,
Morimoto T, Yamaji K, Watanabe H, Yoshikawa Y, Shiomi H, Nakagawa Y, Furukawa Y, Kadota K, Ando K, Akasaka T, Hanaoka KI, Kozuma K, Tanabe K, Morino Y, Muramatsu T, Kimura T; CREDO‐Kyoto PCI/CABG registry Cohort 2, RESET, and NEXT trial investigators. Prediction of thrombotic and bleeding events after percutaneous coronary intervention: CREDO-Kyoto thrombotic and bleeding risk scores.
J Am Heart Assoc 2018;7:e008708.
Taniguchi T,
Morimoto T, Shiomi H, Ando K, Kanamori N, Murata K, Kitai T, Kawase Y, Izumi C, Kato T, Ishii K, Nagao K, Nakagawa Y, Toyofuku M, Saito N, Minatoya K, Kimura T; CURRENT AS registry investigators. Sudden death in patients with severe aortic stenosis: Observations from the CURRENT AS registry.
J Am Heart Assoc 2018;7:e008397.
Yamashita Y,
Morimoto T, Toyota T, Shiomi H, Makiyama T, Ono K, Kimura T. Asian patients versus non-Asian patients in the efficacy and safety of direct oral anticoagulants relative to vitamin K antagonist for venous thromboembolism: A systemic review and meta-analysis.
Thromb Res2018;166:37-42.
Fujimoto D, Sato Y,
Morimoto T, Uehara K, Ito M, Otsuka K, Nagata K, Sakanoue I, Hamakawa H, Nakagawa A, Takahashi Y, Imai Y, Tomii K. Programmed cell death ligand 1 expression in non-small-cell lung cancer patients with interstitial lung disease: A matched case-control study.
Clin Lung Cancer2018;19:e667-e673.
Kawachi H, Fujimoto D,
Morimoto T, Ito M, Teraoka S, Sato Y, Nagata K, Nakagawa A, Otsuka K, Tomii K. Clinical characteristics and prognosis of patients with advanced non-small cell lung cancer who are ineligible for clinical trials.
Clin Lung Cancer2018;19:e721-e734.
Kanamori N, Taniguchi T,
Morimoto T, Shiomi H, Ando K, Murata K, Kitai T, Kawase Y, Izumi C, Miyake M, Mitsuoka H, Kato M, Hirano Y, Matsuda S, Nagao K, Inada T, Mabuchi H, Takeuchi Y, Yamane K, Toyofuku M, Ishii M, Minamino-Muta E, Kato T, Inoko M, Ikeda T, Komasa A, Ishii K, Hotta K, Higashitani N, Kato Y, Inuzuka Y, Maeda C, Jinnai T, Morikami Y, Saito N, Minatoya K, Aoyama T, Kimura T; CURRENT AS registry investigators. Asymptomatic versus symptomatic patients with severe aortic stenosis.
Sci Rep2018;8:10080.
Hashimoto T, Kanematsu A, Nojima M, Nagasawa S, Fukui K, Aihara K, Kokura K, Hanasaki T, Ueda Y, Takiuchi H, Togo Y, Kondoh N, Doi Y, Nakanishi Y, Higuchi Y, Kawaguchi R,
Morimoto T, Yamamoto S. Retrospective analysis of clinical efficacy of luteinizing hormone-releasing hormone antagonist as compared to agonists with combined anti-androgen blockade (CAB) in advanced prostate cancer.
Clinics Oncol2018;3:1474.
Yoshimura J, Yamakawa K, Kinoshita T, Ohta Y,
Morimoto T. GRam stain-guided Antibiotics ChoicE for Ventilator-Associated Pneumonia (GRACE-VAP) trial: Rationale and study protocol for a randomised controlled trial.
Trials 2018;19:614.
Nishida K, Nakatsuma K, Shiomi H, Natsuaki M, Kawai K,
Morimoto T, Kozuma K, Igarashi K, Kadota K, Tanabe K, Morino Y, Hibi, K Akasaka T, Abe M, Suwa S, Muramatsu T, Kobayashi M, Dai K, Nakao K, Uematsu M, Tarutani Y, Fujii K, Kimura T; RESET and NEXT Investigators. Secondgeneration vs. first-generation drug-eluting stents in patients with calcified coronary lesions -Pooled analysis from the RESET and NEXT trials.
Circ J2018;82:376-387.
Kawazoe Y, Sato T, Miyagawa N, Yokokawa Y, Kushimoto S, Miyamoto K, Ohta Y,
Morimoto T, Yamamura H. Mortality effects of prolonged hemoperfusion therapy using a polymyxin B-immobilized fiber column for patients with septic shock: A sub-analysis of the DESIRE trial.
Blood Purif.2018;46:309-314.
Natsuaki M, Kozuma K,
Morimoto T, Kadota K, Muramatsu T, Nakagawa Y, Akasaka T, Hanaoka KI, Tanabe K, Morino Y, Nishikawa H, Kimura T. Five-year outcome of a randomised trial comparing second-generation drug-eluting stents using either biodegradable polymer or durable polymer: The NOBORI biolimus-eluting versus XIENCE/PROMUS everolimus-eluting stent trial (NEXT).
EuroIntervention2018;14:815-818.
Yamashita Y,
Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Saga S, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Watanabe H, Shiomi H, Kato T, Makiyama T, Ono K, Kimura T; COMMAND VTE registry investigators. Influence of baseline platelet count on outcomes in patients with venous thromboembolism (from the COMMAND VTE registry).
Am J Cardiol2018;122:2131-2141.
Yaku H, Ozasa N,
Morimoto T, Inuzuka Y, Tamaki Y, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Su K, Kawato M, Sasaki K, Toyofuku M, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Sato Y, Kuwahara K, Kato T, Kimura T; KCHF study investigators. Demographics, management, and in-hospital outcome of hospitalized acute heart failure syndrome patients in contemporary real clinical practice in Japan -Observations from the prospective, multicenter Kyoto congestive heart failure (KCHF) registry.
Circ J2018;82:2811-2819.
Matsumura-Nakano Y, Shiomi H,
Morimoto T, Shizuta S, Yamaji K, Watanabe H, Yoshikawa Y, Taniguchi T, Kawaji T, Natsuaki M, Akasaka T, Hanaoka K, Kadota K, Kozuma K, Tanabe K, Nakagawa Y, Muramatsu T, Morino Y, Ando K, Kimura T. Sex differences in long-term clinical outcomes in patients with atrial fibrillation undergoing coronary stent implantation.
Circ J2018;82:1754-1762.
Miyake M, Izumi C, Taniguchi T,
Morimoto T, Amano M, Nishimura S, Kitai T, Kato T, Kadota K, Ando K, Furukawa Y, Inada T, Inoko M, Ishii K, Sakaguchi G, Yamazaki F, Koyama T, Komiya T, Yamanaka K, Nishiwaki N, Kanemitsu N, Saga T, Ogawa T, Nakayama S, Tsuneyoshi H, Iwakura A, Shiraga K, Hanyu M, Ohno N, Fukumoto A, Yamada T, Nishizawa J, Esaki J, Minatoya K, Nakagawa Y, Kimura T; CURRENT AS registry investigators. Early surgery vs. surgery after watchful waiting for asymptomatic severe aortic stenosis.
Circ J2018;82:2663-2671.
Higami H, Toyofuku M,
Morimoto T, Ohya M, Fuku Y, Yamaji K, Muranishi H, Yamaji Y, Nishida K, Furukawa D, Tada T, Ko E, Ando K, Sakamoto H, Tamura T, Kawai K, Kadota K, Kimura T; AOI LMCA stenting registry investigators. Acute coronary syndrome with unprotected left main coronary artery culprit: An observation from the AOI-LMCA registry.
Circ J2018;83:198-208.
Noguchi M, Ako J,
Morimoto T, Homma Y, Shiga T, Obunai K, Watanabe H. Modifiable factors associated with prolonged door to balloon time in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Heart Vessels2018;33:1139-1148.
Nakai K, Watari J, Tozawa K, Tamura A, Hara K, Yamasaki T, Kondo T, Kono T, Tomita T, Ohda Y, Oshima T, Fukui H, Sakurai J, Kim Y, Hayakawa Y, Fujisawa T,
Morimoto T, Miwa H. Sex differences in associations among metabolic syndrome, obesity, related biomarkers, and colorectal adenomatous polyp risk in a Japanese population.
J Clin Biochem Nutr2018;63:154-163.
Ito J, Nagata K, Sato S, Shiraki A, Nishimura N, Izumi S, Tachikawa R,
Morimoto T, Tomii K. The clinical practice of high-flow nasal cannula oxygen therapy in adults: A Japanese cross-sectional multicenter survey.
Respir Investig2018;56:249-257.
Nakatsuma K, Shiomi H,
Morimoto T, Watanabe H, Nakagawa Y, Furukawa Y, Kadota K, Ando K, Ono K, Shizuta S, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Influence of a history of cancer on long-term cardiovascular outcomes after coronary stent implantation (an observation from coronary revascularization demonstrating outcome study-Kyoto registry cohort-2).
Eur Heart J Qual Care Clin Outcomes2018;4:200-207.
Minamino-Muta E, Kato T,
Morimoto T, Taniguchi T, Nakatsuma K, Kimura Y, Inoko M, Shirai S, Kanamori N, Murata K, Kitai T, Kawase Y, Miyake M, Izumi C, Mitsuoka H, Hirano Y, Sasa T, Nagao K, Inada T, Nishikawa R, Takeuchi Y, Yamagami S, Yamane K, Su K, Komasa A, Ishii K, Yamashita Y, Kato Y, Takabayashi K, Saito N, Minatoya K, Kimura T; CURRENT AS registry investigators. Malignant disease as a comorbidity in patients with severe aortic stenosis: Clinical presentation, outcomes, and management.
Eur Heart J Qual Care Clin Outcomes.2018;4:180-188.
Kawaji T, Shiomi H,
Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Ando K, Mizoguchi T, Abe M, Takahashi M, Kimura T; CREDO-Kyoto AMI investigators. Long-term clinical outcomes in patients with ST-segment elevation acute myocardial infarction complicated by cardiogenic shock due to acute pump failure.
Eur Heart J Acute Cardiovasc Care2018;7:743-754.
Fujimoto D, Yoshioka H, Kataoka Y,
Morimoto T, Kim YH, Tomii K, Ishida T, Hirabayashi M, Hara S, Ishitoko M, Fukuda Y, Hwang MH, Sakai N, Fukui M, Nakaji H, Morita M, Mio T, Yasuda T, Sugita T, Hirai T. Efficacy and safety of nivolumab in previously treated patients with non-small cell lung cancer: A multicenter retrospective cohort study.
Lung Cancer2018;119:14-20.
Watanabe H, Ozasa N,
Morimoto T, Shiomi H, Bingyuan B, Suwa S, Nakagawa Y, Izumi C, Kadota K, Ikeguchi S, Hibi K, Furukawa Y, Kaji S, Suzuki T, Akao M, Inada T, Hayashi Y, Nanasato M, Okutsu M, Kametani R, Sone T, Sugimura Y, Kawai K, Abe M, Kaneko H, Nakamura S, Kimura T; CAPITAL-RCT investigators. Long-term use of carvedilol in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
PLoS One2018;13:e0199347.
Natsuaki M,
Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Ando K, Shiomi H, Toyota T, Watanabe H, Ono K, Shizuta S, Tamura T, Inoko M, Inada T, Shirotani M, Matsuda M, Aoyama T, Onodera T, Suwa S, Takeda T, Inoue K, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Short versus prolonged dual antiplatelet therapy duration after bare-metal stent implantation: 2-month landmark analysis from the CREDO-Kyoto registry cohort-2.
Cardiovasc Interv Ther 2018;33:23-34.
Yoshimura S,
Uchida K,
*Morimoto T. Response by Yoshimura et al to letter regarding article, "Randomized controlled trial of early versus delayed statin therapy in patients with acute ischemic stroke: ASSORT trial (administration of statin on acute ischemic stroke patient)".
Stroke2018;49:e132.
Ito S, Watanabe H,
Morimoto T, Yoshikawa Y, Shiomi H, Shizuta S, Ono K, Yamaji K, Soga Y, Hyodo M, Shirai S, Ando K, Horiuchi H, Kimura T. Impact of baseline thrombocytopenia on bleeding and mortality after percutaneous coronary intervention.
Am J Cardiol2018;121:1304-1314.
Yamamura H, Kawazoe Y, Miyamoto K, Yamamoto T, Ohta Y,
Morimoto T. Effect of norepinephrine dosage on mortality in patients with septic shock.
J Intensive Care2018;6:12.
Taniguchi T,
Morimoto T, Shiomi H, Ando K, Kanamori N, Murata K, Kitai T, Kadota K, Izumi C, Nakatsuma K, Sasa T, Watanabe H, Kuwabara Y, Makiyama T, Ono K, Shizuta S, Kato T, Saito N, Minatoya K, Kimura T; CURRENT AS registry investigators. Prognostic impact of left ventricular ejection fraction in patients with severe aortic stenosis.
JACC Cardiovasc Interv2018;11:145-157.
Yoshikawa Y, Shiomi H, Watanabe H, Natsuaki M, Kondo H, Tamura T, Nakagawa Y,
Morimoto T, Kimura T. Validating utility of dual antiplatelet therapy score in a large pooled cohort from 3 Japanese percutaneous coronary intervention studies.
Circulation2018;137:551-562.
Toyota T,
Morimoto T, Shiomi H, Yamaji K, Ando K, Ono K, Shizuta S, Saito N, Kato T, Kaji S, Furukawa Y, Nakagawa Y, Kadota K, Horie M, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Single-session versus staged procedures for elective multivessel percutaneous coronary intervention.
Heart2018;104:936-944.
Kogo M, Nagata K,
Morimoto T, Ito J, Fujimoto D, Nakagawa A, Otsuka K, Tomii. What is the impact of mildly altered consciousness on acute hypoxemic respiratory failure with non-invasive ventilation?
Intern Med2018;57:1689-1695.
Fujimoto D, Sato Y, Uehara K, Ishida K, Fukuoka J,
Morimoto T, Kawachi H, Mori R, Ito M, Teraoka S, Nagata K, Nakagawa A, Otsuka K, Imai Y, Tomii K. Predictive performance of four programmed cell death ligand 1 assay systems on nivolumab response in previously treated patients with non-small cell lung cancer.
J Thorac Oncol2018;13:377-386.
Yamashita Y,
Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Konishi T, Akao M, Kobayashi Y, Inoue T, Oi M, Izumi T, Takahashi K, Tada T, Chen P, Murata K, Tsuyuki Y, Sakai H, Saga S, Sasa T, Sakamoto J, Yamada C, Kinoshita M, Togi K, Ikeda T, Ishii K, Kaneda K, Mabuchi H, Otani H, Takabayashi K, Takahashi M, Shiomi H, Makiyama T, Ono K, Kimura T. Anticoagulation therapy for venous thromboembolism in the real world -From the COMMAND VTE registry.
Circ J2018;82:1262-1270.
Nagao K, Taniguchi T,
Morimoto T, Shiomi H, Ando K, Kanamori N, Murata K, Kitai T, Kawase Y, Izumi C, Miyake M, Mitsuoka H, Kato M, Hirano Y, Matsuda S, Inada T, Murakami T, Takeuchi Y, Yamane K, Toyofuku M, Ishii M, Minamino-Muta E, Kato T, Inoko M, Ikeda T, Komasa A, Ishii K, Hotta K, Higashitani N, Kato Y, Inuzuka Y, Maeda C, Jinnai T, Morikami Y, Saito N, Minatoya K, Kimura T; CURRENT AS Registry Investigators. Acute heart failure in patients with severe aortic stenosis -Insights from the CURRENT AS registry.
Circ J2018;82:874-885.
Ueda S, Shimabukuro M, Arasaki O, Node K, Nomiyama T,
Morimoto T. Effect of anagliptin and sitagliptin on low-density lipoprotein cholesterol in type 2 diabetic patients with dyslipidemia and cardiovascular risk: Rationale and study design of the REASON trial.
Cardiovasc Drugs Ther2018;32:73-80.
Ohya M,
Morimoto T, Kubo S, Habara S, Kuwayama A, Miura K, Shimada T, Amano H, Otsuru S, Tada T, Tanaka H, Fuku Y, Goto T, Kadota K. Two-year outcomes and predictors of target lesion revascularization for non-left main coronary bifurcation lesions following two-stent strategy with 2nd-generation drug-eluting stents.
Circ J2018;82:798-806.
Yabushita T, Satake H, Maruoka H, Morita M, Katoh D, Shimomura Y, Yoshioka S,
Morimoto T, Ishikawa T. Expression of multiple leukemic stem cell markers is associated with poor prognosis in de novo acute myeloid leukemia.
Leuk Lymphoma 2018;59:2144-2151.
Miyamoto K, Nakashima T, Shima N, Kato S, Ueda K, Kawazoe Y, Ohta Y,
Morimoto T, Yamamura H; DESIRE trial investigators. Effect of dexmedetomidine on lactate clearance in patients with septic shock: A subanalysis of a multicenter randomized controlled trial.
Shock2018;50:162-166.
Watanabe H,
Morimoto T, Shiomi H, Yoshikawa Y, Kato T, Saito N, Shizuta S, Ono K, Yamaji K, Ando K, Kaji S, Furukawa Y, Akao M, Ishikawa T, Tamura T, Yamamoto Y, Muramatsu T, Suwa S, Nakagawa Y, Kadota K, Takatsu Y, Nishikawa H, Hiasa Y, Hayashi Y, Miyazaki S, Kimura T. Mortality impact of post-discharge myocardial infarction size after percutaneous coronary intervention: A patient-level pooled analysis from the 4 large-scale Japanese studies.
Cardiovasc Interv Ther 2018;34:47-58.
Higami H, Toyofuku M,
Morimoto T, Ohya M, Fuku Y, Yamaji K, Muranishi H, Yamaji Y, Nishida K, Furukawa D, Tada T, Ko E, Ando K, Sakamoto H, Tamura T, Kawai K, Kadota K, Kimura T; AOI LMCA stenting registry investigators. Impact of previous drug-eluting stent restenosis in non-left main coronary artery lesions on long-term outcomes after left main coronary artery stenting: An observation from the AOI-LMCA registry.
Cardiovasc Interv Ther 2018;33:350-359.
Watanabe H,
Morimoto T, Shiomi H, Kawaji T, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Kimura T; CREDO-Kyoto AMI investigators. Chronic total occlusion in non-infarct-related artery is associated with increased short-and long-term mortality in patients with ST-segment elevation acute myocardial infarction complicated by cardiogenic shock (from the CREDO-Kyoto AMI registry).
Catheter Cardiovasc Interv2018;92:455-463.
Watari J, Kobayashi M, Nakai K, Ito C, Tamura A, Ogawa T, Yamasaki T, Okugawa T, Kondo T, Kono T, Tozawa K, Tomita T, Oshima T, Fukui H,
Morimoto T, Miwa H. Objective image analysis of non-magnifying image-enhanced endoscopy for diagnosis of small depressed early gastric cancers.
Endosc Int Open2018;6:E1445-E1453.
Yamamura H, Kawazoe Y,
Morimoto T. Dexmedetomidine in patients with sepsis requiring mechanical ventilation.
JAMA2017;318:480.
Yoshimura S,
Uchida K, Daimon T, Takashima R, Kimura K,
*Morimoto T; ASSORT Trial Investigator. Randomized controlled trial of early versus delayed statin therapy in patients with acute ischemic stroke: ASSORT trial (administration of statin on acute ischemic stroke patient).
Stroke2017;48:3057-3063.
Kawazoe Y, Miyamoto K,
Morimoto T, Yamamoto T, Fuke A, Hashimoto A, Koami H, Beppu S, Katayama Y, Itoh M, Ohta Y, Yamamura H; Dexmedetomidine for Sepsis in Intensive Care Unit Randomized Evaluation (DESIRE) trial investigators. Effect of dexmedetomidine on mortality and ventilator-free days in patients requiring mechanical ventilation with sepsis: A randomized clinical trial.
JAMA2017;317:1321-1328.
Saito Y, Ogawa H,
Morimoto T. Response by Saito et al to letter regarding article, "Low-dose aspirin for primary prevention of cardiovascular events in patients with type 2 diabetes mellitus: 10-year follow-up of a randomized controlled trial".
Circulation2017;135:e1010-e1011.
Minamino-Muta E, Kato T,
Morimoto T, Taniguchi T, Shiomi H, Nakatsuma K, Shirai S, Ando K, Kanamori N, Murata K, Kitai T, Kawase Y, Miyake M, Izumi C, Mitsuoka H, Kato M, Hirano Y, Matsuda S, Nagao K, Inada T, Murakami T, Takeuchi Y, Yamane K, Toyofuku M, Ishii M, Inoko M, Ikeda T, Komasa A, Tada E, Ishii K, Hotta K, Higashitani N, Jinnai T, Kato Y, Inuzuka Y, Maeda C, Morikami Y, Saito N, Sakata R, Minatoya K, Kimura T. Causes of death in patients with severe aortic stenosis: An observational study.
Sci Rep2017;7:14723.
Michigami Y, Watari J, Ito C, Hara K, Yamasaki T, Kondo T, Kono T, Tozawa K, Tomita T, Oshima T, Fukui H,
Morimoto T, Das KM, Miwa H. Effects of long-term aspirin use on molecular alterations in precancerous gastric mucosa in patients with and without gastric cancer.
Sci Rep2017;7:13384.
Taniguchi T,
Morimoto T, Shiomi H, Ando K, Kanamori N, Murata K, Kitai T, Kawase Y, Izumi C, Miyake M, Mitsuoka H, Kato M, Hirano Y, Matsuda S, Inada T, Nagao K, Murakami T, Takeuchi Y, Yamane K, Toyofuku M, Ishii M, Minamino-Muta E, Kato T, Inoko M, Ikeda T, Komasa A, Ishii K, Hotta K, Higashitani N, Kato Y, Inuzuka Y, Maeda C, Jinnai T, Morikami Y, Saito N, Minatoya K, Kimura T; CURRENT AS registry investigators. High-versus low-gradient severe aortic stenosis: Demographics, clinical outcomes, and effects of the initial aortic valve replacement strategy on long-term prognosis.
Circ Cardiovasc Interv2017;10:e004796.
Nakatsuma K, Taniguchi T,
Morimoto T, Shiomi H, Ando K, Kanamori N, Murata K, Kitai T, Kawase Y, Izumi C, Miyake M, Mitsuoka H, Kato M, Hirano Y, Matsuda S, Inada T, Nagao K, Murakami T, Takeuchi Y, Yamane K, Toyofuku M, Ishii M, Minamino-Muta E, Kato T, Inoko M, Ikeda T, Komasa A, Ishii K, Hotta K, Higashitani N, Kato Y, Inuzuka Y, Maeda C, Jinnai T, Morikami Y, Saito N, Minatoya K, Kimura T; CURRENT AS registry investigators. Prognostic impact of peak aortic jet velocity in conservatively managed patients with severe aortic stenosis: An observation from the CURRENT AS registry.
J Am Heart Assoc 2017;6:e005524.
Kawase Y, Taniguchi T,
Morimoto T, Kadota K, Iwasaki K, Kuwayama A, Ohya M, Shimada T, Amano H, Maruo T, Fuku Y, Izumi C, Kitai T, Saito N, Minamino-Muta E, Kato T, Inada T, Inoko M, Ishii K, Komiya T, Hanyu M, Minatoya K, Kimura T; CURRENT AS registry investigators. Severe aortic stenosis in dialysis patients.
J Am Heart Assoc 2017;6:e004961.
Abe M,
Morimoto T, Nakagawa Y, Furukawa Y, Ono K, Kato T, Kadota K, Ando K, Ishii M, Masunaga N, Akao M, Kimura T. Impact of transient or persistent contrast-induced nephropathy on long-term mortality after elective percutaneous coronary intervention.
Am J Cardiol2017;120:2146-2153.
Taniguchi T, Shiomi H,
Morimoto T, Watanabe H, Ono K, Shizuta S, Kato T, Saito N, Kaji S, Ando K, Kadota K, Furukawa Y, Nakagawa Y, Horie M, Kimura T. Incidence and prognostic impact of heart failure hospitalization during follow-up after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction.
Am J Cardiol2017;119:1729-1739.
Kawaji T, Shizuta S,
Morimoto T, Aizawa T, Yamagami S, Yoshizawa T, Ota C, Onishi N, Sasaki Y, Yahata M, Nakai K, Hayano M, Nakao T, Hanazawa K, Goto K, Doi T, Ono K, Kimura T. Very long-term clinical outcomes after radiofrequency catheter ablation for atrial fibrillation: A large single-center experience.
Int J Cardiol2017;249:204-213.
Yamashita Y, Shiomi H,
Morimoto T, Yaku H, Kaji S, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Abe M, Akao M, Nagao K, Shizuta S, Ono K, Kimura T; CREDO-Kyoto AMI registry investigators. Transradial versus transfemoral approach in patients undergoing primary percutaneous coronary intervention for ST-elevation acute myocardial infarction: Insight from the CREDO-Kyoto AMI registry.
Heart Vessels2017;32:1448-1457.
Watanabe H,
Morimoto T, Shiomi H, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Kimura T. Chronic total occlusion in a non-infarct-related artery is closely associated with increased five-year mortality in patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention (From the CREDO-Kyoto AMI registry).
EuroIntervention2017;12:e1874-e1882.
Yamamoto E, Kato T, Ozasa N, Yaku H, Inuzuka Y, Tamaki Y, Kitai T,
Morimoto T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Kawashima T, Motohashi Y, Kawato M, Toyofuku M, Sato Y, Kuwahara K, Shioi T, Kimura T; KCHF study investigators. Kyoto congestive heart failure (KCHF) study: Rationale and design.
ESC Heart Fail2017;4:216-223.
Minamino-Muta E, Kato T,
Morimoto T, Taniguchi T, Inoko M, Haruna T, Izumi T, Miyamoto S, Nakane E, Sasaki K, Funasako M, Ueyama K, Shirai S, Kitai T, Izumi C, Nagao K, Inada T, Tada E, Komasa A, Ishii K, Saito N, Sakata R, Minatoya K, Kimura T. Impact of the left ventricular mass index on the outcomes of severe aortic stenosis.
Heart2017;103:1992-1999.
Toyota T, Shiomi H,
Morimoto T, Natsuaki M, Kimura T. Short versus prolonged dual antiplatelet therapy (DAPT) duration after coronary stent implantation: A comparison between the DAPT study and 9 other trials evaluating DAPT duration.
PLoS One2017;12:e0174502.
Fujimoto D,
Morimoto T, Ito J, Sato Y, Ito M, Teraoka S, Otsuka K, Nagata K, Nakagawa A, Tomii K. A pilot trial of nivolumab treatment for advanced non-small cell lung cancer patients with mild idiopathic interstitial pneumonia.
Lung Cancer2017;111:1-5.
Teraoka S, Fujimoto D,
Morimoto T, Kawachi H, Ito M, Sato Y, Nagata K, Nakagawa A, Otsuka K, Uehara K, Imai Y, Ishida K, Fukuoka J, Tomii K. Early immune-related adverse events and association with outcome in advanced non-small cell lung cancer patients treated with nivolumab: A prospective cohort study.
J Thorac Oncol2017;12:1798-1805.
Sato Y, Fujimoto D,
Morimoto T, Uehara K, Ito M, Teraoka S, Nagata K, Nakagawa A, Otsuka K, Sakanoue I, Hamakawa H, Takahashi Y, Imai Y, Tomii K. Natural history and clinical characteristics of multiple pulmonary nodules with ground glass opacity.
Respirology2017;22:1615-1621.
Nagai S, Kawai M, Myowa-Yamakoshi M,
Morimoto T, Matsukura T, Heike T. Gonadotropin levels in urine during early postnatal period in small for gestational age preterm male infants with fetal growth restriction.
J Perinatol2017;37:843-847.
Kogo M, Nagata K,
Morimoto T, Ito J, Sato Y, Teraoka S, Fujimoto D, Nakagawa A, Otsuka K, Tomii K. Enteral nutrition during noninvasive ventilation: We should go deeper in the investigation.
Respir Care2017;62:1119-1120.
Yamashita Y, Shiomi H,
Morimoto T, Yoneda T, Yamada C, Makiyama T, Kato T, Saito N, Shizuta S, Ono K, Kimura T. Asymptomatic lower extremity deep vein thrombosis: Clinical characteristics, management strategies, and long-term outcomes.
Circ J2017;81:1936-1944.
Shiomi H, Kosuge M,
Morimoto T, Watanabe H, Taniguchi T, Nakatsuma K, Toyota T, Yamamoto E, Shizuta S, Tada T, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Kimura K, Kimura T; CREDO-Kyoto AMI registry investigators. QRS score at presentation electrocardiogram is correlated with infarct size and mortality in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.
Circ J2017;81:1129-1136.
Toyofuku M, Taniguchi T,
Morimoto T, Yamaji K, Furukawa Y, Takahashi K, Tamura T, Shiomi H, Ando K, Kanamori N, Murata K, Kitai T, Kawase Y, Izumi C, Miyake M, Mitsuoka H, Kato M, Hirano Y, Matsuda S, Inada T, Murakami T, Takechi Y, Yamane K, Ishii M, Minamino-Muta E, Kato T, Inoko M, Ikeda T, Komasa A, Ishii K, Hotta K, Higashitani N, Kato Y, Inuzuka Y, Maeda C, Jinnai T, Morikami Y, Saito N, Minatoya K, Kimura T; CURRENT AS registry investigators. Sex differences in severe aortic stenosis. -Clinical presentation and mortality-
Circ J2017;81:1213-1221.
Kogo M, Nagata K,
Morimoto T, Ito J, Sato Y, Teraoka S, Fujimoto D, Nakagawa A, Otsuka K, Tomii K. Enteral nutrition is a risk factor for airway complications in subjects undergoing noninvasive ventilation for acute respiratory failure.
Respir Care2017;62:459-467.
Saito Y, Okada S, Ogawa H, Soejima H,
Sakuma M, Nakayama M, Doi N, Jinnouchi H, Waki M, Masuda I,
Morimoto T; JPAD Trial Investigators. Low-dose aspirin for primary prevention of cardiovascular events in patients with type 2 diabetes mellitus: 10-year follow-up of a randomized controlled trial.
Circulation2017;135:659-670.
Shiomi H,
Morimoto T, Kitaguchi S, Nakagawa Y, Ishii K, Haruna Y, Takamisawa I, Motooka M, Nakao K, Matsuda S, Mimoto S, Aoyama Y, Takeda T, Murata K, Akao M, Inada T, Eizawa H, Hyakuna E, Awano K, Shirotani M, Furukawa Y, Kadota K, Miyauchi K, Tanaka M, Noguchi Y, Nakamura S, Yasuda S, Miyazaki S, Daida H, Kimura K, Ikari Y, Hirayama H, Sumiyoshi T, Kimura T; ReACT investigators. The ReACT Trial: Randomized evaluation of routine follow-up coronary angiography after percutaneous coronary intervention trial.
JACC Cardiovasc Interv2017;10:109-117.
Toyota T,
Morimoto T, Shiomi H, Yoshikawa Y, Yaku H, Yamashita Y, Kimura T. Very late scaffold thrombosis of bioresorbable vascular scaffold: Systematic review and a meta-analysis.
JACC Cardiovasc Interv2017;10:27-37.
Yamashita Y, Shiomi H,
Morimoto T, Yaku H, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Abe M, Nagao K, Shizuta S, Ono K, Kimura T; CREDO-Kyoto AMI registry investigators. Cardiac and noncardiac causes of long-term mortality in ST-segment-elevation acute myocardial infarction patients who underwent primary percutaneous coronary intervention.
Circ Cardiovasc Qual Outcomes2017;10:e002790.
Yamaji K, Kohsaka S,
Morimoto T, Fujii K, Amano T, Uemura S, Akasaka T, Kadota K, Nakamura M, Kimura T; J-PCI registry investigators. Relation of ST-segment elevation myocardial infarction to daily ambient temperature and air pollutant levels in a Japanese nationwide percutaneous coronary intervention registry.
Am J Cardiol2017;119:872-880.
Morimoto T. Editor’s reply.
J Cardiol2017;69:896.
Vlachojannis GJ, Puricel S, Natsuaki M,
Morimoto T, Smits PC, Kimura T. Biolimus-eluting versus everolimus-eluting stents in coronary artery disease: A pooled analysis from the NEXT (NOBORI biolimus-eluting versus XIENCE/PROMUS everolimus-eluting stent) and COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent) randomised trials.
EuroIntervention2017;12:1970-1977.
Ohya M, Kadota K, Toyofuku M,
Morimoto T, Higami H, Fuku Y, Yamaji K, Muranishi H, Yamaji Y, Nishida K, Furukawa D, Tada T, Ko E, Ando K, Sakamoto H, Tamura T, Kawai K, Kimura T; AOI LMCA stenting registry investigators. Long-term outcomes after stent implantation for left main coronary artery (from the multicenter assessing optimal percutaneous coronary intervention for left main coronary artery stenting registry).
Am J Cardiol2017;119:355-364.
Nagao K, Tamura A,
Morimoto T, Shimamura K, Yukawa H, Ito H, Hayashi F, Makita T, Takemura G, Sato Y, Inada T, Kimura T, Tanaka M. Liver fibrogenesis marker, 7S domain of collagen type IV in patients with acutely decompensated heart failure: Correlates, prognostic value and time course.
Int J Cardiol2017;236:483-487.
Kitai T, Taniguchi T,
Morimoto T, Toyota T, Izumi C, Kaji S, Kim K, Saito N, Nagao K, Inada T, Minamino-Muta E, Kato T, Inoko M, Ishii K, Koyama T, Sakata R, Furukawa Y, Kimura T; CURRENT AS registry investigators. Different clinical outcomes in patients with asymptomatic severe aortic stenosis according to the stage classification: Does the aortic valve area matter?
Int J Cardiol2017;228:244-252.
Shirai S, Taniguchi T,
Morimoto T, Ando K, Korai K, Minakata K, Hanyu M, Yamazaki F, Koyama T, Komiya T, Kanamori N, Murata K, Kitai T, Kawase Y, Izumi C, Inada T, Minamino-Muta E, Kato T, Inoko M, Ishii K, Saito N, Yamanaka K, Nishiwaki N, Nakajima H, Saga T, Nakayama S, Sakaguchi G, Iwakura A, Shiraga K, Ueyama K, Fujiwara K, Miwa S, Nishizawa J, Kitano M, Kitayama H, Sakata R, Kimura T; CURRENT AS registry investigators. Five-year clinical outcome of asymptomatic vs. symptomatic severe aortic stenosis after aortic valve replacement.
Circ J2017;81:485-494.
Toyota T,
Morimoto T, Shiomi H, Ando K, Ono K, Shizuta S, Kato T, Saito N, Furukawa Y, Nakagawa Y, Horie M, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Ad hoc vs. non-ad hoc percutaneous coronary intervention strategies in patients with stable coronary artery disease.
Circ J2017;81:458-467.
Kawaji T, Shiomi H, Morishita H,
Morimoto T, Taylor CA, Kanao S, Koizumi K, Kozawa S, Morihiro K, Watanabe H, Tazaki J, Imai M, Saito N, Shizuta S, Ono K, Togashi K, Kimura T. Feasibility and diagnostic performance of fractional flow reserve measurement derived from coronary computed tomography angiography in real clinical practice.
Int J Cardiovasc Imaging2017;33:271-281.
Kusunoki T,
Takeuchi J,
Morimoto T,
Sakuma M, Yasumi T, Nishikomori R, Higashi A, Heike T. Fruit intake reduces the onset of respiratory allergic symptoms in schoolchildren.
Pediatr Allergy Immunol2017;28:793-800.
Taniguchi T,
Morimoto T, Sakata R, Kimura T. Reply: Is it time for a new paradigm in asymptomatic severe aortic stenosis?: Asymptomatic severe aortic stenosis: Oxymoron? A randomized trial in patients with asymptomatic severe aortic stenosis: A future has begun! Might outcome of patients with asymptomatic severe AS be improved by an initial surgical strategy?
J Am Coll Cardiol2016;67:1972-1973.
Yamaji K, Shiomi H,
Morimoto T, Nakatsuma K, Toyota T, Ono K, Furukawa Y, Nakagawa Y, Kadota K, Ando K, Shirai S, Onodera T, Watanabe H, Natsuaki M, Sakata R, Hanyu M, Nishiwaki N, Komiya T, Kimura T. Effects of age and sex on clinical outcomes after percutaneous coronary intervention relative to coronary artery bypass grafting in patients with triple-vessel coronary artery disease.
Circulation2016;133:1878-1891.
Kaitani K, Inoue K, Kobori A, Nakazawa Y, Ozawa T, Kurotobi T, Morishima I, Miura F, Watanabe T, Masuda M, Naito M, Fujimoto H, Nishida T, Furukawa Y, Shirayama T, Tanaka M, Okajima K, Yao T, Egami Y, Satomi K, Noda T, Miyamoto K, Haruna T, Kawaji T, Yoshizawa T, Toyota T, Yahata M, Nakai K, Sugiyama H, Higashi Y, Ito M, Horie M, Kusano KF, Shimizu W, Kamakura S,
Morimoto T, Kimura T, Shizuta S; EAST-AF Trial Investigator. Efficacy of Antiarrhythmic drugs Short-Term use after catheter ablation for Atrial Fibrillation (EAST-AF) trial.
Eur Heart J2016;37:610-618.
Shiomi H, Yamaji K,
Morimoto T, Shizuta S, Nakatsuma K, Higami H, Furukawa Y, Nakagawa Y, Kadota K, Ando K, Sakata R, Okabayashi H, Hanyu M, Shimamoto M, Nishiwaki N, Komiya T, Kimura T. Very long-term (10 to 14 year) outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for multivessel coronary artery disease in the bare-metal stent era.
Circ Cardiovasc Interv2016;9:e003365.
Fujimoto D, Kato R,
Morimoto T, Shimizu R, Sato Y, Kogo M, Ito J, Teraoka S, Nagata K, Nakagawa A, Otsuka K, Tomii K. Characteristics and prognostic impact of pneumonitis during systemic anti-cancer therapy in patients with advanced non-small-cell lung cancer.
PLoS One2016;11:e0168465.
Tanaka H, Morino Y, Abe M, Kimura T, Hayashi Y, Muramatsu T, Ochiai M, Noguchi Y, Kato K, Shibata Y, Hiasa Y, Doi O, Yamashita T,
Morimoto T, Hinohara T, Fujii T, Mitsudo K. Impact of J-CTO score on procedural outcome and target lesion revascularisation after percutaneous coronary intervention for chronic total occlusion: A substudy of the J-CTO Registry (Multicentre CTO Registry in Japan).
EuroIntervention2016;11:981-988.
Natsuaki M,
Morimoto T, Yamamoto E, Shiomi H, Furukawa Y, Abe M, Nakao K, Ishikawa T, Kawai K, Yunoki K, Shimizu S, Akao M, Miki S, Yamamoto M, Okada H, Hoshino K, Kadota K, Morino Y, Igarashi K, Tanabe K, Kozuma K, Kimura T. One-year outcome of a prospective trial stopping dual antiplatelet therapy at 3 months after everolimus-eluting cobalt-chromium stent implantation: ShortT and OPtimal duration of Dual AntiPlatelet Therapy after everolimus-eluting cobalt-chromium stent (STOPDAPT) trial.
Cardiovasc Interv Ther 2016;31:196-209.
Naito R, Miyauchi K, Daida H,
Morimoto T, Hiro T, Kimura T, Nakagawa Y, Yamagishi M, Ozaki Y, Matsuzaki M; JAPAN-ACS investigators. Impact of total risk management on coronary plaque regression in diabetic patients with acute coronary syndrome.
J Atheroscler Thromb2016;23:922-931.
Okada S,
Morimoto T, Ogawa H,
Sakuma M, Soejima H, Nakayama M, Jinnouchi H, Waki M, Akai Y, Ishii H, Saito Y; Investigators for the Japanese Primary Prevention of Atherosclerosis with Aspirin for Diabetes (JPAD) trial. Is long-term low-dose aspirin therapy associated with renal dysfunction in patients with type 2 diabetes? JPAD2 cohort study.
PLoS One2016;11:e0147635.
Kusunoki T,
Takeuchi J,
Morimoto T,
Sakuma M, Mukaida K, Yasumi T, Nishikomori R, Heike T. Sports activities enhance the prevalence of rhinitis symptoms in schoolchildren.
Pediatr Allergy Immunol2016;27:209-213.
Nakatsuma K, Shiomi H,
Morimoto T, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Yamamoto T, Suwa S, Horie M, Kimura T; CREDO-Kyoto AMI investigators. Inter-facility transfer vs. direct admission of patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention.
Circ J2016;80:1764-1772.
Taniguchi T, Shiomi H, Kosuge M,
Morimoto T, Nakatsuma K, Nishiga M, Sasa T, Saito N, Kimura T. Prognostic significance of ST-segment elevation in leads V₁-₂ in patients with severe aortic stenosis.
Circ J2016;80:526-534.
Nakatsuma K, Shiomi H,
Morimoto T, Ando K, Kadota K, Watanabe H, Taniguchi T, Yamamoto T, Furukawa Y, Nakagawa Y, Horie M, Kimura T; CREDO-Kyoto AMI registry investigators. Intravascular ultrasound guidance vs. angiographic guidance in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction - Long-term clinical outcomes from the CREDO-Kyoto AMI registry.
Circ J2016;80:477-484.
Toyota T, Shiomi H, Taniguchi T,
Morimoto T, Furukawa Y, Nakagawa Y, Horie M, Kimura T; CREDO-Kyoto AMI registry investigators. Culprit vessel-only vs. staged multivessel percutaneous coronary intervention strategies in patients with multivessel coronary artery disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Circ J2016;80:371-378.
Morimoto T, Crawford B, Wada K, Ueda S. Comparative efficacy and safety of novel oral anticoagulants in patients with atrial fibrillation: A network meta-analysis with the adjustment for the possible bias from open label studies.
J Cardiol2015;66:466-474.
Taniguchi T,
Morimoto T, Shiomi H, Ando K, Kanamori N, Murata K, Kitai T, Kawase Y, Izumi C, Miyake M, Mitsuoka H, Kato M, Hirano Y, Matsuda S, Nagao K, Inada T, Murakami T, Takeuchi Y, Yamane K, Toyofuku M, Ishii M, Minamino-Muta E, Kato T, Inoko M, Ikeda T, Komasa A, Ishii K, Hotta K, Higashitani N, Kato Y, Inuzuka Y, Maeda C, Jinnai T, Morikami Y, Sakata R, Kimura T; CURRENT AS Registry Investigators. Initial surgical versus conservative strategies in patients with asymptomatic severe aortic stenosis.
J Am Coll Cardiol2015;66:2827-2838.
Yamaji K, Shiomi H,
Morimoto T, Toyota T, Ono K, Furukawa Y, Nakagawa Y, Kadota K, Ando K, Shirai S, Kato M, Takatsu Y, Doi O, Kambara H, Suwa S, Onodera T, Watanabe H, Natsuaki M, Kimura T. Influence of sex on long-term outcomes after implantation of bare-metal stent: A multicenter report from the coronary revascularization demonstrating outcome study-Kyoto (CREDO-Kyoto) registry cohort-1.
Circulation2015;132:2323-2333.
Kobori A, Shizuta S, Inoue K, Kaitani K,
Morimoto T, Nakazawa Y, Ozawa T, Kurotobi T, Morishima I, Miura F, Watanabe T, Masuda M, Naito M, Fujimoto H, Nishida T, Furukawa Y, Shirayama T, Tanaka M, Okajima K, Yao T, Egami Y, Satomi K, Noda T, Miyamoto K, Haruna T, Kawaji T, Yoshizawa T, Toyota T, Yahata M, Nakai K, Sugiyama H, Higashi Y, Ito M, Horie M, Kusano KF, Shimizu W, Kamakura S, Kimura T; UNDER-ATP Trial Investigators. Adenosine triphosphate-guided pulmonary vein isolation for atrial fibrillation: The unmasking dormant electrical reconduction by adenosine triphosphate (UNDER-ATP) trial.
Eur Heart J2015;36:3276-3287.
Watanabe H,
Morimoto T, Natsuaki M, Furukawa Y, Nakagawa Y, Kadota K, Yamaji K, Ando K, Shizuta S, Shiomi H, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Tamura T, Shirotani M, Miki S, Matsuda M, Takahashi M, Ishii K, Tanaka M, Aoyama T, Doi O, Hattori R, Kato M, Suwa S, Takizawa A, Takatsu Y, Shinoda E, Eizawa H, Takeda T, Lee JD, Inoko M, Ogawa H, Hamasaki S, Horie M, Nohara R, Kambara H, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kastrati A, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Antiplatelet therapy discontinuation and the risk of serious cardiovascular events after coronary stenting: Observations from the CREDO-Kyoto registry cohort-2.
PLoS One2015;10:e0124314.
Natsuaki M, Kozuma K,
Morimoto T, Kadota K, Muramatsu T, Nakagawa Y, Akasaka T, Igarashi K, Tanabe K, Morino Y, Ishikawa T, Nishikawa H, Awata M, Abe M, Okada H, Takatsu Y, Ogata N, Kimura K, Urasawa K, Tarutani Y, Shiode N, Kimura T. Final 3-year outcome of a randomized trial comparing second-generation drug-eluting stents using either biodegradable polymer or durable polymer: NOBORI biolimus-eluting versus XIENCE/PROMUS everolimus-eluting stent trial.
Circ Cardiovasc Interv2015;8:e002817.
Fujimoto D, Shimizu R,
Morimoto T, Kato R, Sato Y, Kogo M, Ito J, Teraoka S, Otoshi T, Nagata K, Nakagawa A, Otsuka K, Katakami N, Tomii K. Analysis of advanced lung cancer patients diagnosed following emergency admission.
Eur Respir J2015;45:1098-1107.
Nagata K,
Morimoto T, Fujimoto D, Otoshi T, Nakagawa A, Otsuka K, Seo R, Atsumi T, Tomii K. Efficacy of high-flow nasal cannula therapy in acute hypoxemic respiratory failure: Decreased use of mechanical ventilation.
Respir Care2015;60:1390-1396.
Shiomi H,
Morimoto T, Furukawa Y, Nakagawa Y, Tazaki J, Sakata R, Okabayashi H, Hanyu M, Shimamoto M, Nishiwaki N, Komiya T, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-2 investigators. Comparison of five-year outcome of percutaneous coronary intervention with coronary artery bypass grafting in triple-vessel coronary artery disease (from the coronary revascularization demonstrating outcome study in Kyoto PCI/CABG registry cohort-2).
Am J Cardiol2015;116:59-65.
Toyota T, Shiomi H,
Morimoto T, Kimura T. Meta-analysis of long-term clinical outcomes of everolimus-eluting stents.
Am J Cardiol2015;116:187-194.
Yamaji K, Natsuaki M,
Morimoto T, Ono K, Furukawa Y, Nakagawa Y, Kadota K, Ando K, Shirai S, Watanabe H, Shiomi H, Kimura T. Long-term outcomes after coronary stent implantation in patients presenting with versus without acute myocardial infarction (an observation from coronary revascularization demonstrating outcome study-Kyoto registry cohort-2).
Am J Cardiol2015;116:15-23.
Yano M, Natsuaki M,
Morimoto T, Nakagawa Y, Kawai K, Miyazaki S, Muramatsu T, Shiode N, Namura M, Sone T, Oshima S, Nishikawa H, Hiasa Y, Hayashi Y, Nobuyoshi M, Mitsudo K, Kimura T; j-Cypher Registry Investigators. Antiplatelet therapy discontinuation and stent thrombosis after sirolimus-eluting stent implantation: Five-year outcome of the j-Cypher Registry.
Int J Cardiol2015;199:296-301.
Izuhara M, Ono K, Shiomi H,
Morimoto T, Furukawa Y, Nakagawa Y, Shizuta S, Tada T, Tazaki J, Horie T, Kuwabara Y, Baba O, Nishino T, Kita T, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-2 investigators. High-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after percutaneous coronary intervention: A report from the CREDO-Kyoto registry cohort-2.
Atherosclerosis2015;242:632-638.
Watanabe H, Shiomi H, Nakatsuma K,
Morimoto T, Taniguchi T, Furukawa Y, Nakagawa Y, Horie M, Kimura T; CREDO‐Kyoto AMI investigators. Clinical efficacy of thrombus aspiration on 5-year clinical outcomes in patients with ST-segment elevation acute myocardial infarction undergoing percutaneous coronary intervention.
J Am Heart Assoc2015;4:e001962.
Hashimoto M, Yamazaki T, Hamaguchi M,
Morimoto T, Yamori M, Asai K, Isobe Y, Furu M, Ito H, Fujii T, Terao C, Mori M, Matsuo T, Yoshitomi H, Yamamoto K, Yamamoto W, Bessho K, Mimori T. Periodontitis and porphyromonas gingivalis in preclinical stage of arthritis patients.
PLoS One2015;10:e0122121.
Hiejima E, Kawai T, Nakase H, Tsuruyama T,
Morimoto T, Yasumi T, Taga T, Kanegane H, Hori M, Ohmori K, Higuchi T, Matsuura M, Yoshino T, Ikeuchi H, Kawada K, Sakai Y, Kitazume MT, Hisamatsu T, Chiba T, Nishikomori R, Heike T. Reduced numbers and proapoptotic features of mucosal-associated invariant T cells as a characteristic finding in patients with inflammatory bowel disease.
Inflamm Bowel Dis2015;21:1529-1540.
Yamamoto T, Yagi S, Kinoshita H, Sakamoto Y, Okada K, Uryuhara K,
Morimoto T, Kaihara S, Hosotani R. Long-term survival after resection of pancreatic cancer: A single-center retrospective analysis.
World J Gastroenterol2015;21:262-268.
Kawaji T, Shiomi H,
Morimoto T, Nishikawa R, Yano M, Higami H, Tazaki J, Imai M, Saito N, Makiyama T, Shizuta S, Ono K, Kimura T. Noninvasive detection of functional myocardial ischemia: Multifunction cardiogram evaluation in diagnosis of functional coronary ischemia study (MED-FIT).
Ann Noninvasive Electrocardiol2015;20:446-453.
*Morimoto T. Investigating the quality of care in cardiovascular medicine.
Circ J2015;79:966-968.
Shiomi H,
Morimoto T, Furukawa Y, Nakagawa Y, Sakata R, Okabayashi H, Hanyu M, Shimamoto M, Nishiwaki N, Komiya T, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Comparison of percutaneous coronary intervention with coronary artery bypass grafting in unprotected left main coronary artery disease - 5-year outcome from CREDO-Kyoto PCI/CABG registry Cohort-2.
Circ J2015;79:1282-1289.
Kawaji T, Shiomi H,
Morimoto T, Tazaki J, Imai M, Saito N, Makiyama T, Shizuta S, Ono K, Kimura T. Clinical impact of left ventricular outflow tract obstruction in takotsubo cardiomyopathy.
Circ J2015;79:839-846.
Yamano S, Horii M, Takami T,
Sakuma M,
Morimoto T, Okada S, Taoka T, Kichikawa K, Sasamura H, Itoh H, Furuya Y, Ueno S, Imamura T, Sugiyama S, Ogawa H, Saito Y. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of stroke recurrence and longitudinal progression of white matter lesions and silent brain infarcts on MRI (CEREBRAL study): Rationale, design, and methodology.
Int J Stroke2015;10:452-456.
Ueda S,
Morimoto T, Ando S, Takishita S, Kawano Y, Shimamoto K, Ogihara T, Saruta T; DIME Investigators. A randomised controlled trial for the evaluation of risk for type 2 diabetes in hypertensive patients receiving thiazide diuretics: Diuretics In the Management of Essential hypertension (DIME) study.
BMJ Open2014;4:e004576.
Natsuaki M, Kozuma K,
Morimoto T, Shiomi H, Kimura T. Two-year outcome of a randomized trial comparing second-generation drug-eluting stents using biodegradable or durable polymer.
JAMA2014;311:2125-2127.
Natsuaki M,
Morimoto T, Furukawa Y, Shiomi H, Ono K, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators. Effect of statin therapy on cardiovascular outcomes after coronary revascularization in patients ≥ 80 years of age: Observations from the CREDO-Kyoto Registry Cohort-2.
Atherosclerosis2014;237:821-828.
Tokushige A, Shiomi H,
Morimoto T, Ono K, Furukawa Y, Nakagawa Y, Kadota K, Ando K, Shizuta S, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Hamasaki S, Ohishi M, Nakashima H, Mitsudo K, Nobuyoshi M, Kita T, Imoto Y, Sakata R, Okabayashi H, Hanyu M, Shimamoto M, Nishiwaki N, Komiya T, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators. Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: A report from the coronary revascularization demonstrating outcome study in Kyoto PCI/CABG registry cohort-2.
Circ Cardiovasc Interv2014;7:482-491.
Shiomi H, Kozuma K,
Morimoto T, Igarashi K, Kadota K, Tanabe K, Morino Y, Akasaka T, Abe M, Suwa S, Muramatsu T, Kobayashi M, Dai K, Nakao K, Uematsu M, Tarutani Y, Fujii K, Simonton CA, Kimura T; RESET Investigators. Long-term clinical outcomes after everolimus- and sirolimus-eluting coronary stent implantation: Final 3-year follow-up of the randomized evaluation of sirolimus-eluting versus everolimus-eluting stent trial.
Circ Cardiovasc Interv2014;7:343-354.
Natsuaki M,
Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Yamaji K, Ando K, Shizuta S, Shiomi H, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Tamura T, Shirotani M, Miki S, Matsuda M, Takahashi M, Ishii K, Tanaka M, Aoyama T, Doi O, Hattori R, Kato M, Suwa S, Takizawa A, Takatsu Y, Shinoda E, Eizawa H, Takeda T, Lee JD, Inoko M, Ogawa H, Hamasaki S, Horie M, Nohara R, Kambara H, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Late adverse events after implantation of sirolimus-eluting stent and bare-metal stent: Long-term (5-7 years) follow-up of the coronary revascularization demonstrating outcome study-Kyoto registry cohort-2.
Circ Cardiovasc Interv2014;7:168-179.
Abe M,
Morimoto T, Akao M, Furukawa Y, Nakagawa Y, Shizuta S, Ehara N, Taniguchi R, Doi T, Nishiyama K, Ozasa N, Saito N, Hoshino K, Mitsuoka H, Toma M, Tamura T, Haruna Y, Kita T, Kimura T. Relation of contrast-induced nephropathy to long-term mortality after percutaneous coronary intervention.
Am J Cardiol2014;114:362-368.
Taniguchi T, Shiomi H, Toyota T,
Morimoto T, Akao M, Nakatsuma K, Ono K, Makiyama T, Shizuta S, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Horie M, Kimura T. Effect of preinfarction angina pectoris on long-term survival in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention.
Am J Cardiol2014;114:1179-1186.
Nakatsuma K, Shiomi H, Watanabe H,
Morimoto T, Taniguchi T, Toyota T, Furukawa Y, Nakagawa Y, Horie M, Kimura T; CREDO-Kyoto AMI Investigators. Comparison of long-term mortality after acute myocardial infarction treated by percutaneous coronary intervention in patients living alone versus not living alone at the time of hospitalization.
Am J Cardiol2014;114:522-527.
Shiomi H,
Morimoto T, Makiyama T, Ono K, Furukawa Y, Nakagawa Y, Kadota K, Onodera T, Takatsu Y, Mitsudo K, Kita T, Sakata R, Okabayashi H, Hanyu M, Komiya T, Yamazaki F, Nishiwaki N, Kimura T; CREDO-Kyoto Investigators. Evolution in practice patterns and long-term outcomes of coronary revascularization from bare-metal stent era to drug-eluting stent era in Japan.
Am J Cardiol2014;113:1652-1659.
Goto K, Nakai K, Shizuta S,
Morimoto T, Shiomi H, Natsuaki M, Yahata M, Ota C, Ono K, Makiyama T, Nakagawa Y, Furukawa Y, Kadota K, Takatsu Y, Tamura T, Takizawa A, Inada T, Doi O, Nohara R, Matsuda M, Takeda T, Kato M, Shirotani M, Eizawa H, Ishii K, Lee JD, Takahashi M, Horie M, Takahashi M, Miki S, Aoyama T, Suwa S, Hamasaki S, Ogawa H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T; CREDO-Kyoto Registry Cohort-2 Investigators. Anticoagulant and antiplatelet therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
Am J Cardiol2014;114:70-78.
Tazaki J,
Morimoto T, Sakata R, Okabayashi H, Yamazaki F, Nishiwaki N, Mitsudo K, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Impact of statin therapy on patients with coronary heart disease and aortic aneurysm or dissection.
J Vasc Surg2014;60:604-612.
Kawaji T, Shiomi H,
Morimoto T, Tamura T, Nishikawa R, Yano M, Tazaki J, Imai M, Saito N, Makiyama T, Shizuta S, Ono K, Kimura T. Long-term efficacy and safety outcomes after unrestricted use of drug-eluting stents in patients with acute coronary syndrome: Mortality and major bleeding in a single-center registry.
Circ J2014;78:1628-1635.
Imai M, Kimura T,
Morimoto T, Saito N, Shiomi H, Kawaguchi R, Kan H, Mukawa H, Fujita H, Ishise T, Hayashi F, Nagao K, Take S, Taniguchi H, Sakamoto H, Yamane T, Shirota K, Tamekiyo H, Okamura T, Kishi K, Miyazaki S, Yamamoto S, Yamaji K, Kawasaki T, Taguchi E, Nakajima H, Kosedo I, Tada T, Kadota K, Mitsudo K. Impact of angiographic peri-stent contrast staining (PSS) on late adverse events after sirolimus-eluting stent implantation: An observation from the multicenter j-Cypher registry PSS substudy.
Cardiovasc Interv Ther 2014;29:226-236.
Ko E, Natsuaki M, Toyofuku M,
Morimoto T, Matsumura Y, Oi M, Motohashi Y, Takahashi K, Kawase Y, Tanaka M, Kitada M, Yuzuki Y, Tamura T, Inoue K, Mitsudo K, Kimura. Sirolimus-eluting stent implantation for ostial right coronary artery lesions: Five-year outcomes from the j-Cypher registry.
Cardiovasc Interv Ther 2014;29:200-208.
2. 日常診療の質に関する研究：
Inaba T,
Sakuma M,
Sakakibara F, Uchida K,
*Morimoto T. Quality-adjusted life years and costs of mechanical thrombectomy for very elderly patients with acute ischemic stroke.
Neurol Med Chir 2025;65:52-60.
Takahashi Y,
Morimoto T, Iekushi K, Arai H. A medical claims database study of factors associated with medication adherence and treatment persistence in patients receiving PCSK9 monoclonal antibodies.
J Atheroscler Thromb2025;32:163-175.
Bates DW,
Sakuma M.Improving medication safety in both adults and children: What will it take?
BMJ Qual Saf2024;33:619-621.
*Sakuma M,
Ohta Y,
Takeuchi J, Yuza Y, Ida H, Bates DW,
Morimoto T. Adverse events in pediatric inpatients: The Japan adverse event study.
JPatient Saf2024;20:38-44.
Nezu M, Greenfield D, Iqbal U,
*Morimoto T. Developing a patient-centered computerized clinical decision support system with patient-level outcome measures.
Int J Qual Health Care2024;7:36.
Yoshimatsu Y, Ohtake Y, Ukai M, Miyagami T,
Morikawa T, Shimamura Y, Kataoka Y, Hashimoto T. “Diagnose, Treat, and SUPPORT”. Clinical competencies in the management of older adults with aspiration pneumonia: a scoping review.
Eur Geriatr Med2024;15:57-66.
Nezu M,
Sakuma M, Nakamura T, Sonoyama T,
Matsumoto C,
Takeuchi J,
Ohta Y, Kosaka S,
*Morimoto T. Monitoring for adverse drug events of high-risk medications with a computerized clinical decision support system: A prospective cohort study.
Int J Qual Health Care2023;35:mzad095.
Ayani N, Oya N, Kitaoka R, Kuwahara A,
Morimoto T,
Sakuma M, Narumoto J. Epidemiology of adverse drug events and medication errors in four nursing homes in Japan: The Japan adverse drug events (JADE) study.
BMJ Qual Saf2022;31:878-887.
Morikawa T,
Sakuma M, Nakamura T, Sonoyama T,
Matsumoto C,
Takeuchi J, Ohta Y, Kosaka S,
*Morimoto T. Effectiveness of a computerized clinical decision support system for prevention of glucocorticoid-induced osteoporosis.
Sci Rep2022;12:14967.
Inoue M,
Takeuchi J,
Sakuma M, Nakamura T,
*Morimoto T. Low serum total protein at admission predicts in-hospital mortality among general inpatients: Historical cohort study.
Int J Gen Med2022;15:7941-7949.
Oya N, Ayani N, Kuwahara A, Kitaoka R, Omichi C,
Sakuma M,
Morimoto T, Narumoto J. Over half of falls were associated with psychotropic medication use in four nursing homes in Japan: A retrospective cohort study.
Int J Environ Res Public Health2022;19:3123.
*orimoto T,
Uchida K,
Sakakibara F, Kinjo N, Ueda S. Effect of concomitant antiplatelet therapy on ischemic and hemorrhagic events in patients taking oral anticoagulants for nonvalvular atrial fibrillation in daily clinical practice.
Pharmacoepidemiol Drug Saf2021;30:1321-1331.
Takeuchi J,
*Sakuma M, Ohta Y, Ida H,
Morimoto T. Differences in adverse drug events and medication errors among pediatric inpatients aged <3 and ≧3 years: The JADE study.
J Patient Saf Risk Manag2021;26:261-266.
Iwasaki H,
*Sakuma M, Ida H,
Morimoto T. The burden of preventable adverse drug events on hospital stay and healthcare costs in Japanese pediatric inpatients: The JADE study.
Clin Med Insights Pediatr2021;15:1179556521995833.
Ayani N,
Morimoto T,
Sakuma M, Kikuchi T, Watanabe K, Narumoto J. Antipsychotic polypharmacy is associated with adverse drug events in psychiatric inpatients: The Japan adverse drug events study.
J Clin Psychopharmacol2021;41:397-402.
Omichi C, Ayani N, Oya N, Matsumoto Y, Tanaka M,
Morimoto T, Kadotani H, Narumoto J. Association between discontinuation of benzodiazepine receptor agonists and post-operative delirium among inpatients with liaison intervention: A retrospective cohort study.
Compr Psychiatry2021;104:152216.
Takedani Y, Nakamura T, Fukiwake N, Imada T, Mashino J,
*Morimoto T. Clinical characteristics and factors related to antibiotic-associated diarrhea in elderly patients with pneumonia: A retrospective cohort study.
BMC Geriatr2021;21:317.
Wada R,
Takeuchi J, Nakamura T, Sonoyama T, Kosaka S,
Matsumoto C,
Sakuma M, Ohta Y,
*Morimoto T. Clinical decision support system with renal dose adjustment did not improve subsequent renal and hepatic function among inpatients: The Japan adverse drug event study.
Appl Clin Inform2020;11:846-856.
Sakuma M, Kanemoto Y, Furuse A, Bates DW,
*Morimoto T. Frequency and severity of adverse drug events by medication classes: The JADE study.
J Patient Saf2020;16:30-35.
Yamamoto M, Ohta Y,
Sakuma M,
Matsumoto C,
*Morimoto T. Adverse drug events due to central nervous system depressant drugs in pediatric patients with or without surgery.
J Pediatr Pharmacol Ther2020;25:295-302.
Higaonna M,
Morimoto T, Ueda S. Association between nursing care delivery models and patients’ health outcomes in a university hospital: A retrospective cohort study based on the diagnostic procedure combination database.
Jpn J Nurs Sci2020;17:e12319.
Yamamoto M, Ohta Y,
Sakuma M,
Takeuchi J,
Matsumoto C,
*Morimoto T. Association between heart rate on admission and in-hospital mortality among general inpatients: Insights from Japan adverse drug events (JADE) Study.
Medicine2019;98:e15165.
Higaonna M,
Morimoto T. Effect of the partnership nursing model on in-hospital mortality in Japan.
Ryukyu Med J2019;38:89-97.
Ohta Y, Miki I, Kimura T, Abe M,
Sakuma M, Koike K,
Morimoto T. Epidemiology of adverse events and medical errors in the care of cardiology patients.
J Patient Saf2019;15:251-256.
Takahashi Y,
Sakuma M, Murayama H,
*Morimoto T. Effect of baseline renal and hepatic function on the incidence of adverse drug events: The Japan adverse drug events (JADE) study.
Drug Metab Pers Ther2018;33:165-173.
Murayama H,
Sakuma M, Takahashi Y,
*Morimoto T. Improving the assessment of adverse drug reactions using the Naranjo algorithm in daily practice: The Japan adverse drug events (JADE) study.
Pharmacol Res Perspect2018;6:e00373.
Doi A,
Morimoto T, Iwata K. Shorter duration of antibiotic treatment for acute bacteraemic cholangitis with successful biliary drainage: A retrospective cohort study.
Clin Microbiol Infect2018;24:1184-1189.
Koizumi A, Ohta Y,
Sakuma M, Okamoto R,
Matsumoto C, Bates DW,
*Morimoto T. Differences in adverse drug events among pediatric patients with and without cancer: Sub-analysis of a retrospective cohort study.
Drugs Real World Outcomes2017;4:167-173.
Noguchi C,
Sakuma M, Ohta Y, Bates DW,
*Morimoto T. Prevention of medication errors in hospitalized patients: The Japan adverse drug events study.
Drug Saf2016;39:1129-1137.
Ayani N,
Sakuma M,
Morimoto T, Kikuchi T, Watanabe K, Narumoto J, Fukui K. The epidemiology of adverse drug events and medication errors among psychiatric inpatients in Japan: The JADE study.
BMC Psychiatry2016;16:303.
Yamamoto T,
Morimoto T, Kita R, Masui H, Kinoshita H, Sakamoto Y, Okada K, Komori J, Miki A, Kondo M, Uryuhara K, Kobayashi H, Hashida H, Kaihara S, Hosotani R. The preventive surgical site infection bundle in patients with colorectal perforation.
BMC Surg2015;15:128.
Morimoto T. Investigating quality of care in cardiovascular medicine.
Circ J2015;79:966-968.
Boeker EB, Ram K, Klopotowska JE, de Boer M, Creus MT, de Andrés AL,
Sakuma M,
Morimoto T, Boermeester MA, Dijkgraaf MG. An individual patient data meta-analysis on factors associated with adverse drug events in surgical and non-surgical inpatients.
Br J Clin Pharmacol2015;79:548-557.
Sakuma M, Ida H, Nakamura T, Ohta Y, Yamamoto K, Seki S, Hiroi K, Kikuchi K, Nakayama K, Bates DW,
Morimoto T. Adverse drug events and medication errors in Japanese pediatric inpatients: A retrospective cohort study.
BMJ Qual Saf2014;23:830-837.
Ohta Y,
Sakuma M, Koike K, Bates DW,
Morimoto T. Influence of adverse drug events on morbidity and mortality in intensive care units: The JADE study.
Int J Qual Health Care2014;26:573-578.
Khurelbat D, Dorj G, Bayarsaikhan E, Chimedsuren M, Sanjjav T,
Morimoto T, Morley M, Morley K. Prevalence estimates of substandard drugs in Mongolia using a random sample survey.
Springerplus2014;3:709.
3. 臨床推論・医学教育に関する研究：
Ohno M, Shiomi H, Baba O, Yano M, Aizawa T, Nakano-Matsumura Y, Yamagami S, Kato M, Ohya M, Chen PM, Nagao K, Ando K, Yokomatsu T, Kadota K, Kouchi I, Inada T, Valentine C, Kitagawa T, Kurokawa M, Ohtsuru S,
Morimoto T, Kimura T, Nishi E. Auxiliary roles of nardilysin in the early diagnosis of acute coronary syndrome: a prospective cohort study, the Nardi-ACS study.
Intern Emerg Med2024;19:649-659.
Higuchi H, Nakamura T, Mashino J, Imada T,
*Morimoto T. Prediction of ESBL-producing
E colifor suspected urinary tract infection.
Urologia2023;90:151-156.
Takeuchi J, Yanamoto Y, Sato Y, Ochiai R, Moriichi A, Ishizaki Y, Nakayama T. Efficacious interventions for improving the transition readiness of adolescents and young adult patients with chronic illness: A narrative review of randomized control trials assessed with the transition readiness assessment questionnaire (TRAQ).
Front Pediatr2022;10:983367.
Takeuchi J, Sakagami Y. Belief of safety and ethicality associated with agreement to electroconvulsive therapy among universities and other research institution employees.
Psychiatry and Clinical Neurosciences Reports2022;1:e40.
*Takeuchi J, Sakanishi Y, Okada T, Nakayama K, Chiba H, Suganaga R, Nishioka Y, Kishi T, Suzuki T. Factors associated between behavior of administrating or recommending mumps vaccine and primary care physicians’ knowledge about vaccination: A nationwide cross-sectional study in Japan.
J Gen Fam Med2022;23:9-18.
Takeuchi J, Sakagami Y. Association between autistic tendencies and mental health when studying abroad.
Pediatr Int2022; 64:e14724.
Takamura A,
*Morimoto T.Experience of receiving care by interns reduces psychological barrier of community residents to further care in Japan.
Rural Remote Health2018;18:4613.
Takeuchi J, Sakagami Y. Stigma among international students is associated with knowledge of mental illness.
Nagoya J Med Sci2018;80:367-378.
Fujii T, Matsuyama T,
Takeuchi J, Hara M, Kitamura T, Yamauchi-Takihara K. Women among first authors in Japanese cardiovascular journal.
Int Heart J2018;59:372-377.
*Takeuchi J, Sakagami Y, Perez RC. The mother and child health handbook in Japan as a health promotion tool: An overview of its history, contents, use, benefits, and global influence.
Glob Pediatr Health2016;3:1–9.
Yoshida C,
*Morimoto T.
Clinical problem solving: Sudden midnight upset syndrome?
J Gen Fam Med2015;16:131-137.
Takeuchi J, Goto M, Kawamura T, Hiraide A. Social regulations predispose people to complete vaccination for vaccine-preventable diseases.
Tohoku J Exp Med2014;234:183-187.
Murata K,
Sakuma M, Seki S,
*Morimoto T. Public attitudes toward practice by medical students: A nationwide survey in Japan.
Teach Learn Med2014;26:335-343.
4. 臨床研究の方法論に関する研究：
Sakuma M,
*Morimoto T. Patient-reported outcomes for quality of care among pediatric patients.
Int J Qual Health Care2023;35:mzad020.
*Takeuchi J, Kawamura T. Comparison among conventional multivariable analysis, proxy exposure analysis, and instrumental variable analysis: Effectiveness of two-or-more-dose vaccination for measles and rubella in university students.
Jpn J Infect Dis 2023;76:34-38.
Matsuzaki J, Takahashi S, Yamaguchi A, Wada K, Miyazaki J, Mugiya S, Matsuda T, Nutahara K, Seki S,
Morimoto T, Yamamoto S. Japanese linguistic validation of the ureteral stent symptoms questionnaire.
Int J Urol2022;29:332-336.
Uchida K, Kouno J, Yoshimura S, Kinjo N,
Sakakibara F, Araki H,
*Morimoto T. Development of machine learning models to predict probabilities and types of stroke at prehospital stage: The Japan urgent stroke triage score using machine learning (JUST-ML).
Transl Stroke Res2022;13:370-381.
*Takeuchi J, Noma H, Sakanishi Y, Kawamura T. Adverse events associated with human papillomavirus vaccines: A protocol for systematic review with network meta-analysis incorporating all randomised controlled trials comparing with placebo, adjuvants, and other vaccines.
BMJ Open2019;21;9:e026924.
Matsuyama M, Fujii T,
Takeuchi J, Hara M, and Kitamura T. Prevalence of randomized controlled trials in Japanese cardiovascular journals: A descriptive study.
Heart Asia2017;9:1-5.
5. 臨床研究スキルの教育に関する研究：
Nishimura R,
Takeuchi J,
Sakuma M, Higaonna M, Kinjo N,
Sakakibara F, Nakamura T, Kosaka S, Yoshimura S, Ueda S,
*Morimoto T.
Experience and awareness of research integrity among Japanese physicians: A nationwide cross-sectional study.
BMJ Open2021;11:e052351.
